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Mammalian kidney development was one of the sections in anatomy and embryology, 
which was the central medical discipline I learnt in the medical college. It offered me 
fundamental knowledge behind renal physiology and pathology to enable me better 
to manage the diverse clinical problems of nephrology. However, every time that I 
encounter patients with end stage renal disease, renal cancer or a congenital anomaly 
of the urinary system, I can only offer them medical services specified by current 
treatment guidelines. Unfortunately, even the most up-to-date treatment guidelines 
are a compromise between existing knowledge and the clinical facilities developed 
so far. In order to do something more than simply following treatment guidelines, I 
feel the key in extending the knowledge we have about diseases and hence improving 
the methods of treatment lies in basic medical research. Mammalian kidney 
development is central to the pathomechanisms of all three of these miserable 





Mammalian kidney development proceeds through a series of interactions among 
metanephric mesenchyme, ureteric bud, extracellular matrix, growth factors and 
various other signalling molecules.  These complex, but well integrated, networks 
control cell proliferation, differentiation, migration and survival and thus orchestrate 
kidney development. More and more molecules in these networks have been 
identified since the past few years. Therefore, it is crucial to explore their functions 
and the mechanisms by which they work to fill the research gaps. DACTs have 
recently been reported as pathway-specific regulators in WNT signalling, known to 
be important in kidney development, but their expressions and functions in 
mammalian kidneys are yet to be elucidated. The aims of this thesis are to describe 
the expression patterns of these two new genes, Dact1 and Dact2, in mouse 
embryonic kidneys and to further investigate their functional roles by applying RNAi 
to cell culture-based models. The first goal of this thesis is to establish the 
temporospatial expression patterns of Dact1 and Dact2 in kidneys by conventional 
end-point RT-PCR, quantitative real time PCR and RNA in situ hybridisation. Based 
on the expression patterns and preliminary observations in cell cultures, I 
hypothesize that Dact1 regulates cell proliferation while Dact2 governs cell 
migration. Experiments including siRNA transfection, BrdU proliferation assay, 
generation of stable cell lines expressing Dact2 shRNA and wound assay, are 
designed to test these hypotheses and the results may offer implications of functional 
roles of both molecules in kidney development. The results obtained are as follows. 
 
• Dact1 and Dact2 show different temporal expression patterns in mouse 
kidneys. In adult kidneys, Dact1 is greatly downregulated while Dact2 is still 
expressed at a comparable level to that at E14.5.  
• Dact1 is initially expressed in metanephric mesenchyme and, as development 
proceeds, shows a characteristic pattern of renal stroma whilst Dact2 is 
exclusively expressed in ureteric buds throughout embryonic stages. 
• Dact1 and Dact2 expressions are regulated by known regulators of kidney 




• Silencing of Dact1 facilitates proliferation of embryonic cells. 
• Silencing of Dact2 hinders migration of renal collecting duct cells. 
 
Taken together, I have characterised temporospatial expression patterns of Dact1 and 
Dact2 in kidneys and provided evidences of functional roles of both novel molecules 
in cell cultures. Based on this thesis, further studies on Dact1 and Dact2 using either 
in vitro or in vivo mammalian kidney models will offer more insights into their 




































There has been a growing body of research on kidney development since the 
nineteenth century. Mammalian kidney development can be approached from several 
angles such as anatomical structure, genetics, mechanisms, and signalling pathways. 
During the past two decades, more and more novel molecules in kidney development 
have been identified. The trend of research in this field is to move towards its 
molecular basis. Great efforts have been made to integrate these emerging results 
into a public online database, GUDMAP (The GenitoUrinary Development 
Molecular Anatomy Project), which can be found at the URL: 
http://www.gudmap.org/ (Little et al., 2007).  
 
This thesis is about two novel genes, Dact1 and Dact2, in mouse kidney 
development. The aim of this thesis is to characterise the expression patterns and the 
functional roles of these two genes in mouse kidney development. Therefore, as an 
introduction, I will present an overview of mammalian kidney development, describe 
its basic mechanisms including cell proliferation, differentiation, migration and 
survival, review crucial molecules and signalling pathways and finally introduce 
background knowledge of these two genes.  
 
1.2 Overview of mammalian kidney development 
 
During mammalian kidney development, three types of kidneys develop successively. 
They are the pronephros, mesonephros and the metanephros (Figure 1-1). All of 
them are derived from the intermediate mesoderm. The first two are transient 
structures while the metanephros eventually differentiates into the permanent kidney. 
The pronephros forms as early as embryonic day eight (E8) in the mouse and E22 in 
the human (O'Rahilly and Muecke, 1972; Saxen, 1987). The pronephric duct 
originates from the cranial region of the intermediate mesoderm just ventral to the 
somites. As the cells of this duct migrate caudally, the anterior portion of the duct 
induces the adjacent mesenchyme to form the pronephric tubules. The pronephros is 
characterised by its vascularised structure, the glomus, which filters waste into the 
 2
 
coelomic cavity. The pronephric tubules and most of the pronephric ducts degenerate 
but the caudal portion of the duct becomes part of the later excretory system and is 




Figure 1-1 Mammalian kidney development. (A) Kidney development starts from 
pronephros formation. (B) As nephric duct migrates caudally and induces 
mesonephric tubule formation, the pronephros degenerates. (C) The metanephros is 
induced by the ureteric bud originating from the outgrowth of the Wolffian duct 
(Modified from Gilbert, 2006). 
 
As the pronephric tubules degenerate, the middle portion of the nephric duct induces 
the presumptive mesonephric mesenchyme to condense and form a new set of 
tubules constituting the mesonephros (Saxen, 1987).  This process begins at E9 in the 
mouse and E24 in the human (O'Rahilly and Muecke, 1972; Saxen, 1987). 
Mammalian mesonephric nephrons consist of glomeruli-like structures and proximal 
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and distal tubules. In humans, mesonephric nephrons are functional excretory organs 
during embryogenesis whereas the murine mesonephros is a non-excretory organ 
(Smith and Mackay, 1991). As development proceeds, more tubules form caudally 
but the anterior ones degenerate through apoptosis. In female mammals, 
mesonephroi eventually disappear whilst in male mammals some of the mesonephric 
tubules remain and form the vas deferens and efferent ducts of the testes (Sainio, 
2003a; Saxen, 1987).  
 
The metanephros begins to form at E10.5 in the mouse and E32 of human gestation 
(O'Rahilly and Muecke, 1972; Saxen, 1987). At this stage an unbranched epithelial 
tube called the ureteric bud (UB) sprouts from the posterior end of the Wolffian duct 
at the level of the hindlimb.  The UB extends towards and invades a distinct region of 
the intermediate mesoderm called the metanephric mesenchyme. On invasion, 
reciprocal induction happens between these two primordia. The UB is induced to 
branch dichotomously and undergoes branching morphogenesis within the 
metanephric mesenchyme. The branching ureteric buds finally form a tree-like 
arrangement, which is the collecting system of the kidney. The tips of the branching 
tree send out inductive signals to the surrounding mesenchyme. Once induced, the 
metanephric mesenchyme condenses at the tips of the ureteric buds. These 
condensed mesenchymal cells then form cell aggregates and undergo mesenchyme-
to-epithelia transition (MET) to form renal vesicles, comma-shaped and S-shaped 
bodies. The S-shaped bodies will further differentiate and also they fuse with the 
ureteric bud-derived collecting ducts to form the nephrons, the functional units of the 
kidney (Bard, 2003; Saxen, 1987). This process is depicted in Figure 1-2. In addition 
to epithelisation, some mesenchymal cells die via apoptosis and others follow the 
fates of endothelial cells, smooth muscle cells, neuronal cells and renal stroma 





Figure 1-2 Development of metanephroi. The development of metanephros occurs 
from the reciprocal induction between the UB and the metanephric mesenchyme (A). 
As the development proceeds, some of the induced mesenchymal cells form the cap 
condensate at the UB tips (B) and turn into pretubular condensate (C), comma-
shaped body (D), and S-shaped body (E). The distal end of the S-shaped body fuses 
with the collecting duct (F) and the whole structure eventually differentiated into a a 
mature nephron (G) (Modified from Gilbert, 2006). 
 
This overview section has outlined the three phases of mammalian kidney 
development by describing their anatomical structures in a temporal sequence. The 
development of the three major compartments of the metanephric kidney (i.e. the UB, 
metanephric mesenchyme and renal stroma) is described in more detail in the 
following sections. Furthermore, as knowledge of kidney development has been 
greatly extended from anatomical structures into molecular bases over the last two 
decades, developmental biologists have been devoting much time to characterising 
expression of these molecules, exploring their functions and investigating the 




development. For the better understanding of key developmental events within and 
between each compartment, the following sections will describe them on a molecular 
level. This background knowledge is central to the study of new genes (i.e. Dact1 
and Dact2 in this thesis) that may play roles in these developmental events. 
 
1.2.1 UB development 
 
UB development consists of a series of developmental events. Anatomically, these 
events include the outgrowth of the UB from the Wolffian duct, the elongation of the 
UB and the iterative branching. Genetic studies and data from in vitro systems have 
offered great understanding into the functions of specific molecules in these events. 
The accumulating data from these studies have elucidated a delicate molecular 
network that underlies development. Table 1-1 summarises principal molecules 
involved in UB development. 
 
 
Table 1-1 Principal molecules involved in UB development 
 
Molecules  Function in UB development References  
GDNF/Ret/GFRα1 Induction of UB outgrowth from Wolffian duct and maintenance of 
UB branching 
(Cacalano et al., 1998; Moore et al., 1996; 
Pichel et al., 1996; Schuchardt et al., 1994) 
BMP2, BMP7 BMP2 and high doses of BMP7 inhibit branching whilst low doses 
of BMP7 simulate branching 
(Piscione et al., 1997) 
Activin A Inhibits branching (Ritvos et al., 1995) 
TGFβ Delays branching while allowing elongation (Bush et al., 2004; Ritvos et al., 1995) 
HGF Supports elongation ( but transgenic knockout is normal) (Davies et al., 1995; Uehara et al., 1995; 
Woolf et al., 1995) 
HSPG Required for branching and elongation (Davies et al., 1995) 
Integrins  Required for branching and elongation (Kreidberg et al., 1996; Muller et al., 1997) 
MMP9 Required elongation (but transgenic knockout is normal) (Andrews et al., 2000; Lelongt et al., 1997) 
MAP-kinase Positive regulator of branching; downstream of GDNF (Fisher et al., 2001) 
Protein kinase A Negative regulator of branching (Gupta et al., 1999) 






In parallel to studies on the molecular network, by analyzing the morphometric 
parameters, Cebrian et al. found that both the UB tip numbers and the branching 
events increased rapidly from E11.5 to E15.5 and then slowed down until birth 
(Cebrian et al., 2004). This would suggest that there may be distinct regulatory 
mechanisms for UB branching during different developmental stages. In addition, 
microarray data suggest that global gene expression patterns change in concert with 
specific developmental stages (Stuart et al., 2001; 2003). Therefore, as some 
investigators have suggested, the UB development can be considered as several 
discrete stages. These stages could be classified as the initial outgrowth of the UB 
(Stage I), early rapid branching (Stage II), late branching and maturation (Stage III) 
and branching termination (Stage IV)  (Figure 1-3) (Sampogna and Nigam, 2004; 
Shah et al., 2004). Although how many stages ought to be considered is still 
debatable (Monte et al., 2007), this staging system, together with studies that aim to 
define the functional roles of  specific molecules, (Table 1-1) help to  provide a 
deeper insight into factors that control UB development. 
 
 
Figure 1-3 Stages of UB development (Adapted from Sampogna and Nigam, 2004). 
 
In this staging system, stage I is characterised by the outgrowth of the UB from the 
Wolffian duct. Many genes required for this developmental event are linked to 
GDNF signalling. Examples include Eya1, Pax2, Hox11, Six1 and Sall1. Six1 and 
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Sall1 mutant embryos show reduced Gdnf expression and incomplete UB outgrowth 
(Nishinakamura et al., 2001; Xu et al., 2003). Embryos mutant for Eya1, Pax2 or 
Hox11 paralogous genes show loss of Gdnf expression and thus have no UB (Brophy 
et al., 2001; Wellik et al., 2002; Xu et al., 1999).  
 
Stage II is characterised by rapid branching of the ureteric buds. In this stage, factors 
that promote growth and branching are thought to be highly active. Stage III is the 
period when growth and branching are slowed down by predominantly inhibitory 
molecules that offer negative feedback information. Principal molecules involved in 
stage II and III are summarised in Table 1-1 and depicted in Figure 1-4. In addition 
to these molecules, a wealth of genes has been reported to control the iterative 
branching and elongation and is reviewed comprehensively elsewhere (Shah et al., 
2004). Finally, in stage IV when the ureteric tree reaches certain size and maturity, 
branching is terminated probably by the inhibitory molecules such as TGFβ (Bush et 





Figure 1-4 Factors involved in UB development. At stage I, genes that regulate the 
expression of GDNF are required for the UB outgrowth. GDNF binds to the 
Ret/Gfrα1 receptor complex to stimulate this developmental event. During stage II-
III, many molecules and pathways are involved. Branch-stimulating factors (green) 
favour a feed-forward iterative branching state (stage II); increasing expression of 
branching inhibitors (red) slows down branching via negative-feedback mechanisms
(stage III). Signals to stop branching at stage IV are yet to be defined. Some 




1.2.2 Nephron induction and differentiation 
 
The metanephric mesenchyme consists of numerous morphologically similar cells 
which show different gene expression patterns and may eventually follow different 
fates to form secretory nephrons, endothelial cells, juxtaglomerular complex, 
vascular smooth muscle cells, neuronal cells and embryonic renal stroma (Sariola et 
al., 2003b). When the UB invades the metanephric mesenchyme, it sends out 
inductive signals to the surrounding mesenchyme. In response to these inductive 
signals, a subset of mesenchymal cells condenses, undergoes MET and eventually 
differentiates into nephrons following an intrinsic differentiation programme in the 
metanephric mesenchyme. The induction and differentiation of nephrons happen 
repeatedly throughout the whole process of metanephric kidney development and 
eventually generate adequate number of nephrons, which is about 1600 nephrons in 
newborn mice (Yuan et al., 2000).  
 
As research in kidney development has progressed into a molecular level, a key 
question about nephron induction is what these inductive signals are. One strategy to 
find the inductive molecules is to culture the metanephric mesenchyme together with 
cells expressing various WNT proteins or other potential inducers and look for 
nephron formation (details of WNT signalling is described in section 1.4.1). 
Combined data from these cellular assays with Wnt genes’ expression patterns in 
developing kidneys have identified WNT6 and WNT9b as probable inducers (Carroll 
et al., 2005; Itaranta et al., 2002; Kispert et al., 1998). Another strategy is to purify 
factors from rat UB cell lines. This approach identifies a cocktail of factors including 
leukaemia inhibitory factor (LIF), TGFβ2, TGFα, and fibroblast growth factor 2 
(FGF2) (Barasch et al., 1999; Karavanova et al., 1996; Plisov et al., 2001). A new 
strategy is built on microarray analysis to find out UB tip-derived secreted molecules. 
This method led to the discovery of CLF-1, which is capable of inducing nephron 





In addition to the inductive signals, nephron induction also relies on many genes 
expressed by the mesenchyme including Pax2, Wt1 and Six1. Metanephric 
mesenchyme mutant for Pax2, Wt1, or Six1 completely fail to form nephrons in 
tissue recombination experiments (Brophy et al., 2001; Donovan et al., 1999; Xu et 




Figure 1-5 Nephron development. Schematic diagram outlines the process of 
nephron development. Nephron induction (A) depends on inductive signals and 
several mesenchymal genes. Once induced, cells begin to show signs of epithelial 
polarisation and form the renal vesicle (B). The polarised renal vesicle elongates and 
forms the S-shaped body (C). At the stage of elaboration (D), endothelial cells 
infiltrate the distal end of the S-shaped body. Finally, segmentation occurs along the 
proximal-distal axis of tubular epithelia (E) (Adapted from Cho and Dressler, 2003).
 
Once induced, the metanephrogenic mesenchymal cells undergo MET and eventually 
differentiate into nephrons. This process consists of several developmental events 
including polarisation, epithelisation, elaboration and segmentation of the nephron 
(Figure 1-5). By changing cell adhesion properties, cells are able to aggregate around 
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the ureteric bud tips. These cell aggregates proliferate and begin to show signs of 
epithelial cell polarity. They begin to express proteins associated with adherens and 
tight junctions, adopt a more columnar shape, and form a small lumen. The whole 
structure at this stage is called a renal vesicle. An epithelial basement membrane is 
then laid down around the growing vesicle, which remains associated with the UB 
epithelia. The vesicle develops clefts and changes into comma- and S-shaped bodies. 
By the S-shaped body stage, the distal end of the developing nephron has fused to the 
epithelium of the collecting duct to form a continuous lumen. Factors that drive MET 
include those that control cell aggregation and adhesion and cell-matrix interactions. 
For example, in kidney organ culture, the exogenous Fab fragment of antibody 
against cadherin6 inhibits cell adhesion and thus blocks the formation of comma- and 
S-shaped bodies (Cho et al., 1998). At the stage of S-shaped body, its distal end is 
invaded by endothelial precursor cells. As the nephron develops further, 
segmentation occurs along the proximal-distal axis of tubular epithelia. This is 
demonstrated by segment-specific gene expression of cadherins, integrins and 
laminins (Cho and Dressler, 2003). The factors controlling nephron segmentation 
probably include the regional expression of transcriptional factors (e.g. Lim1 and 
Brn1) along this axis and the Notch signalling pathway (Cheng et al., 2007; 
Kobayashi et al., 2005; Nakai et al., 2003). 
 
1.2.3 Development of renal stroma 
 
When the mesenchymal cells around the ureteric tip condense, some subsets of 
mesenchymal cells adopt the fate of forming the renal stroma. The condensed cap 
mesenchymal cells express Pax2 and finally differentiate into nephrons. By E11, a 
region peripheral to the condensed cap mesenchyme forms as a looser domain of 
cells. These cells express Foxd1 and are presumptive stromal progenitor cells (Hatini 
et al., 1996). By E12-13, in addition to the stromal progenitor cells which are located 
in the nephrogenic zone, stromal cells surround the epithelial components of the 
developing kidney. These stromal cells are characterised by their large fibroblastic 
spindle shape with clear cytoplasm and are referred to as the primary interstitium 
(Sariola et al., 2003a). Primary interstitial cells express the cell surface glycolipid 
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GD3 (Sariola et al., 1988), Tenascin C (Tnc) (Ekblom and Weller, 1991) and Foxd1 
(Hatini et al., 1996).  By E14, stromal cells are grouped into the cortical and 
medullary stroma (Cullen-McEwen et al., 2005). Both groups of stromal cells 
comprise the secondary interstitium. Stromal cells in these two groups show distinct 
gene expression patterns. For example, Rarb2 is expressed in both groups of stromal 
cells whilst Foxd1 is expressed predominantly in cortical stroma (Mendelsohn et al., 
1999). By birth, many of the medullary stromal cells have regressed by apoptosis 
(Coles et al., 1993). When growth and differentiation of the kidney is complete, the 
primary interstitium differentiates into adult interstitium.  
 
Renal stromal cells synthesize and secrete extracellular matrix (ECM) to offer a 
structural support to developing ureteric buds and nephrons. They also play active 
roles in UB branching and nephrogenesis. Targeted mutation in stromal genes Foxd1 
(Hatini et al., 1996), Pod1 (Quaggin et al., 1999) or Pbx1 (Schnabel et al., 2003) 
generates similar kidney phenotypes which exhibit defects in stromal cells, failure to 
expand the condensing mesenchymal cells around the tips and impaired branching. 
Another important stromal signal that regulates branching morphogenesis and 
nephrogenesis is the interplay between retinoids and Ret. This pathway will be 
described in section 1.4.4. 
 
1.3 Mechanisms that underlie kidney development 
 
Branching morphogenesis, nephrogenesis and stromal development are 
accomplished by well-controlled cellular proliferation, differentiation, migration and 
death.  Deregulation of these mechanisms in the developing kidney causes diverse 
malformations including hypoplasia, dysplsia and agenesis (Woolf and Welham, 
2002). This section reviews literature on these four fundamental mechanisms in each 
compartment of the developing kidney. It covers known signalling factors, growth 
factors and molecules responsible for these four key mechanisms in the developing 
kidneys because they are likely to be the components with which the genes studied in 
this thesis (Dact1 and Dact2) interact. This review is crucial to the exploration of 
gene functions when using conventional two-dimensional (2D) cell culture and 
 13
 
advanced cell culture-based model for kidney development. Biological functions of 





Proliferation is a simple engine of morphogenetic change and is a key mechanism for 
normal kidney development. BrdU incorporation assay has demonstrated that there is 
considerable proliferation throughout the developing mouse kidney, especially in the 
nephrogenic zone locating at the periphery of the developing kidney (Coles et al., 
1993). Mesenchymal cells in this zone have to proliferate to expand the whole 
nephrogenic zone outwards while receiving signals from the invading ureteric buds. 
The expansion of the mesenchymal population is controlled at least in part by BMP4 
which is made by developing tubules and stroma (Miyazaki et al., 2000). In this way, 
the more mesenchymal cells differentiate into developing nephrons, the more BMP4 
is produced, which in turn signals to the remaining mesenchyme to proliferate so that 
the nephrogenic mesenchyme will not be exhausted (Davies and Fisher, 2002).  
 
In the branching ureteric buds, cell proliferation is responsible for branching and 
elongation of the buds. Michael and Davies identified a high proliferation zone in the 
very tips of the branching epithelium and found it present at UB tips only when they 
are undergoing active morphogenesis (Michael and Davies, 2004). Stromal cells also 
regulate the normal growth control of both metanephric mesenchyme and ureteric 
buds. In mice lacking Foxd1, which is only expressed in the renal stroma, reduced 
growth and branching of the ureteric buds are noted. The Foxd1 knockout mice also 
show that the condensed mesenchyme stops epithelialising but grows to a large size 
(Hatini et al., 1996). The developmental implications of this phenotype remain 
unclear, but suggest that rapid growth is inhibited in the early stages of 
nephrogenesis. Another example of stroma derived factor is FGF7. In FGF7 null 
mice, the size of the collecting system is reduced. Exogenous FGF7 is able to 
increase the cell number of the UB in organ culture (Qiao et al., 1999). Many 
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molecules have been found to regulate cell proliferation in developing kidneys. 
Examples are listed in Table 1-2.  
 
Table 1-2 Examples of molecules controlling cell proliferation in developing 
kidneys.  
Molecules Functions References 
FGF7 cell proliferation within collecting duct 
system 
(Qiao et al., 1999) 
GDNF ureteric bud cell proliferation (Pepicelli et al., 1997; 
Sanchez et al., 1996) 
VEGF endothelial cell proliferation and 
differentiation 
(Kitamoto et al., 1997; 
Tufro, 2000) 
PDGF-B mesangial cell proliferation and 
differentiation 
(Lindahl et al., 1998; 
Wagner et al., 2007) 
Notch2 mesangial cell proliferation and 
migration, endothelial migration 
(McCright et al., 2001) 
IGF I/II cell proliferation in many compartments 
of developing kidneys 
(Lindenbergh-Kortleve et 
al., 1997; Liu et al., 1997) 
RA cell proliferation in many compartments 
of developing kidneys including stroma 
(Batourina et al., 2001; 
Mendelsohn et al., 1999) 
Glypican-3 inhibit cell proliferation in many 
compartments of developing kidneys 
(Cano-Gauci et al., 1999) 
N-myc cell proliferation in metanephric 
mesenchyme and ureteric bud 
(Bates et al., 2000) 
 
1.3.2 Cell survival 
 
In addition to proliferation, normal kidney development requires a strict control of 
programmed cell death through apoptosis (Coles et al., 1993). Increased apoptosis 
may result in polycystic and dysplastic kidney diseases (Veis et al., 1993; Winyard et 
al., 1996). Apoptosis occurs in all the three compartments of the developing kidney. 
One of the first tasks of the UB invasion is to send out signals to rescue the 
surrounding mesenchyme from apoptosis. One of these UB-derived molecules is 
FGF2 as it is able to promote survival of isolated mesenchyme in culture (Barasch et 
al., 1997). In early nephrogenesis, cells on the borders of mesenchymal aggregates 
show a high rate of apoptosis. This process may limit the number of cells being 
incorporated into nascent nephrons (Coles et al., 1993). Apoptosis in the UB is 
mediated at least in part by BMP2 because BMP2 has been shown to promote 
apoptosis in the UB in kidney organ culture system (Gupta et al., 1999). Apoptosis 
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also happens in the stroma cells of the medulla towards the end of development 
(Koseki et al., 1992). Cell loss in this area is to generate space for the extension of 
the Henle’s loop and blood vessels (Bard, 2002; Loughna et al., 1996). Several 
molecules have been reported to regulate apoptosis in developing kidneys. I have 
summarised a list of examples (Table 1-3). In addition to these molecules, however, 
environmental factor such as maternal diet has recently been suggested an important 
factor controlling apoptosis of metanephric progenitor cells at stages glomeruli have 
yet to form (Welham et al., 2005). 
 
Table 1-3 Examples of molecules controlling apoptosis in developing kidneys. 
 
Molecules Functions References 
FGF2 Promote mesenchymal cell survival and 
lead to differentiation 
(Barasch et al., 1997; 
Perantoni et al., 1995) 
EGF receptor 
and ligands 
Prevent apoptosis in cultured 
metanephric mesenchyme without 
leading to differentiation 
(Koseki et al., 1992; 
Weller et al., 1991) 
BMP2 Promote apoptosis in the UB (Gupta et al., 1999) 
BMP4 Prevent apoptosis in cultured 
metanephric mesenchyme without 
leading to differentiation 
(Miyazaki et al., 2003) 
BMP7 Prevent apoptosis in cultured 
metanephric mesenchyme without 
leading to differentiation 
(Dudley et al., 1999) 
Bcl2 Protect cells from apoptosis in all 
compartments of the developing 
kidneys but mainly in the mesenchyme 
(Nagata et al., 1996; 
Sorenson et al., 1995) 
AP-2β Protect cells of distal tubules and 
collecting ducts from apoptosis 
(Moser et al., 1997) 
Pax2 Protect UB cells from apoptosis (Porteous et al., 2000; 




Cell migration is an important mechanism for kidney morphogenesis. To date, 
research on cell migration in developing kidneys have focused on nephrogenesis and 
the branching morphogenesis. In early nephrogenesis, mesenchymal cells migrate 
and aggregate in response to signals emanating from the UB tips. This process is 
followed by the condensation of the mesenchymal cells at the UB tips. Signalling by 
 16
 
Rho-GTPase via ROCK has been reported to reduce the migratory activity of the 
mesenchymal cells at this early stage (Meyer et al., 2006). WNT signalling seems to 
control the appropriate size of mesenchymal condensates. On receiving signals from 
the UB tips, mesenchymal cells start to secrete WNT4 as they condense. When the 
local concentration of WNT4 is high enough to cross the threshold, it will drive the 
mesenchymal cells to undergo MET. This idea is supported by the Wnt4 knockout 
phenotype in which cells migrate and aggregate while waiting for a cross-threshold 
WNT4 level that can never be achieved in these mice and therefore form large, 
diffuse groups of mesenchymal cells (Stark et al., 1994). On the contrary, treating the 
mesenchyme with lithium ions, which activate the WNT/β-catenin canonical 
pathway, seems to mimic enough WNT signals and force the cells undergo MET 
earlier. This can explain why lithium treatment results in the formation of small 
nephrons that have abnormally few cells (Davies and Garrod, 1995). sFRP1 is an 
inhibitor of WNT signalling and is secreted by stromal cells. Mesenchymal cells 
away from a forming condensate may use sFRP1 to antagonise WNT4 that diffuses 
from the condensate (Davies, 2005).  
 
At the stage of comma- and S-shaped bodies, the epithelial cell adhesion molecule 
(EpCAM) is expressed by these structures (Trzpis et al., 2007). Although the 
function of EpCAM in nephrogenesis is yet to be determined, it is able to modulate 
migration in breast epithelial cell lines (Osta et al., 2004). In late nephrogenesis, 
platelet-derived growth factor (PDGF) B-chain has been shown to act in a paracrine 
fashion to stimulate the migration of mesangial cell precursors from metanephric 
mesenchyme to the mesangial area (Arar et al., 2000).  
 
In branching morphogenesis, when the UB invades the mesenchyme, UB cells 
proliferate and migrate to generate an ampullae that branches to form new buds. 
These processes of proliferation, migration and branching repeat for several times 
and eventually generate a complex arborised epithelial tree. The pattern of 
arborisation depends on positive regulators to promote proliferation and migration 
and negative regulators to inhibit excessive budding and bifurcation. One insightful 
study to show the extensive cell migration within the branching ureteric buds has 
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been performed by using time-lapse imaging of Hoxb7-GFP kidneys in organ culture 
(Shakya et al., 2005). However, the mechanisms underlying this cell migration 
within the ureteric buds are yet to be determined. 
 
To further investigate the intracellular mechanism regulating UB cell migration and 
branching morphogenesis, most research is carried out using cell culture based 
models. Commonly-used approaches include migration assays and three-dimensional 
(3D) matrices. By using these approaches, the GDNF/Ret pathway has been found to 
be required for migration of MDCK cells through a chemotactic mechanism (Tang et 
al., 1998). This GDNF/Ret-mediated chemotaxis is suppressed by PTEN, which 
antagonises a downstream effector, phosphatidylinositol 3-kinase (PI3K) (Kim and 
Dressler, 2007). Protein kinase X (PRKX) stimulates epithelial branching 
morphogenesis by activating cAMP-dependent collecting duct cell migration (Li et 
al., 2005). H-Ras, expressed in the collecting systems of the late embryonic kidneys 
from E17.5, is shown to encourage cell migration and generation of elongated 




Cell differentiation occurs in every compartment and stage of the developing kidneys. 
During differentiation, numerous aspects of cell physiology including shape, polarity 
and responsiveness to signals will change and the differentiated cells finally develop 
specific structures and may have specific functions. When the reciprocal induction 
between the UB and the metanephric mesenchyme starts, the mesenchymal cells will 
differentiate and eventually turn into mature nephrons, stroma, endothelial cells and 
neuronal cells (Sariola et al., 2003a). The process of nephron differentiation has been 
reviewed in section 1.2.2. UB cells will develop into different types of specialised 
cells. For example, UB tip cells express Wnt11 (Kispert et al., 1996) and Ret 
(Pachnis et al., 1993) whereas non-tip cells do not. At later stages, collecting duct 
cells differentiate into a major population of ‘principal’ cells and a minor population 
of ‘intercalated’ cells. Principal cells are characterised by a single cilium and round 
mitochondria and are able to recover sodium from urine and secrete potassium. 
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Intercalated cells have copious microvilli and large mitochondria and are responsible 
for acid/base balance. The zone of differentiation into these specific cell types lies a 
short distance behind the ampullary tip of the developing collecting duct (Davies, 
2003). Cell differentiation in developing kidneys has been comprehensively 
reviewed elsewhere (Davies, 2006; Ribes et al., 2003; Sariola et al., 2003a). The 
accumulating molecular data for the differentiation of the developing genitourinary 
system can be found at the online database GUDMAP (Little et al., 2007). 
Reviewing the literature on cell differentiation in detail is beyond the scope of this 
thesis because the work involved in my PhD only touches briefly in the area of cell 
differentiation in developing kidneys. Nevertheless, the genes studied in this thesis 
might have undiscovered functional roles in cell differentiation within the developing 
kidneys. 
 
1.4 Key molecules in kidney development 
 
When describing developmental events (section 1.2) or the cellular mechanisms 
(section 1.3) of developing kidneys, I have already mentioned some molecules 
important in those processes. The details of the interactions between these key 
molecules in kidney development have been comprehensively reviewed in the 
literature (Davies and Fisher, 2002). Also a growing list of genes and proteins in 
kidney development can be found at the GUDMAP database (Little et al., 2007). 
Some signalling pathways and crucial molecules that are highly relevant to Dact1 
and Dact2 have been reported in different developmental contexts. Interestingly, 
these signalling and molecules are indeed critical in kidney development and 
therefore are reviewed in detail in this section. Once the developmental events and/or 
cellular mechanisms modulated by Dact1 or Dact2 are identified, this review may 




1.4.1 WNT signalling molecules 
 
WNT proteins comprise a large family of secreted glycoproteins that are responsible 
for the development of many organs including the kidneys. WNT proteins initiate 
several distinct signalling pathways, which can be classified into β-catenin-
dependent (canonical) and β-catenin-independent (non-canonical) pathways. The 
non-canonical pathways include diverse pathways that are yet to be fully 
characterised. As Dact genes have been implicated in the canonical WNT/β-catenin 
pathway in the current literature, it is worth reviewing this pathway (Figure 1-6). In 
the cytoplasm, the tumour suppressors adenomatous polyposis coli (APC), Axin, 
casein kinase I (CKI) and glycogen synthase kinase 3 (GSK3) constitute a protein 
complex termed destruction complex. In the absence of WNT ligands, APC and Axin 
within the destruction complex will bind to the newly synthesised β-catenin. CKI and 
GSK3 will phosphorylate β-catenin. The phosphorylated β-catenin will recruit a β-
TrCP containing E3 ubiquitin ligase leading to its degradation by proteasome. The 
canonical signalling is initiated when WNT ligands bind to their cognate receptor 
complex, consisting of a serpentine receptor of the Frizzled family and a member of 
the LDL receptor family, LRP5/6. The binding of WNT ligands to receptors inhibits 
the kinase activity of the destruction complex. Consequently, β-catenin accumulates 
in the cytoplasm and translocates into the nucleus where it binds to DNA-binding 
proteins of the TCF/LEF family and converts them into transcriptional activators 
(Gordon and Nusse, 2006; Reya and Clevers, 2005).  
 
Key intermediates that determine which WNT pathway is used in a given 
developmental context are the Dishevelled (DSH or DVL in mammals) proteins and 
their associated proteins (Wharton, 2003). DVL proteins have three highly conserved 
domains which contribute to signalling: an amino terminal DIX domain, a central 
PDZ domain and a carboxyl terminal DEP domain (Boutros and Mlodzik, 1999; 
Semenov and Snyder, 1997). A growing body of DVL-associated proteins has been 
identified. Each of these binds to one of the conserved domains of DVL and activates 
a downstream signalling cascade (Wharton, 2003). DACT has been reported to bind 
directly to the PDZ domain of the DVL (Cheyette et al., 2002). DACT may be thus 
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Figure 1-6 The canonical WNT/β-catenin pathway. In the absence of WNT ligand 
or when it binds to its inhibitor (i.e. sFRP) (a) the newly synthesized β-catenin is 
removed by the GSK3-APC-AXIN destruction protein complex via ubiquitin-
mediated proteolysis whereas when WNT engages its receptor complex (i.e.
Frizzled-LRP 5/6) (b), DVL binds to the destruction complex and thus stabilises β-
catenin and activates the transcription factors (e.g. TCF). The roles of DACT in both 
cellular states are yet to be determined (Modified from Moon et al., 2004). 
 
Six Wnt genes are expressed in developing kidneys. Wnt6, Wnt7b, Wnt9b, and Wnt11 
are expressed exclusively by the UB. Wnt6 is expressed as early as E10.5 in the 
Wolffian duct and the UB and is expressed more strongly in the UB tips than in the 
stalk. Wnt9b is expressed as early as E9.5 in the Wolffian duct and as development 
proceeds, it shows stronger expression at the UB tips than stalks (Carroll et al., 2005; 
Itaranta et al., 2002). Wnt11 expression is restricted to the UB tips (Christiansen et al., 
1995; Kispert et al., 1996). Wnt7b expression is restricted to the maturing collecting 
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ducts from E13.5 (Kispert et al., 1996). Wnt4 is expressed by the condensing 
mesenchyme, comma- and S-shaped bodies of the developing nephrons (Kispert et 
al., 1998; Stark et al., 1994). Wnt2b is expressed in the perinephric mesenchymal 
cells (Lin et al., 2001). Cell lines expressing Wnt4, Wnt6, Wnt7b and Wnt9b are 
capable of inducing isolated mesenchyme to form nephrons in culture. Cell lines 
expressing Wnt11 do not have this ability though Wnt11 is expressed in the UB tips 
(Carroll et al., 2005; Itaranta et al., 2002; Kispert et al., 1998). Wnt6-expressing 
fibroblasts are able to induce nephrons even in Wnt4-/- mesenchyme but Wnt9b-
expressing fibroblasts are not able to do so. Taking together the expression patterns 
and the cellular assay results, WNT6 and WNT9b are likely to be inducers for 
nephron formation. However, whether Wnt9b, Wnt6 and Wnt4 act in a hierarchy or 
they signal through distinct receptors to induce nephrons is yet to be determined. 
 
Wnt4 is expressed by the condensing metanephric mesenchyme and the periureteric 
stroma in the medullary region of the embryonic kidney (Stark et al., 1994). This 
protein is critical for regulating MET in the cortical region for nephrogenesis 
(Kispert et al., 1998). Besides, WNT4 signalling regulates the fate of smooth muscle 
cells in the developing medullary region (Itaranta et al., 2006). Wnt2b is expressed 
by the perinephric mesenchymal cells in the region of the presumptive stroma in the 
developing kidney at E11.5. Cells expressing Wnt2b fail to induce tubulogenesis in 
cultured mesenchyme but instead they can promote UB survival and growth in a co-
culture experiment (Lin et al., 2001).  
 
Although the expression patterns and functions of these Wnt genes in developing 
kidneys have been identified at least partially, the intracellular signalling by which 






The GDNF family ligands include GDNF, neurturin, persephin, and artemin. They 
all signal through the Ret receptor tyrosine kinase and activation is facilitated by the 
GFRα1 co-receptors (Airaksinen et al., 2006). Genes encoding each of these ligands 
except artemin are expressed by developing kidneys and are described briefly below. 
 
GDNF is perhaps the best characterized morphogen in kidney development. In the 
developing kidney, GDNF is secreted by the uninduced metanephric mesenchyme 
(Hellmich et al., 1996). The Ret receptor is found at the UB at early stages of its 
outgrowth and later locates only at the tips of the ureteric trees. The Gfra1 co-
receptor is expressed by the UB and also by the surrounding mesenchyme (Sainio et 
al., 1997). Gdnf, Gfra1 and Ret are critical to kidney development. Homozygous 
knockouts of Gdnf, Gfra1, or Ret show renal malformations ranging from severe 
dysgenesis to complete agenesis (Cacalano et al., 1998; Moore et al., 1996; Pichel et 
al., 1996; Schuchardt et al., 1994). The importance of GDNF in UB induction, 
branching maintenance, UB cell proliferation and MDCK cell migration have been 
described in section 1.2.1, 1.3.1 and 1.3.3. 
 
Nrtn (neurturin) is expressed in the UB of the developing kidney (Widenfalk et al., 
1997). Nrtn knockout mice show grossly and microscopically normal kidneys 
(Heuckeroth et al., 1999). In kidney organ culture NRTN stimulates UB branching 
only in the presence of function-blocking anti-GDNF antibodies (Davies et al., 1999). 
PSPN (persephin) is also expressed by the developing kidney. In kidney organ 
culture, it can partially rescue the inhibitory effect of sodium chlorate on UB 
branching (Milbrandt et al., 1998). 
 
1.4.3 TGFβ signalling molecules 
 
The transforming growth factor β superfamily comprises a collection of structurally 
related ligands, including TGFβs, BMPs, Activins, Nodal and growth differentiation 
factors (GDFs). They are involved in regulating an array of developmental processes 
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including those in developing kidneys. These ligands signal through type II and type 
I receptors, both of which are transmembrane serine-threonine kinases, leading to the 
phosporylation and activation of Smad family of transcription factors. TGFβs signal 
via the ALK5 receptor whilst Activins and Nodal signal via the ALK4 receptor 
(Kitisin et al., 2007; Piscione et al., 1997). A schematic diagram for these signalling 
pathways is shown in Figure 1-7. Members of the TGFβ superfamily and their 
receptors are expressed in the developing kidneys and play diverse and essential 
roles in outgrowth and positioning of the UB (Esquela and Lee, 2003), renewal of the 
mesenchymal progenitor population (Dudley et al., 1999), recruitment of 
nephrogenic mesenchyme (Oxburgh et al., 2004), and shaping the branching ureteric 




Figure 1-7 A scheme of TGFβ superfamily signalling. Different ligands signal 
through their type II and type I receptors. Type II receptors are ligand-binding 
receptors including TβRII, ActRIIA, ActRIIB, and BMPRII. The type I receptor 
family includes ALK1 through ALK7. Receptor-activated Smads (R-Smads) include 
Smad1, Smad2, Smad3, Smad5, and Smad8. Smad4 is the common Smad. (Modified 
from Kitisin, Saha et al. 2007) 
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Tgfb1 is expressed by the stroma in developing kidneys (Partanen, 1990; Vrljicak et 
al., 2004). Tgfb1 knockout mice do not have renal defects (Boivin et al., 1995). 
Exogenous TGFβ1 inhibits UB branching in kidney organ culture (Bush et al., 2004; 
Ritvos et al., 1995). Results from cell culture based tubulogenesis also support the 
idea that TGFβ1 inhibits branching (Sakurai and Nigam, 1997). 
 
Activin is expressed by the metanephric mesenchyme. Like TGFβ1, exogenous 
Activin inhibits UB branching in kidney rudiment culture. This inhibitory effect can 
be rescued by follistatin, a natural inhibitor of Activin (Bush et al., 2004; Ritvos et al., 
1995). In addition to the inhibitory effect on branching, Activin is further 
characterised as an endogenous inhibitor of UB outgrowth from the Wolffian duct 
(Maeshima et al., 2006). In the cell culture-based tubulogenesis model, HGF has 
been established as an inducer of tubulogenesis (Cantley et al., 1994). Further studies 
have proved that this HGF-mediated tubulogenesis is achieved by blocking the 
production of Activin within the cells (Maeshima et al., 2000). Transgenic mice 
expressing the truncated Activin type II receptor, which act as a dominant-negative 
receptor and block the Activin signalling, present a mild renal phenotype with 
increased number of glomeruli in the renal cortex. This is possibly due to increase 
UB branching (Maeshima et al. 2001).  
 
Nodal signals through Activin type II receptors, ALK4, Smad2 and Smad4 
(Goumans and Mummery, 2000). However, the expression of Nodal in developing 
kidneys is yet to be confirmed. 
 
1.4.4 Retinoids  
 
Retinoids are important in mammalian kidney development. Vitamin A deficiency 
during gestation leads to congenital renal abnormalities in rats (Wilson and Warkany, 
1948). In humans, the reduced maternal vitamin A level has been shown to be 
correlated with the reduced newborn renal volume (Goodyer et al., 2007). In 
agreement with these findings, the addition of retinoids to kidney organ culture 
stimulates the UB branching and the nephron formation (Vilar et al., 1996). 
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Developing kidneys express Rara and Rarb2 in the stroma (Mendelsohn et al., 1999). 
They also express genes encoding enzymes essential for retinoic acid (RA) synthesis 
such as retinaldehyde dehydrogenases (Raldh1, Raldh2 and Raldh3) (Gilbert, 2002; 
Niederreither et al., 2002) and retinol dehydrogenases (Rdh10) (Cammas et al., 2007). 
Mice carrying mutations in both Rara and Rarb2 present severe kidney malformation 
(Mendelsohn et al., 1994).  
 
A more interesting finding is that exogenous RA is able to increase the expression of 
Ret by kidney rudiment growing in culture (Moreau et al., 1998). Retinoids cause 
translocation of the membrane-bound receptors into the nucleus where they act as 
transcription factors (Duester, 2000). A signal then sends out from the stroma, 
directly or indirectly, to the UB resulting in upregulation of Ret. Batourina et al. 
further showed that enforced expression of Ret in mice lacking both Rara and Rarb2 
restores UB growth and stromal patterning (Batourina et al., 2001). These results 
therefore build up a plausible link between retinoid signalling and Ret, which 
modulates branching morphogenesis, nephrogenesis and stromal cell patterning. 
 
1.5 Dact genes and kidney development 
 
1.5.1 Dact as a novel gene family 
 
DACT was initially named Dapper. It was identified in a screen for proteins directly 
binding to DVL, a cytoplasmic protein central to the WNT signalling (Figure 1-6). 
Cheyette et al. performed a yeast two-hybrid screen of a Xenopus maternal cDNA 
library using as bait the PDZ domain and adjacent sequences of Xenopus Dishevelled 
(XDSH). The novel protein thus isolated was further verified by 
immunoprecipitation and an in vitro binding assay. Cheyette et al. subsequently 
proved it to be an antagonist of Dishevelled and named it Dapper (Dpr), the antonym 
of Dishevelled (Cheyette et al., 2002). Dpr orthologues have been found in 
vertebrates examined so far but they have not yet identified in invertebrates. Dact is 
now the official name for all members of this gene family annotated by the Human 
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Genome Organization Nomenclature Committee and the Mouse Genome Informatics 
website. 
 
The open reading frame of Xenopus Dpr (XDpr) cDNA encodes a protein of 824 
amino acids. As predicted from the genomic sequences, the open reading frames of 
the mouse and human orthologues (Dpr1 and DPR1) encode proteins of 778 and 836 
amino acids, respectively. These three proteins are highly conserved and featured 
with a leucine zipper domain at the amino terminus and a PDZ binding domain at the 
carboxyl terminus. The two mammalian proteins are more than 75% identical to each 
other (Figure 1-8). More strikingly, the carboxyl terminal 28 amino acids are 
completely conserved among all the three proteins, including the final four amino 




Figure 1-8 Alignment of mouse DACT1 with orthologues from Xenopus and 
human. Amino acid residues shown in black are identical and grey are similar. 
Green outline shows the leucine zipper domain and red outline indicates PDZ 
binding motif (M: mouse; X: Xenopus; H: Human) (Modified from Cheyette et al., 
2002). 
 
By using the Dapper sequences from frogs and fish, Fisher et al. scanned the mouse 
genome and expressed sequence tag (EST) databases for similar sequences, and 
carried out reverse transcriptase-polymerase chain reaction (RT-PCR) to clone full-
length cDNAs. Three paralogues in the Dact family were thus identified: Dact1 
mapping to chromosome 12D1, Dact2 to chromosome 17A2 and Dact3 to 
chromosome 7A2 (Fisher et al., 2006). The intron-exon structure is conserved among 
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these three paralogues, comprising three small 5’coding exons, which encode a short 
5’-utranslated region (UTR) and the amino terminus of the polypeptide, and a larger 
fourth exon encoding about two thirds of the translated sequences plus a longer 3’-
UTR. The amino acid sequences for DACT1, DACT2 and DACT3 proteins are 778, 
757 and 610 residues respectively (Fisher et al., 2006). The orthologues of Dact1 and 
Dact2 have also been identified in zebrafish, Xenopus and humans (Fisher et al., 
2006; Waxman et al., 2004; Yau et al., 2005). However, Dact3 is not yet reported in 
other species. Because it was identified just a few months ago, I was not able to 
investigate it as part of this thesis. 
 
1.5.2 Biological functions of Dact genes 
 
Because DACT proteins were discovered as DVL-associated proteins, most research 
to date have focused on their roles in developmental events or disease processes 
controlling by WNT signalling. The first report described the functional role of 
Dact1 in Xenopus notochord formation. Depletion of maternal Dact1 RNA from 
embryos leads to acephalic or microcephalic embryos whilst overexpression of 
Dact1 results in embryos with enlarged head and spinal curvature. Cheyette et al. 
further showed that DACT1 and DVL colocalised intracellularly and formed a 
complex with Axin, GSK3, CKI, and β-catenin, which are all key components of the 
WNT/β-catenin pathway. Dact1 has been also shown to inhibit activation by 
Dishevelled of c-Jun N-terminal kinase (JNK) pathway. Cheyette et al. therefore 
concluded that Dact1 is a common antagonist of Dishevelled (Cheyette et al., 2002).  
 
In zebrafish, however, Dact genes were reported as pathway-specific modulators of 
WNT signalling. Endogenous Dact1 is able to augment WNT/β-catenin activity in 
embryos hypomorphic for Wnt8 whereas Dact2 is required for normal convergence 
extension movement in embryos that are hypomorphic for Stbm or Wnt11 (Waxman 
et al., 2004). In mice, Suriben et al. noticed that Dact1 presomitic mesoderm 
expression oscillates in time with Axin2 in the somitogenesis clock (Suriben et al., 




In addition to the involvement in the WNT signalling, DACT2 has been implicated 
as a modulator in TGFβ signalling. In zebrafish, DACT2 binds to the TGFβ receptors 
ALK4 and ALK5, promoting degradation of these receptors thereby repressing 
mesoderm induction (Zhang et al., 2004). The ability of DACT2 to antagonise TGFβ 
signalling is evolutionally conserved. Su et al. demonstrated that in mammalian cells, 
overexpression of mouse Dact2 inhibited the TGFβ induced expression of the Smad-
responsive reporters and accelerated the degradation of TGFβ receptor ALK5. More 
strikingly, overexpression of mouse Dact2 in zebrafish embryos results in a 
phenotype mimicking that generated by overexpression of fish Dact2 (Su et al., 
2007). Dact1 is also regulated by BMP2, a member of the TGFβ superfamily. BMP2 
is a key regulator in the transformation of the uterine stroma during embryo 
implantation. Ablation of Bmp2 results in the reduction of Dact1 in the uterus (Lee et 
al., 2007).  
 
Also there are emerging papers on Dact genes and diseases. Human DACT1 has been 
reported to be downregulated in hepatocellular carcinoma wherein oncogenic 
activation of WNT/β-catenin is a common mechanism (Yau et al., 2005). Increased 
DACT1 expression is noted in invasive ductal carcinoma of breast (Schuetz et al., 
2006). In a mouse model for systemic sclerosis, the mRNA levels of several genes of 
WNT signalling components including both Dact1 and Dact2 are found to be 
increased (Bayle et al., 2007). DACT2 is also implicated in genitourinary tract 
tumours and endometrial adenocarcinoma (Katoh and Katoh, 2003). Notably Dact 
genes seem to play roles in these currently non-curable diseases of various organs. It 
is therefore important to understand their functional roles in basic cellular 
mechanisms such as proliferation, survival, differentiation and migration, which may 
contribute to the identification of novel pharmaceutical targets and the development 
of new therapeutic strategies. 
 
1.5.3 Dact genes in mammalian kidneys 
 
To date, the literature describing the biological functions of Dact genes have focused 
on somitogenesis and nervous system development. Little is known about their 
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functions in kidney development. Fisher et al. characterised the expression patterns 
of the three Dact genes in E14 mouse embryos. Although their whole work put more 
emphasis on central nervous system, they also showed that Dact2 was expressed by 
the ureteric buds of the kidneys at E14 (Fisher et al., 2006). This has been so far the 
only evidence providing a link between Dact genes and developing mammalian 
kidneys.  
 
1.6 Aims of this thesis 
 
WNT signalling is required for normal kidney development but the details of the 
pathways used remain a challenging question to most developmental biologists in 
this field. One strategy is to work out the intracellular pathways by which WNT 
exerts its function. DVL-associated proteins seem to be the ideal candidates for this 
strategy as they regulate the cytoplasmic scaffold protein, DVL, which acts as a 
hinge of diverse WNT signalling pathways. My initial drive to use DACT as a tool to 
dissect WNT pathways in developing kidneys arose from two encouraging papers in 
which Dact was found to be expressed in E14 kidneys and, more importantly, Dact1 
and Dact2 were shown to be pathway-specific modulators of WNT signalling (Fisher 
et al., 2006; Waxman et al., 2004). However, as information on Dact genes in 
developing kidneys is so limited in the literature, there are many interesting areas 
worth exploring. Based on the reviews in previous sections, several interesting 
questions on Dact genes in kidney development can be addressed. Examples of these 
questions are as follows. 
1. When, where and how are Dact genes expressed in developing kidneys? 
2. In what developmental events of kidney development are Dact genes 
involved? Possibilities include; 
(a) UB induction 
(b) UB branching 
(c) Nephron induction 
(d) Nephron differentiation 
(e) Stromal development 







4. What are the possible signalling pathways that Dact genes are involved in 
regulating kidney development? 
 
It is not possible for this thesis to answer all the questions listed above but this 
question list serves as a theme for the present and future projects on Dact genes in 
kidney development. In this study, I started with establishing the expression patterns 
of both Dact1 and Dact2 in embryonic and postnatal kidneys. Based on these 
expression patterns, I designed experiments on a hypothesis-driven basis to explore 
the functions of both Dact genes. The specific aims of this thesis were as follows. 
1. To characterise the temporospatial expression patterns of Dact1 and Dact2 in 
embryonic and postnatal mouse kidneys. 
2. To explore Dact1 function by siRNA-mediated RNAi in 2D cell culture. 
3. To examine Dact1 function in kidneys growing in organ culture. 
4. To make stable renal epithelial cell lines expressing Dact2 shRNA. 
5. To investigate Dact2 functions in both 2D cell culture and a 3D cell culture-
based tubulogenesis model. 
The functions of these two genes found in this study shed light on their functional 



































2.1 Cell and organ culture 
 
Culture media, salts and supplements were purchased from Sigma unless otherwise 
stated. They were all stored at 4°C. 
 
2.1.1 Cell culture 
 
The NIH3T3 cell line was purchased from ATCC-LGC Promochem (ATCC number: 
CRL-1658). The culture medium was composed of 1:1 mixture of Nutrient Mixture 
F-12 Ham and Dulbecco’s modified Eagle’s medium (DMEM) and was 
supplemented with 10% (v/v) foetal calf serum (Biosera), 2mM L-glutamine, 
100units/ml penicillin and 100µg/ml streptomycin.  Cells were maintained at 37°C 
with 5% CO2. 
 
The mIMCD-3 (murine inner medullary collecting duct) cell line was purchased 
from ATCC-LGC Promochem (ATCC number: CRL-2123) and was cultured in the 
same way as NIH3T3 cells except that L-glutamine was not added to the culture 
media.  
 
2.1.2 Kidney dissections and culture 
 
CD1 outbred mice were raised and mated liberally. The morning when the vaginal 
plug was detected was defined as E0.5. Metanephric kidneys were dissected from 
E11.5 embryos. Dissections were performed in 35mm petri dishes in Eagle’s 
minimum essential medium (MEM) using 0.5x16m needles (BD Microlance 3). The 
dissection procedures are depicted in Figure 2-1. Dissections were started with the 
removal of the unnecessary tissues including the rostral end of the embryo and its tail. 
Longitudinal bisection was then done on the caudal part rudiment. At this stage, 
kidney was located close to the hindlimb and was ready to be dissected out. Kidneys 
were cultured on 5μm pore size polycarbonate filters (Millipore) at a gas-medium 
interface on metal grids in petri dishes. The culture medium was composed of MEM 
 33
 
with 10% (v/v) foetal calf serum, 100units/ml penicillin and 100µg/ml streptomycin. 




Figure 2-1 Stepwise procedures of kidney dissections in an E11.5 embryo. The 
first two steps were to remove the unnecessary tissues including head and forelimbs.
Step 3 was to longitudinally bisect the caudal part of the embryo. At step 4, kidney 
was identified close to the hindlimb.
 
2.2 Nucleic acid manipulation 
 
2.2.1 Solutions for nucleic acid manipulation 
 
All chemicals were purchased from Sigma, BDH and Invitrogen unless otherwise 
stated. Solutions were prepared in deionised water and were stored at room 
temperature. Autoclaving procedures were carried out at 121°C, 15lbs/square inch 
for 30 min. 
 
EDTA 
EDTA (ethyldiaminetetraacetic acid di-sodium salt) was dissolved in water and was 




Tris base (tris[hydroxymethyl]aminomethane) was dissolved in water and was 
titrated to required pH value by HCl. 
 
TE buffer  
TE buffer was made up of 10mM Tris.HCl (pH 7.5) and 1mM EDTA.  
 
TBE buffer 
TBE (Tris-Borate-EDTA) was purchased as 5X concentrate powder and was diluted 
in water to 1X buffer containing 89mM Tris-borate and 2mM EDTA, pH 8.3. 
 
Gel loading dye, 6X  
Blue/Orange Loading Dye, 6X (Promega) contained 0.4% orange G, 0.03% 
bromophenol blue, 0.03% xylene cyanol FF, 15% Ficoll® 400, 10mM Tris-HCl (pH 
7.5) and 50mM EDTA (pH 8.0).  
 
Ethidium bromide 
Ethidium bromide was purchased as a 10mg/ml solution and was added directly to 
the agarose gel to obtain the final concentration of 0.3µg/ml. 
 
PCR Primers  
Primers were designed from published sequences and by Primer3 online software 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). They were carefully 
checked by BLAST (National Centre for Biotechnology Information, website: 
http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) to confirm the specificity of these 
primers. Primers were purchased as lyophilised, desalted compounds (MWG 
Biotech). Stocks were made up to 100µM using TE buffer and stored at -20°C. 
Working stocks were diluted to 5µM with nuclease-free water and stored at –20°C.  
 
dNTPs  
dNTPs (deoxyribonucleotide triphosphate) were purchased as individual stocks 
(dATP, dCTP, dGTP, dTTP) of 100mM (Promega). Working stocks were made by 
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mixing each of the dNTPs with distilled water to a final concentration of 10mM. 
Stocks were kept at –20°C. 
 
2.2.2 Total RNA isolation 
 
Total RNA was extracted from mouse metanephroi or cultured cells with the SV 
Total RNA Isolation System (Promega) according to the manufacturer’s instructions 
and quantified by a Cecil 2000 spectrophotometer (Cecil Instruments). RNA samples 




The mixture of 250ng total RNA, 500ng of random primers and nuclease-free water 
together in a final volume of 12.5μl was heated to 70°C for 5 min to melt secondary 
structure within the template. 5X reverse transcription buffer, 10mM dNTPs, 20units 
of RNase inhibitor, and 200units of reverse transcriptase were added in order to 
produce a final volume of 20µl. One reaction mixture was prepared without adding 
the reverse transcriptase and was used as a negative control in the downstream PCR. 
After incubation at 37°C for 1 hour, the reverse transcription reaction was terminated 
by heating at 75°C for 8 min. The newly synthesized cDNA was amplified by PCR. 
The reaction mixture contained 2μl of cDNA template, 25mM MgCl2, 1unit of Taq 
polymerase, and 50ng of primers. β-actin primers were used as an internal control. 
The reactions were carried out in a TC-312 thermal cycler (Techne). Amplification 
thermal cycles were: 94°C for 5 min, then 35 cycles of 94°C for 1 min, 55°C for 1 
min, 72°C for 1 min, followed by a final extension at the end for 10 min at 72°C.  
 
2.2.4 Agarose gel electrophoresis 
 
Agarose gels were used to determine the presence or size of nucleic acid molecules. 
A 1.5% (w/v) agarose gel was made by dissolving 0.75g agarose in 50ml 1X TBE in 
a microwave oven (900w) for 1 min. Ethidium bromide was then added to a final 
concentration of 0.3µg/ml agarose. The molten agarose was poured into a tape-sealed 
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rectangular mould and allowed to set. A 100bp DNA Ladder (Promega) was run 
alongside experimental samples to estimate the size and amount of DNA in the 
samples. 10µl of each DNA sample was mixed with 2µl of 6X loading dye. When 
electrophoresis finished, gels were visualised by UV trans-illumination and 
photographed. 
 
2.2.5 Quantitative real time PCR 
 
QuantiTect SYBR Green PCR Kit (Qiagen) was used according to manufacturer’s 
instructions. Each reaction contained 25µl of 2X QuantiTect SYBR Green PCR 
Master Mix, primer pairs 0.3µM and 2µl of template DNA. Nuclease-free water was 
added to a final volume of 50µl.   
 
Amplification was carried out in a 96-well plate on the DNA Engine Opticon® 
system (MJ Research). Thermal cycles were: 95°C for 15 min to activate HotStarTaq 
DNA polymerase (Qiagen), then 40 cycles of 15 sec of denaturation at 94°C, 30 sec 
of annealing at 55°C and 30 sec extension at 72°C, followed by a plate reading with 
a final extension at the end for 10 min at 72°C. All reactions were performed in 
triplicate unless otherwise stated. Each run included at least two non-template 
controls for the PCR amplification step. Data were analysed by the Opticon Monitor 
software (MJ Research) using a standard curve method. Standard curves were 
generated by using serial two-fold dilutions of a reverse-transcribed RNA containing 
the sequence of interest for every primer pair. The resulting standard curve plots 
were then used to convert the threshold cycle number into arbitrary quantities of 
initial template of a given sample.  
 
2.2.6 PCR products purification 
 
PCR products were purified by QIAquick PCR purification kit or Gel extraction kit 
(Qiagen) according to the manufacturer’s protocols. The choice of kit depended on 
the purity of the PCR products shown on agarose gel. Purified products were used 
directly for ligations or stored at -20°C. 
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2.2.7 Ligations  
 
Specific PCR products were cloned into pGEM®-T Easy vector system (Promega). In 
this project, the subsequent use of these ligations included riboprobe synthesis and 
DNA sequencing. Each reaction contained 50ng of pGEM®-T Easy vector, 5µl of 2X 
ligation buffer, 3units of T4 DNA ligase and 2µl of insert DNA. Distilled water was 
added to produce a final volume of 10µl. Positive control of the ligation reaction was 
carried out by setting up a ligation reaction using the positive control insert DNA 
provided. A ligation reaction set up without adding any insert DNA served as the 
negative control. Both the positive and negative control ligations were used for 
subsequent transformations. Ligations were incubated at 4°C overnight and were 
used on the next day.  
 
2.2.8 Plasmid linearisation 
 
Plasmids were linearised by restriction enzymes to facilitate riboprobe synthesis by 
in vitro transcription. Restriction enzyme digestion was carried out using Promega 
enzymes and buffers. The restriction enzyme digest was performed in a volume of 
50µl containing 1µg of substrate DNA, 5µl of appropriate buffer, 5µg of BSA and 
deionised water and was incubated in a 37°C water bath for 2 hours. Linearised 
plasmids were analysed on a gel at once or stored at 4°C. The choice of restriction 
enzyme and its appropriate buffer was made according to the manufacturer’s 
recommendation.  
 
2.2.9 DNA sequencing 
 
Plasmid DNA containing the insert sequences was purified by QIAprep Spin 
Miniprep Kit (Qiagen) according to the manufacturer’s instructions and was sent to 
DBS Genomics at the University of Durham for sequencing. The instrument used for 





2.3.1 Solutions  
 
All chemicals were purchased from Sigma, BDH and Invitrogen unless otherwise 
stated. Solutions were stored at room temperature.  
 
Luria-Bertani (LB) Broth  
LB broth was made up of tryptone 5.0g, yeast extract 2.5g, NaCl 5.0g and glucose 
0.5g. Distilled water was added to a final volume of 500ml and the solution was then 
autoclaved. 
 
LB Agar  
LB agar was made up of tryptone 5.0g, yeast extract 2.5g, NaCl 5.0g and agar 7.5g. 
Distilled water was added to a final volume of 500ml. The solution was then 
autoclaved.  
 
X-Gal, 500X  
40mg of X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside) was diluted in 2ml of 
N,N-dimethylformamide (DMF) and stored at -20°C. 
 
Ampicillin, 1000X  
100mg of ampicillin (D-[-]-α-aminobenzylpenicillin sodium salt) was diluted in 2ml 
of ethanol and stored at -20°C.  
 
Glycerol, 80% 




2.3.2 Heat shock transformation 
 
Transformants were made by adding 2µl of the DNA ligation reaction (described in 
section 2.2.7) to 50µl of thawed competent E. coli cells (JM109, Promega) in a 
sterile 1.5ml microcentrifuge tube. The ligation/cell suspension was incubated on ice 
for 30 min. Cells were then heat shocked in a 42°C water bath for 20 sec followed by 
incubation on ice for additional 2 min. The transformed bacteria were suspended in 
1ml of LB broth and incubated at 37 °C for 1 hour in an orbital shaker. By using a 
sterile inoculation loop, 50µl of bacterial suspension were spread onto a LB agar 
plate containing 1X X-Gal and 1X ampicillin. The agar plates were left upside down 
and incubated at 37°C overnight.  
 
2.3.3 Screening transformants for inserts 
 
The vector used contained a lacZ gene coding for β-galactosidase. When β-
galactosidase was produced by the E. coli, it converted the colourless X-Gal, which 
was supplied in the agar plate, into a bright blue product. Successful cloning of an 
insert into the pGEM®-T Easy vectors interrupted the coding sequence of β-
galactosidase and therefore recombinant clones were shown as white colonies on the 
agar plates. After the overnight incubation, a single white colony was picked, spotted 
onto a new agar plate and incubated at 37°C overnight. 
 
2.3.4 Isolation of recombinant plasmid DNA 
 
To isolate recombinant plasmid DNA from the bacteria, a single white colony was 
picked and inoculated in 10ml of LB broth containing 1X ampicillin. This culture 
was incubated at 37°C in an orbital shaker overnight (16-24 hours). Recombinant 
plasmid DNA was extracted by using the QIAprep Spin Miniprep Kit (Qiagen) 
according to the manufacturer’s instructions. The concentration of the purified 
plasmid DNA was determined by a spectrophotometer (Cecil Instruments). Using the 
purified plasmid DNA as templates, RT-PCR was performed to confirm to correct 
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DNA inserts and/or to determine the direction of the cloned PCR products in the 
plasmids. 
 
2.3.5 Preparation of bacterial stocks  
 
Once a plasmid harbouring the correct insert was verified, a single colony of the host 
bacteria was picked from the agar plate and inoculated in 10ml of LB broth 
containing 1X ampicillin. This culture was left at 37°C in an orbital shaker overnight. 
Cells were pelleted by centrifugation. The bacterial pellet was harvested and 
resuspended in 1ml of LB broth. The glycerol bacterial stock was made by adding 
800µl of this suspension to 200µl of 80% glycerol in a sterile 1.5ml cryotube. The 
bacterial stock was stored at -70°C. 
 
2.4 RNA in situ hybridisation 
 





1ml of DEPC was added to 1000ml of deionised water and agitated overnight at 
37°C. The solution was then autoclaved and kept at room temperature. 
 
PBS 
One PBS tablet was dissolved in 200ml of DEPC-treated water to yield 0.01M 
phosphate buffer, 0.0027M potassium chloride and 0.137M sodium chloride, pH 7.4, 
at 25°C.  The solution was then autoclaved and kept at 4°C. 
 
PBST  





4% PFA in PBS 
2g of PFA was added to 50ml of DEPC-treated PBS and was heated to 60˚C until the 
PFA fully dissolved. The solution was aliquoted and stored at -20°C. 
 
SSC, 20X, pH 7.0 
20X SSC stock solution was made by dissolving 8.82g of sodium citrate and 17.5g of 
NaCl in DEPC-treated water. The final volume was 100ml and the pH was adjusted 
to 7 with 1M HCl. The solution was stored at room temperature.  
 
SSC, 20X, pH 5.0 
This solution was made by adding 1ml of 1M citric acid to 40ml of 20X SSC (pH 
7.0). 
 
Torula yeast tRNA 
Torula yeast tRNA solution was made by adding 3g of torula yeast tRNA powder to 
45ml of boiling DEPC-treated water. The solution was allowed to cool and was 
centrifuged. Any undissolved powder was discarded. The concentration of RNA was 
measured by a spectrophotometer (Cecil Instruments) and was adjusted accordingly 
to achieve 50mg/ml. The solution was then aliquoted and stored at -20°C 
 
Hybridisation solution  
To make hybridisation solution, 1.0g of blocking powder (Roche) was added to 25ml 
of deionised formamide (Ambion) and 12.5ml of SSC (20X, pH5.0). This solution 
was heated at 65°C until completely dissolved. Once dissolved, 1ml of yeast torula 
RNA (50mg/ml), 0.25ml of heparin (10mg/ml), 0.25ml of Tween-20 (20%), 0.5ml of 
CHAPS (10%) and 1.25ml of EDTA (0.2M) were added. DEPC-treated water was 
added to a final volume of 50ml. The solution and was then filtered through a 
0.20µm filter. The solution was aliquoted and stored at -20°C. 
 
Solution I 





Solution II consisted of 50% formamide, 2X SSC, pH 4.5. 
 
MAB  
MAB consisted of 5.8g of maleic acid and 4.38g of NaCl. DEPC-treated water was 
added to a final volume of 500ml and the pH was titrated to 7.5 with 1M NaOH. The 
solution was autoclaved and stored at room temperature.  
 
MABT  
MABT consisted of 0.1% Tween-20 in MAB and was stored at room temperature.  
 
NTMT  
NTMT solution was made immediately prior to use from concentrated stocks 
including 1ml of 5M NaCl, 5ml of 1M Tris.HCl (pH 9.5), 2.5ml of 1M MgCl2, 
0.25ml of Tween-20 (20%) and 41.25ml of DEPC-treated water. 
 
Staining solution  
18µl of 18.75 mg/ml NBT/ 9.4 mg/ml BCIP (Roche) was added to 1ml of NTMT 
buffer. 
 
2.4.1.2 Riboprobe synthesis 
 
Riboprobes for in situ hybridisation histochemistry were made by in vitro 
transcription using digoxigenin (DIG)-labelled dNTP mix. The DIG labelling mix, 
polymerases, and transcription buffers were from Roche. Measures taken to prevent 
RNA degradation included wearing gloves all the time, keeping RNA products on ice 
as much as possible and soaking the electrophoresis equipment in 0.1% SDS 
overnight. 
 
Plasmids containing the riboprobe sequence were linearised by restriction enzymes 
following the procedures described in the section 2.2.8. 1µg of linearised plasmid 
was precipitated in 1/10th volume of 3M sodium acetate and 2 volumes of pure 
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ethanol. After centrifugation at 13000rpm for 15 min, the supernatant was discarded 
and the pellet was resuspended in 5µl of DEPC-treated water. The choices of 
restriction enzyme and of RNA polymerase were determined by the direction of the 
DNA cloned into the pGEM®-T Easy vector (Table2-1). The reaction was carried out 
in a 500µl microcentrifuge tube containing 1µg of linearised plasmid, 2µl of 10X 
transcription buffer, 2µl of 10X DIG RNA labelling mix, 40units of T7 or Sp6 RNA 
polymerase and 40units of RNase inhibitor. DEPC-treated water was added to a final 
volume of 20µl. 
 
 
Table 2-1 Restriction enzymes and RNA polymerases used to generate 
riboprobes. 
Gene Antisense Probe Sense Probe 
 Polymerase Enzyme Polymerase Enzyme 
Dact1 T7 SpeI Sp6 NcoI 
Dact2 T7 SpeI Sp6 NcoI 
 
The reaction was incubated at 37°C for 2 hours using a heating block. The template 
DNA was then digested by incubating with RNase-free DNase1 (Promega) at 37°C 
for additional 15 min. 2µl of 0.2M EDTA (pH8.0) was added to stop the digestion. 
The DIG-labelled RNA probes were precipitated by adding 2.5µl of 4M LiCl and 
75µl of prechilled pure ethanol followed by incubation at -20°C overnight. The 
following day, the RNA probes were centrifuged for 15 min at 13000rpm. The 
supernatant was carefully removed and the pellet was washed with 50µl of prechilled 
70% ethanol. After centrifugation for further 15 min, the supernatant was removed 
and the pellet was resuspended in 50µl of DEPC-treated water. 1µl of RNase 
inhibitor was added. RNase-free gel electrophoresis was performed using 1μl of the 
RNA solution to check the integrity of the RNA and to estimate its concentration. 
The RNA solution was diluted in the hybridisation solution, aliquoted and stored at -
70°C until use. 
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2.4.1.3 Tissue preparation 
 
At the end of the kidney culture, the culture medium was aspirated off and replaced 
by 100% ice cold methanol. This was left for 10 min so that kidneys could fix to the 
filters. The filters with attached kidneys were transferred to a labelled bijou and fixed 
in 4% PFA at 4°C overnight. For long term storage, these samples were kept in 
100% methanol at –20°C. 
 
2.4.1.4 Hybridisation protocol 
 
Kidneys on the filters were processed for in situ hybridisation based on Wilkinson’s 
protocol (Wilkinson, 1992) with slight modifications. Unless otherwise stated, 
washes were for 5 min with gentle rocking. Kidneys were rehydrated through a series 
of graded methanol in PBST on ice. After washing in PBST twice on ice, kidneys 
were digested with 10µg/ml proteinase K (Sigma) in PBST for 30 min at room 
temperature. Digestions were stopped by washing in freshly prepared 2mg/ml 
glycine in PBST for 5 min. Kidneys were washed twice in PBST and were then fixed 
in 4% PFA for 40 min on ice. After two washes in PBST, most of the liquid was 
removed and replaced by the mixture of PBST and hybridisation solution (1:1) 
followed by incubation in pure hybridisation solution. Kidneys were prehybridised in 
this solution for 3 hours at 70°C before the probe was added. The probe at a final 
concentration of 200ng/ml was heated to 80°C for 5 min before adding it to the 
kidneys. Hybridisation with the probe was carried out at 70°C overnight. Protect 
RNA (Sigma), at the concentration of 2µl/ml, was used in all solutions after 
digestion with proteinase K until the end of hybridisation. The following day, 
kidneys were washed in preheated solution I (30 min x 3) at 70°C followed by 
washing in preheated solution II (30 min x 3) at 65°C. Kidneys were then washed 
with MABT before being blocked for 3 hours at 4°C in MABT with 10% sheep 
serum (Sigma) and 2% (w/v) blocking powder (Roche). Samples were incubated in 
alkaline phosphatase-conjugated anti-DIG antibody (Roche) at 1:2000 dilution in 
fresh blocking solution at 4°C overnight. Excess antibody was removed by washing 
the kidneys in MABT (5 min x 3 followed by 1 hour x 5). Final wash was carried out 
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in NTMT (10 min x 3).  Kidneys were then subjected to colour development in 
staining solution. After colour development in the dark, the kidneys were fixed in 
100% methanol before mounting on slides. 
 




Most solutions were the same as those used in whole mount in situ hybridisations 
except some modifications. These modifications are listed in Table 2-2. 
 
Table 2-2 Solutions for in situ hybridisation on kidney sections 
 
Solution Composition 
TEA (triethanolamine) buffer, 0.1M 
TEA pH 8.0 
295ml DEPC-treated water, 4ml 
triethanolamine, 0.525ml 10N HCl 
Proteinase K buffer 50mM Tris-HCl pH 7.5, 5mM CaCl2 
Prehybridisation buffer pH 8.5 50% formamide (Ambion) 




250µg/ml yeast tRNA 
0.1% SDS 
20XSSC pH 7.5 
 
NaCl 87.66g, Trisodium Citrate 44.12g in 
500ml of DEPC-treated water 
Post-hybridisation wash buffer I 1X SSC, 10mM DTT 
Post-hybridisation wash buffer II 0.5XSSC,10mM DTT 
TBS (Tris-buffered saline) pH 7.5 100mM Tris.HCl, 150mM NaCl 
Blocking solution 
 




0.1M Tris pH 9.5, 0.1M NaCl, 50mM MgCl2  
Developing buffer 
 
0.1M Tris pH 9.5, 0.1M NaCl, 1mM 
levamisole 
 
2.4.2.2 Tissue preparation 
 
Immediately after dissection, kidneys were fixed by 4% PFA at 4°C overnight and 
stored in 70% ethanol at 4°C. Kidneys were then embedded in paraffin, sectioned by 
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microtome (10µm in thickness), mounted onto slides and dried at room temperature 
overnight. Dried sections can be directly subjected to in situ hybridisation procedures 
or kept at 4°C for future use.  
 
2.4.2.3 Hybridisation protocol 
 
Kidney sections mounted onto slides were washed twice in Histoclear (Brunel 
Microscopes Ltd) to remove wax and were rehydrated through a series of graded 
ethanol followed by washing twice in PBS. Samples were fixed again in 4% PFA at 
room temperature for 15 min. After two washes in PBS, slides were incubated in 
TEA buffer for 5 min including freshly added acetic anhydride to a concentration of 
0.25% (v/v). Additional acetic anhydride was added to a final concentration of 0.5% 
(v/v) to acetylate samples for another 5 min. Samples were washed in 2X SSC for 3 
min and were subjected to proteinase K digestion at 37°C for 30 min. Digestions 
were stopped by washing in freshly prepared 2mg/ml glycine in PBS for 5 min. 
Kidneys were washed twice in PBS and were then incubated in prehybridisation 
buffer at 37°C in a humidified chamber for 2 hours. After prehybridisation, slides 
were immersed into 2X SSC for 5 min. The probe at a final concentration of 
200ng/ml was heated at 80°C for 5 min before being added onto the sections. 
Hybridisation with the probe was carried out at 50°C overnight. Protect RNA 
(Sigma), at the concentration of 2µl/ml, was used in all solutions after digestion with 
proteinase K until the end of hybridisation. Post-hybridisational washes were 
performed as one quick wash in post-hybridisation wash buffer I at room temperature, 
two 15 minutes’ washes in post-hybridisation wash buffer I at 65°C, two 15 minutes’ 
washes in post-hybridisation wash buffer II at 65°C, and a 10 minutes’ wash in post-
hybridisation wash buffer II at room temperature. After washing in TBS (5 min x 3), 
kidney sections were covered with blocking solution for 30 min and were incubated 
overnight at 4oC in alkaline phosphatase-conjugated anti-DIG antibody (Roche) at 
1:2000 dilution in fresh blocking solution. The next day, sections were washed in 
TBS (5 min x 3) followed by B2 buffer for 10 min. Samples were developed in 
developing buffer containing NBT/BCIP (18µl/ml). When satisfactory staining was 
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obtained, the colour reaction was stopped by rinsing the slides several times in tap 




2.5.1 Tissue preparation 
 
At the end of kidney culture, the culture medium was aspirated off and replaced by 
100% ice cold methanol. This was left for 10 min so that kidneys could fix to the 
filters. The filters with attached kidneys were transferred to a labelled bijou and fixed 
in pure methanol at 4°C overnight. For long term storage, these samples were kept in 
100% methanol at –20°C. 
 
2.5.2 Immunofluorescence protocol 
 
Kidneys were washed in PBS for 1 hour at room temperature with gentle rocking. 
They were then incubated in primary antibodies diluted in PBS at 4°C overnight. 
Next day, the kidneys were washed in PBS for 1 hour at room temperature and were 
then incubated in secondary antibodies diluted in PBS at 4°C overnight (see result 
chapters for the antibodies used and their dilutions). The kidneys were washed again 
in PBS for 30 min at room temperature. Kidneys with filters were then mounted on a 
glass slide using the aqueous mountant Mowiol and were imaged by confocal 
microscopy.  
 
2.6 siRNA-mediated RNA interference 
 
2.6.1 siRNA oligos 
 
siRNA oligos were purchased from Dharmacon. siRNA oligos were resuspended in 
1X siRNA buffer to make 20µM stocks. The siRNA stocks were aliquoted and stored 
at -20°C. The siRNA oligos used in this project included Dact1 siRNA, non-
targeting siRNA (siCONTROL) and fluorescently-labelled siRNA, siGLO. Dact1 
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siRNA was a pool of four rationally designed siRNAs targeting the open reading 
frame of Dact1 mRNA (NCBI RefSeq Database, accession number 
NM_021532). The 5' start positions for each of the four oligos were 381, 656, 1078 
and 1653. Table 2-3 listed the target sequences of these four oligos and Tabe 2-4 
showed the sequences of these four siRNAs. Non-targeting siRNA was designed to 
share little or no homology with known mRNA targets. They were used as controls 
detecting non-specific effects caused by the introduction of any siRNA. siGLO was a 
Cy3-labelled siRNA targeting mouse lamin A (NCBI RefSeq Database, accession 
number NM_019390) and was used to establish the conditions for optimal siRNA 
delivery and to monitor siRNA transfection efficiency during the experimental 
procedures. 
 
Table 2-3 Target sequences of the Dact1 siRNA duplexes.  
Duplex 5' start positions Target sequences 
1 1078 GGAATAACCTCTTTGGAAAAC 
2 381 GCAGATAAGTGACCTGAGACT 
3 656 GGAATGACGTATATCGCTACC 
4 1653 GAAGTGCCGTTTCCCAGACGA 
 
 
Table 2-4 Sequences of the Dact1 siRNA duplexes. All are represented in a 5’ to 3’ 
orientation.  
 Sense siRNA strand Antisense siRNA strand 
Duplex 1 AGAUAAGUGACCUGAGACUUU AGUCUCAGGUCACUUAUCUUU 
Duplex 2 AAUGACGUAUAUCGCUACCUU GGUAGCGAUAUACGUCAUUUU 
Duplex 3 AAUAACCUCUUUGGAAAACUU GUUUUCCAAAGAGGUUAUUUU 
Duplex 4 AGUGCCGUUUCCCAGACGAUU UCGUCUGGGAAACGGCACUUU 
 
2.6.2 siRNA transfections 
 
siRNA transfections were carried out in a 24-well plate. Each treatment was 
performed in triplicate. One day prior to transfection, cells were plated at a density of 
5x104cells/well in plating medium. The medium was replaced by fresh plating 
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medium 0.4ml/well 30 min before transfection. For each well, proper amount of 
siRNA and 1.2µl of siLentFect (Bio-rad) were diluted in 50µl of Opti-MEM (Gibco) 
in two separate tubes and incubated at room temperature for 5 min. Transfection mix 
was made by mixing the solutions of these two tubes and incubated at room 
temperature for 20 min. 100µl of transfection mix was then added to each well, 
yielding 10nM siRNA. After gently rocking, the plate was then moved into the cell 
culture incubator with 5% CO2 at 37°C. 
 
2.7 BrdU incorporation assay 
 
2.7.1 BrdU incorporation 
 
Cells were grown on a coverslip in a well of a 24-well plate. The cell culture medium 
was replaced by BrdU (Sigma) 20µM in DMEM 45 min prior to 
immunocytochemistry. The cells were cultured at 37°C with 5% CO2. 
 
2.7.2 BrdU immunocytochemistry 
 
All the procedures were carried out at room temperature unless otherwise stated. 
Cells were washed in PBS (5 min x 3) and were fixed by 4% PFA at 4ºC for 30 min. 
Following fixation, cells were washed in wash buffer, which was 1% Triton X-100 in 
PBS (5 min x 3). 2N HCl was then used to denature the DNA in cells at 37ºC for 30 
min. After one wash in wash buffer, cells were neutralised by 0.1M sodium 
tetraborate (pH 8.5) for 2 min followed by washing in wash buffer (5 min x 3). 1% 
BSA in wash buffer was used as blocking buffer and primary antibody diluent.  Cells 
were blocked in blocking buffer at 37ºC for 30 min and were then incubated with rat 
anti-BrdU antibody (Oxford biotechnology) at 1:100 dilution in the blocking buffer 
at 4ºC overnight. The next day, cells were washed in wash buffer (5 min x 3) and 
were then incubated in TRITC-conjugated anti-rat IgG (Sigma) at 1:100 dilution in 
PBS at 37ºC for 2 hours. After washing for three times, cells were counterstained by 
2µl of TO-PRO-3 (Invitrogen) in 500µl of PBS for 5 min followed by PBS wash for 
5 min.  Cells were then subjected to mounting and imaging. 
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2.8 Generation of Dact2 shRNA stable cell lines 
 
2.8.1 Vector information 
 
The SureSilencing Dact2 shRNA plasmids (Superarray) were designed and validated 
to knockdown the expression of Dact2 specifically by RNAi. This kit contained four 
Dact2 short-hairpin RNA (shRNA) plasmids and one control plasmid. Each plasmid 
was constructed based on the same parent vector, pGeneClipTM Neomycin vector 
(Figure 2-2, Promega), and was able to express a shRNA under the control of the U1 
promoter. It also expressed a neomycin resistance gene, which enabled selection of 
stably transfected cells. The only difference between control and Dact2 shRNA 
plasmids was the shRNA sequences, as the former contained a scrambled artificial 




Figure 2-2 pGeneClip™ Neomycin Vector.  
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2.8.2 E. coli transformation 
 
2µl of each stock plasmid was added to 50µl of thawed competent E. coli cells 
(JM109, Promega) in a 1.5ml microcentrifuge tube on ice. The following procedures 
were the same as those described in section 2.3.2. 
 
2.8.3 Plasmid purification 
 
Plasmid DNA was isolated using a commercially available kit (EndoFree Plasmid 
Maxi Kits, Qiagen). For the extraction of plasmid DNA, a single colony was picked 
with a sterile loop to inoculate 2.5ml of LB broth containing 50µg/ml ampicillin. 
This starter culture was incubated with vigorous shaking at 37°C until just a hint of 
turbidity observed. 250µl of the starter culture was then inoculated into 250ml of LB 
broth containing 50µg/ml ampicillin. This culture was incubated with vigorous 
shaking at the speed of 225rpm in an orbital shaker at 37°C overnight. After 
incubation of 12-16 hours, plasmid DNA was extracted according to the 
manufacturer’s instructions. The concentration of the isolated DNA was determined 
by spectrophotometry. 
 
2.8.4 Diagnostic restriction digest 
 
To verify the purified plasmids containing the shRNA inserts, a Pst1 restriction 
enzyme (Roche) digestion was performed on each plasmid. The restriction digestion 
procedures were the same as those described in the section 2.2.8. A diagnostic pair of 
bands, with the sizes of 3827bp and 991bp respectively, shown on agarose gel 
confirmed the correct insert in each plasmid. 
 
2.8.5 Plasmid transfection 
 
In a 6-well cell culture plate, mIMCD-3 cells were plated at a density of 
5.0x105cells/well in fresh plating media and were cultured at 37°C in a humidified 
incubator. Transfection mix was prepared when cells have reached 90-100% visual 
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confluency. For each well, 2µg of plasmid and 6µl of Metafectene Pro (Biontex) 
were diluted in 100µl of serum- and antibiotic-free medium in separate tubes and 
incubated at room temperature for 5 min. The DNA solution was then added into the 
Metafectene Pro solution and the mixtures were incubated at room temperature for 
20 min. After incubation, the DNA-lipid complexes were added dropwise into each 
well and cells were cultured at 37°C in a humidified incubator with 5% CO2.  
 
2.8.6 Selection for neomycin resistance 
 
Before plasmid transfection, a G418 (Calbiochem) killing curve was performed to 
determine the effective concentration, that is the minimal concentration needed to 
kill all the untransfected cells. In this project, the minimal G418 concentration 
required to kill untransfected cells was 400μg/ml. After transfection, cells were 
plated at 10% confluency in a 6-well plate growing in culture media containing 
400μg/ml G418.  Control plates, including untransfected cells growing in G418 
media and transfected cells growing in media without G418, were also carried out in 
parallel to ensure the selection conditions were working. Media were replaced every 
three days for two weeks when the drug resistant clones appeared. Cells were then 
passed onto separate sterile 10cm petri dishes. In each dish, several individual cells 
were selected and marked. Once the colonies developed to an appropriate size, they 
were picked by sterile pipette tips and seeded to separate wells in a 24-well plate. 
Eight clones were selected for each transfectant. Cells were cultured in media with 
reduced G418 concentration (100μg/ml). A stock of stably transfected cells was 






Mountants used in this project were 50% glycerol in PBS for in situ hybridisation 




To prepare Mowiol mounting medium, 2.4g of Mowiol (Calbiochem) was added to 
4.76ml of glycerol in a 50ml conical flask and stirred to mix. 12ml of distilled water 
was added and the mixture was left overnight at room temperature. The following 
day, 12ml of 0.2M Tris (pH8.5) was added and the solution was heated to 50°C for 2 
hours with occasional vortexing. When the Mowiol had dissolved, the solution was 
clarified by centrifugation at 2000rpm for 15 min. 0.72g of 1,4-diazobicyclooctane 
was then added. The solution was aliquoted and stored at -20°C. This mountant was 
warmed to room temperature before use. 
 
2.9.2 Confocal microscopy 
 
Samples stained by immunofluorescence were imaged using the TCS NT Leica 
confocal laser scanning microscope (Leica Microsystems). Samples were imaged on 
the FITC and TRITC channels separately to avoid cross talk between the two 
channels. For kidney samples, optical sections were set to 5μm in thickness and 
serial optical sections were obtained. Sections were scanned four times and averaged. 
Maximum projection images of a series were presented. For cell samples, images 
were captured on the FITC and TRITC channels individually and the maximum 
projection images were presented. 
 
2.9.3 In situ hybridisation imaging 
 
In situ hybridisation images were captured by using a Zeiss Axioplan II microscope 
(Carl Zeiss) equipped with a Photometrics CoolSnap HQ CCD camera (Roper 
Scientific). Images were captured using scripts written by Dr. Paul Perry for IPLab 
Spectrum v3.6 (Scanalytics) which controlled camera capture, scale bar generation 









































More and more genes are being shown to be involved in kidney development. To 
learn more about these genes, one important question to address is when, where and 
how they are normally expressed. From the viewpoints of developmental biologists, 
temporal and spatial expression profiles can shed light on particular events (cell 
proliferation, cell differentiation, tissue patterning, etc) in the developmental process. 
This information may also reveal valuable clinical significance when compared to 
those in pathological state such as cancer and degenerative diseases. This will, at 
least, contribute to early and accurate diagnosis and precise prognosis and may 
render new therapeutic strategies.   
 
Expression of Dact genes in mouse embryos has been described before (Cheyette et 
al., 2002; Fisher et al., 2006) but little is known about expression in developing 
kidneys. The first goal of this study was to fill this research gap. In this chapter, I 
will demonstrate the expression of both Dact genes in embryonic kidneys and 
describe their temporal and spatial expression patterns in kidneys at a series of 
developmental stages. These results were expected not only to offer biological 
significance of both genes in kidney development but to serve as a foundation for 
subsequent gene knockdown and regulation experiments.  
 
The importance of transcript diversity in organ development has been published in 
various organ systems including kidneys (Hammes et al., 2001; Igarashi et al., 1995; 
Natoli et al., 2002), testes (Elliott and Grellscheid, 2006) and limbs (Narita et al., 
2007). The crucial roles of transcript diversity in kidney development can be 
exemplified by the work on NKCC2, a gene encoding Na-K-Cl cotransporter, and 
Wt1 (Wilms’ tumour gene). Igarashi et al. showed different expression patterns of 
the three isoforms of NKCC2 in E16.5 metanephroi (Igarashi et al., 1995). By 
generating mouse strains that specifically lack the Wt1(-KTS) or Wt1(+KTS) splice 
variant, Hammes et al. demonstrated that homozygous mice lacking the Wt1(-KTS) 
variant showed hypoplastic kidney whilst homozygous mice lacking the Wt1(+KTS) 




When this project was started, two transcript variants of Dact1 had been reported in 
the database ASD (Alternative Splicing Database Project) (Stamm et al., 2006), 
which has been now combined into a new database ASTD (Alternative Splicing and 
Transcript Diversity) (http://www.ebi.ac.uk/astd/). In this database, they were 
designated as splicing pattern 1 (SP1) and splicing pattern 2 (SP2) with the transcript 
ID TRAN00000167620 and TRAN00000167621, respectively. However, whether 
these transcripts are expressed in developing kidneys remained unknown. In this 
chapter, I will demonstrate the expression of these predicted transcripts in developing 
kidneys. I will also show a novel transcript variant, which was previously 
undiscovered, in developing kidneys. Besides, verifying the expression of these 
Dact1 transcript variants helped to design efficient siRNA duplexes to target all the 
transcripts simultaneously in my subsequent RNAi experiments (refer to chapter 5 
and 6). Therefore, I will examine the expression of these transcript variants in 
developing kidneys and NIH3T3 cells, both of which were key models used to 
investigate Dact1 functions in this project.   
 




Conventional end-point RT-PCR was performed to confirm the expression of Dact1 
and Dact2 expression in embryonic kidneys and, in addition, it was used to show the 
transcript diversity of Dact1 in an embryonic cell line and in kidneys. The primer 
pairs used to confirm the expression of both Dact genes were designed to span exon 
2 (Figure 3-1). The binding sites of these primers are depicted in Figure 3-1 and the 
sequences are listed in Table 3-1. To illustrate the transcript diversity of Dact1, 
primers were designed to span the exon 3-exon 4 boundary. The binding sites of 







Figure 3-1 Binding sites of PCR primers used to clone mouse Dact1 and Dact2
genes. A schematic diagram shows the binding sites of PCR primers on Dact genes. 
Coloured bars refer to different exons i.e. exon 1 (blue), exon 2 (yellow), exon 3 
(magenta) and exon 4 (green). The forward primer binds to the antisense strand, the 
reverse primer to the sense strand. Amplicons generated by Dact1 primers were 
321bp in size whilst those generated by Dact2 primers were 341bp in size. 
Table 3-1 The sequences of the PCR primers used to clone mouse Dact1 and 
Dact2 genes. The forward primer binds to the antisense strand, the reverse primer to 




Forward Primer Reverse Primer 
Dact1 NM_021532 GGAGGAGAAGTTCCTGGAAGA CCGTCTGAGATGGTCAAGG 





Figure 3-2 PCR primer binding sites on cDNA of the two transcripts of Dact1. 
Primer A was designed to only amplify SP1 while primer B would amplify both SP1 
and SP2. Coloured bars refer to different exons. The red segments with 111bp in size 




Table 3-2 The sequences of PCR primers used to illustrate transcript diversity 
of Dact1. The forward primer binds to the antisense strand, the reverse primer to the 
sense strand. All oligos are represented in a 5’ to 3’ orientation.  
 
Primer names Forward Primer Reverse Primer 
A TTCGGGCTCCCTCTCTAACT CAGATCCAATGCAGATGTCG 
B GGTTTTATGAGCTGAGTGATGG GACACAAGATCACACTGGTATTTAGG
 
3.2.2 Quantitative real time PCR 
 
Quantitative real time PCR was used to establish the expression profiles of Dact1 
and Dact2 on kidneys at various times during embryonic and postnatal development. 
In order to validate the technique, I performed quantitative real time PCR to measure 
Notch1 expression in the microdissected kidneys.  Notch1 is a well-investigated gene 
in developing kidneys and I found that the Notch1 expression level was very low at 
E12.5 and was greatly increased from E15.5 to E17.5. This expression pattern was 
consistent with the work that has already been published (Chen and Al-Awqati, 
2005). Table 3-3 shows the sequences of the primer pairs used. Kidneys at stages 
with significant developmental importance were chosen. Namely, E11.5 was the time 
when nephrogenesis started, E14.5 and E15.5 stood for the most intensive renal 
organogenesis period, and P14 was the time when nephrogenesis ceased (Bard, 2003; 
Saxen, 1987). Adult kidneys were also included to complete the temporal expression 
profiles. Expression levels were obtained by normalisation to a housekeeping gene, 
Actb. In Dact1 expression profile, expression levels were converted to those relative 
to E11.5 kidneys while in Dact2 expression profile, expression levels were shown as 
those relative to E17.5 kidneys. Three independent experiments were carried out and 
the results are shown in Figure 3-7 and 3-8. Student t tests were used to assay the 
differences in the expression levels between samples. When a p-value was less than 




Table 3-3 Quantitative real time PCR primers used to profile Dact1 and Dact2 
expressions. The forward primer binds to the antisense strand, the reverse primer to 
the sense strand. All oligos are represented in a 5’ to 3’orientation. Actb was used as 




Forward Primer Reverse Primer 
Dact1 NM_021532 GCCGGTTTGTTGAATCAGTT CGAAGCTCCATCACTCAGC 
Dact2 BC058740  AGCTGGATGTGAGCAGGTCT GCAGGAGGTGGACAGAGAAC
Actb NM_007393 GATCTGGCACCACACCTTCT GTACATGGCTGGGGTGTTG 
 
3.2.3 RNA in situ hybridisation 
 
RNA in situ hybridisation was performed in whole mounts and on sections to 
characterise the spatial expression patterns of both Dact1 and Dact2. DIG-labelled 
RNA probes were made by in vitro transcription as described in section 2.4.1 and 





3.3.1 Demonstration of Dact1 and Dact2 expression in metanephroi 
 
Conventional end-point PCR was used to show the expression of both Dact genes in 
embryonic kidneys (Figure 3-3). On E14.5 kidneys, two single bands of the expected 
size for Dact1 (321bp) and Dact2 (341bp) were apparent. The same reactions, 







Figure 3-3 E14.5 metanephroi express Dact1 and Dact2. Compared with a 100bp 
ladder (left lane), PCR ethidium bands of the appropriate size for Dact1 and Dact2
cDNA were present in E14.5 metanephros RNA samples with RT added (+) but not 
in metanephros samples when no RT was added (−). 
 
3.3.2 Identification of three splicing variants of Dact1 
 
When this project started, there were only two predicted splicing variants of Dact1 in 
the ASTD database. Based on the sequences provided in this database, I designed 
two primer pairs (Figure 3-2 and Table 3-2) to amplify cDNA fragments derived 
from these two transcripts in both NIH3T3 cells and E14.5 kidneys. Primer pair A 
aimed to amplify SP1 transcript whilst primer pair B inevitably amplified both 
transcripts. Figure 3-2 illustrated the binding sites of these primers. 
 
The transcript diversity of Dact1 was examined in NIH3T3 cells and E14.5 kidneys. 
As shown in Figure 3-4, both NIH3T3 cells and E14.5 kidneys expressed the same 
transcript diversity. Primer pair B amplified the cDNA of the two transcripts and 
hence yielded two expected bands of appropriate sizes (301 and 190bp). Primer pair 
A aimed to generate an amplicon at the size of 314bp but also amplified an extra 
product, which was about 110bp larger in size. This extra band may indicate the 






Figure 3-4 Transcript diversity of Dact1 in both NIH3T3 cells and E14.5 
kidneys. Primer pair B amplified cDNA fragments from both transcript variants 
yielding two bands at the expected sizes (301bp and 190bp). Primer A aimed to 
obtain an amplicon only from SP1 at the size of 314bp revealed an additional band 
(425bp) (yellow arrow). Actb was used as a positive control. NTC refers to no 
template control. 
 
By reviewing the sequences of both SP1 and SP2, I noted that the first 111bp of the 
exon 4 of SP2 was exactly the same as part of the intron sequence immediately 
upstream to the exon 4 of SP1 (Figure 3-2). Taking into account the size of the extra 
band, I hypothesized that there may be another transcript, SP3, which shared 
homology with SP1 but contained an insertion of a short segment of intron sequence 
with 111bp in size. To confirm this hypothesis, I cloned each PCR product shown in 
Figure 3-4 into pGEM®-T Easy vectors (Promega) and sent the purified plasmids to 
DNA sequencing service. The sequencing results, shown in Figure 3-5 and 
summarised in Figure 3-6, confirmed that SP3 was generated though an alternative 3’ 





Figure 3-5 DNA sequencing results of cDNA fragments of Dact1. PCR products 
shown in Figure 3-4 were cloned into pGEM®-T Easy vectors and sent to the 
sequencing service. Green colour refers to sequences of exon 4. Magenta colour 
refers to sequences of exon 3 and red to the inserted intron sequences immediately 
upstream to exon 4. The exon organisation of the three transcript variants is depicted 
in Figure 3-6.





















































Figure 3-6 The exon organisation of the three Dact1 splice variants. A schematic 
diagram illustrates the exon organisation of the three Dact1 splice variants. Each 
transcript has four exons. Coloured bars depict different exons, namely exon 1 (blue), 
exon 2 (yellow), exon 3 (magenta) and exon 4 (green in SP1, red and green together 
in SP2 and SP3). The red bar in SP2 and SP3 were from intron sequences 
immediately upstream to exon 4 (green) of SP1.  
 
3.3.3 Temporal expression patterns of Dact1 and Dact2 in mouse kidneys 
 
Having confirmed the expression of both Dact genes in embryonic kidneys (Figure 
3-3), quantitative real time PCR and RNA in situ hybridisation were performed to 
delineate the temporal and spatial expression profiles of both Dact genes in kidneys. 
Quantitative real time PCR showed that the Dact1 expression levels in embryonic 
kidneys were higher than those in adult kidneys. In adults, the expression level of 
Dact1 was about 20% of that at E11.5 (Figure 3-7). However, the level of Dact2 
expression increased from E11.5, peaked at E17.5, and decreased at P14 and in adult. 






Figure 3-7 The temporal expression pattern of Dact1 in mouse kidneys. 
Quantitative real time PCR showed that Dact1 was downregulated in adult kidneys. 
Actb was used as an internal control. Data were collected from three independent 
experiments and are represented as Mean ± SEM. Paired comparisons were made by 
Student t tests. The difference was considered to be statistically significant when a p-






Figure 3-8 The temporal expression pattern of Dact2 in mouse kidneys. 
Quantitative real time PCR showed that Dact2 level increased from E11.5, peaked at 
E17.5 and then decreased at P14 and in adult. In adult kidneys, the expression of 
Dact2 maintained at a level similar to that at E14.5. Actb was used as an internal 
control. Data were collected from three independent experiments and are represented 
as Mean ± SEM. Paired comparisons were made by Student t tests. The difference 
was considered statistically significant when a p-value was less than 0.05. 
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3.3.4 Dact1 is expressed in metanephric mesenchyme followed by renal stroma 
 
Spatial expression patterns of both Dact genes in E11.5, E12.5 and E14.5 kidneys 
were illustrated by RNA in situ hybridisation. The transcripts, detected by DIG-
labelled complementary RNA probes, were shown as purple precipitates in the tissue. 
Both sense and anti-sense probes for each Dact gene were used in parallel to confirm 
the specificity of the detected signal. As shown in Figure 3-9, at E11.5 and E12.5, 
Dact1 was expressed by the metanephric mesenchymal cells. At E14.5, Dact1 
expression showed a honeycomb appearance in the whole kidneys. This pattern was 
a characteristic pattern of renal stroma (Levinson and Mendelsohn, 2003b; Quaggin 
et al., 1999). Notably, at E14.5, the differentiated medullary zone showed stronger 






Figure 3-9 Spatiotemporal expression patterns of Dact1 in kidneys at early 
developmental stages. RNA in situ hybridisation showed that Dact1 was expressed 
by metanephric mesenchyme at E11.5 (a) and E12.5 (b). At E14.5 (c), Dact1
expression exhibited a characteristic honeycomb appearance. Representative sense 
control (d) revealed no staining. The area encompassed by the white box (c) is shown 
at higher magnification in panel (e) to illustrate the UB tips (red arrow) and the 
stroma (blue arrow). Scale bar =100µm. 
 
Expression patterns of both Dact genes in kidneys from later stages were also 
examined. I initially tried to do whole mount in situ hybridisation on E17.5 and P14 
kidneys but obtained no staining at all. This could be due to the penetration problem 
resulted from the gradually-formed renal capsule in late stage kidneys. To overcome 
the penetration problem, the experiments were carried out on kidney sections. These 
experiments aimed not only to reveal expression patterns but to investigate the 
reasons of downregulation of both Dact genes in adult kidney. As quantitative real 
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time PCR revealed decreased levels of both Dact genes in P14 and adult kidneys 
(Figure 3-7 and 3-8), RNA in situ hybridisation would help to answer whether this 
down-regulation was caused by reduced numbers of Dact-expressing cells or by the 
less expressed mRNA in P14 and adult kidneys. Figure 3-10 showed that Dact1 was 
still highly expressed in kidneys at E17.5 and P14 but weakly expressed in adult 
kidneys. In adult kidneys, the Dact1 expression seemed to be restricted only to the 
central medullary zone. By Figure 3-10, the low level of Dact1 expression in adult 
kidneys, as judged by quantitative real time PCR (Figure 3-7), was probably due to 




Figure 3-10 RNA in situ hybridisation of Dact1 on kidney sections at E17.5, P14 
and adult. Sense controls (a) showed no staining. Antisense (b) showed Dact1
expression on E17.5 and P14 kidneys while it was weakly expressed in adult kidney. 
Scale bar =1mm. 
 
In addition to the expression in medullary stroma, Dact1 was detected in tubular 
epithelia on E17.5 kidney sections (Figure 3-11). This finding suggested that Dact1-






Figure 3-11 Dact1 expression on E17.5 kidneys. Sense controls (a) showed no 
staining. Antisense (b) showed Dact1 expression was detected at tubular epithelia 
(green arrows) and stromal cells (yellow arrows). Scale bar =100µm. 
 
3.3.5 Dact2 is expressed exclusively in ureteric buds 
 
Distinct from Dact1, Dact2 was expressed in the ureteric buds throughout the 
developmental stages (Figure 3-12 and 3-14). It was expressed in both tip and stalk 
region of the ureteric buds. Dact2 was easily detected by RNA in situ hybridisation 
on E17.5, P14 and adult kidney sections (Figure 3-13). This finding was compatible 




Figure 3-12 Spatiotemporal expression patterns of Dact2 in kidneys at early 
developmental stages. RNA in situ hybridisation showed that Dact2 was expressed 
exclusively by the collecting duct system. Dact2 transcripts were shown as purple 
staining at the T-bud stage, E11.5 (a) and more advanced branching at E12.5 (b) and 
E14.5 (c). Sense controls, represented as (d), were performed in parallel and showed 





Figure 3-13 RNA in situ hybridisation of Dact2 on kidney sections at E17.5, P14 
and adult. Sense controls (a) showed no staining. Antisense (b) showed strong 






Figure 3-14 Dact2 expression on E17.5 kidneys. Sense controls (a) showed no 
staining. Antisense (b) showed Dact2 expression was found at tubular epithelia 
(arrows). Scale bar =100µm. 
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3.3.6 In vitro kidney culture retains Dact1 and Dact2 expression patterns 
 
Kidney in vitro culture is a powerful system where developing kidneys are accessible 
to exogenous growth factors, drugs, siRNA and to imaging. In this project, I took 
advantage of this system and aimed to investigate impacts of siRNA and some 
regulators on the Dact expression patterns. It was therefore crucial to obtain evidence 
to confirm that cultured kidneys developed the same expression patterns as seen in 
vivo.  Kidneys were dissected at E11.5 and subjected to ex vivo culture for 72 hours. 
Whole mount RNA in situ hybridisation on these cultured kidneys (Figure 3-15) 
illustrated a characteristic honeycomb appearance for Dact1 and a tree-like 
appearance for Dact2. Both resembled their characteristic expression patterns at 
corresponding developmental stages. This confirmed the feasibility of subsequent 
drugs and RNAi experiments and showed the applicability of RNA in situ 






Figure 3-15 Dact1 and Dact2 expression patterns in E11.5 kidneys cultured in 
vitro for 72 hours. Dact1 (a) showed a honeycomb appearance while Dact2 (b)
revealed a tree-like appearance. Both resembled their specific patterns at the 
corresponding developmental stages shown in Figure 3-9 (c) and Figure 3-12 (c). 
Scale bar =200µm. 
3.3.7 Attempts to localise DACT1 protein in mouse kidneys 
 
In addition to detecting transcripts of both Dact genes, I also tried to localise DACT 
proteins in kidneys. However, I have not obtained encouraging results so far. The 
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DACT1 antibody (Orbigen) did not work either in whole mounts or sections with 
5µm in thickness, although I have tried different fixatives, various methods of 
antigen retrieval, a range of incubation time and temperature of the antibody and 
serial dilutions of either primary or secondary antibodies. No DACT2 antibody is 
commercially available or has ever been described in the literature. The DACT1 
antibody used was originally designed to react with human DACT1 and its ability to 
identify DACT1 has been shown only in human tissues (Schuetz et al., 2006). As 
described in the data sheet from the supplier, the immunogen used to develop the 
antibody is KLH-conjugated synthetic peptide consisted of amino acids 152-168 
(ETDSRPSSGFYELSDGT) of the human DACT1 protein. This peptide matches the 
amino acids 145-161 (ETDSRPSSGFYELSDGA) of mouse DACT1 protein except 
the last amino acid changing from T to A. Therefore, this species-specific factor may 





3.4.1 Mapping Dact1 expression pattern to known mesenchymal genes 
 
Mouse metanephric mesenchyme consists of a few thousand cells at E11.5 when they 
have similar morphology but will eventually adopt various fates to become nephrons, 
endothelial cells, vascular smooth muscle cells, neuronal cells and embryonic renal 
stroma (Sariola et al., 2003b). From E12-13, mesenchymal cells that follow the fate 
to form renal stroma surround the epithelial components of the developing kidney 
(refer to section 1.2.3). This arrangement gives rise to a honeycomb expression 
pattern in whole mounts in situ hybridisation. Although those reported genes 
expressed by the renal stroma show a honeycomb appearance, they may express 
different intensity in the different zones throughout the whole kidney. For example, 
the well-researched stromal marker Foxd1 is highly expressed by subcapsular 
stromal cells (Hatini et al., 1996) whilst Smad2 shows a complementary pattern to 




Dact1 showed an expression pattern resembled Smad2. It was expressed by cells 
other than ureteric buds at E11.5 and E12.5. By E14.5, these cells formed a 
characteristic stromal pattern with stronger expression found in the medullary stroma 
where cells were more differentiated. To better understand how Dact1 was expressed 
and regulated by known genes expressed in stroma, an important step was perhaps to 
characterise the mRNA expression patterns of the stromal genes. Figure 3-16 
illustrates four expression patterns. These patterns are based on the relative intensity 
of expression for a given gene among different zones of kidneys and do not reflect 
differences in expression levels between genes. Dact1, Smad2, Smad7, Pod1 and 
Snep were expressed predominantly in medullary stroma (Lee and Davies, 2006; 
Leimeister et al., 2004; Quaggin et al., 1999; Vrljicak et al., 2004). Foxd1, Smad4 
and Smad6 are strongly expressed in the nephrogenic zone, which is a pattern 
complementary to Dact1. Tgfb1, Smad8, Rarb2 and Pbx1 are expressed equally in 
both cortical and medullary stroma. Bmp4, Smad1, Smad3 and Smad5 are expressed 
by both cortical and medullary stroma but have stronger expression in cortical stroma 
(Hatini et al., 1996; Mendelsohn et al., 1999; Schnabel et al., 2003; Vrljicak et al., 
2004). This classification might imply that Dact1 is regulated in a way resembling 
Samd2, Smad7, Pod1 and Snep. Alternatively, it might suggest that Dact1 is 





Figure 3-16 Four expression patterns of stromal genes. Schematic diagram shows 
four different expression patterns of stromal genes based on the relative expression 
intensity of a given gene among different zones of kidneys. Dact1, Smad2, Smad7, 
Pod1 and Snep are expressed predominantly by medullary stroma. 
 
3.4.2 Impacts of the discovery of a novel Dact1 transcript variant 
 
As transcript diversity generated by alternative splicing and associated mechanisms 
contributes heavily to the functional complexity of various biological systems (Elliott 
and Grellscheid, 2006; Hoppler and Kavanagh, 2007; Igarashi et al., 1995; Narita et 
al., 2007; Natoli et al., 2002), it is crucial to examine the expression of these splicing 
variants of Dact1 in developing kidneys. In addition, for the benefit of the 
subsequent RNAi experiments, identification of all potential transcript variants offers 
useful information not only on the design of effective siRNA duplexes but the design 
of primers for efficient real time PCR detection of the gene silencing effect. 
Although the reasons of transcript diversity and the mechanisms of splicing 
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regulation are beyond the scope of this project, confirmation of predicted transcript 
variants and the discovery of new variants of Dact1 gene, render a new direction of 
research into its function and regulation.  
 
3.4.3 Dact2 as a new marker of ureteric buds 
 
Unlike Dact1, Dact2 is expressed exclusively in ureteric buds throughout 
developmental stages and in adult. As development proceeds, ureteric bud cells 
differentiated into at least two distinct types of cells, tip and non-tip cells. Tip cells 
express high levels of c-ros (Kanwar et al., 1995), Ret (Pachnis et al., 1993), and 
Wnt11 (Kispert et al., 1996) and show a round stratified morphology whilst non-tips 
cells do not express these genes and are simple columnar in morphology (Qiao et al., 
1995). Dact2 was expressed in both types of the ureteric bud cells. This pattern 
resembled those of known ureteric bud markers including calbindin-D28K (Liu et al., 
1993), PCD9 (Kloth et al., 1998) and cytokeratin (Brophy et al., 2001).  
 
3.4.4 Implications from the temporal expression profiles of both Dact genes 
 
The level of Dact1 expression was markedly decreased in adult kidneys. This was 
supported by another group (Fisher et al., 2006). By using northern blot, Fisher et al. 
showed that Dact1 was barely detected in normal adult kidneys. As shown in Figure 
3-9, Dact1 was expressed in renal stroma at E14.5. However, during late kidney 
development, many stromal cells are lost through massive apoptosis (Koseki et al., 
1992). This may, at least in part, explain why Dact1 expression was greatly 
decreased in adult kidneys. The temporal expression profile of Dact1 may also 
suggest that Dact1 is likely to exert important functions on embryonic kidney 
development but needs to be turned off in normal adult kidneys. This may be of 
clinical significance. Upregulation of Dact1 in adult kidneys, or any other organs if 
temporal expression profiles available, may thus indicate some pathological process. 
Scheutz et al. incidentally found upregulation of Dact1 in invasive ductal carcinoma 
of breast by using microarray (Schuetz et al., 2006). Although the biological 
functions of Dact1 has not been extensively researched, taking into account its 
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mesenchymal nature and temporal expression profiles, it will not be a great surprise 
to notice its upregulation in invasive cancer where epithelial to mesenchymal 
transition is one of the likely mechanisms of its invasiveness (Hugo et al., 2007; 
Nieman et al., 1999). 
 
The level of Dact2 expression increased as ureteric bud branching advanced and was 
still maintained at a comparable level in adult kidneys. This may imply it was a 
critical component of ureteric buds. Furthermore, as mIMCD-3 cells, a well-
characterised kidney epithelial cell line derived from terminally-differentiated adult 
mouse collecting duct cells, have been used in a well-established tubulogenesis 
model system (Cantley et al., 1994), the expression of Dact2 in adult kidneys 
inspired me the use of this cell line to investigate its functions in branching 




















Expression dependencies of Dact1 and Dact2 on known 





















Chapter 3 answered questions on the expression of both Dact genes in developing 
kidneys. The next question I would like to address was: can their expression be 
modulated by known molecules in developing kidneys? Undoubtedly, there are 
plenty of molecules to be investigated as kidney development is well coordinated by 
a delicate molecular network. In this study, I chose a simple and well known 
molecule, chlorate, to treat the cultured kidneys and assayed the changes in 
expression of both Dact genes.  
 
Sodium chlorate inhibits proteoglycan synthesis and hence stops UB branching, but 
nephrogenesis still occurs in the mesenchyme near the UB tips. Exogenous sodium 
chlorate is known to arrest branching morphogenesis of kidneys growing in culture 
(Davies et al., 1995) and to downregulate mesenchymal gene Gdnf (Sainio et al., 
1997) and UB tip gene Wnt11 (Kispert et al., 1996). Based on the expression patterns 
described in the chapter 3, Dact1 was expressed by stromal mesenchyme and Dact2 
was expressed by the ureteric buds. Therefore, in addition to the well characterised 
morphological change caused by chlorate, chlorate was chosen to assay the 
expression dependencies of both Dact genes because it is able to affect the 
expression of either a mesenchymal gene or a UB gene. 
 
Following the question addressed above, if the expression of Dact genes is regulated 
by known molecules, I would like to investigate if the expression of Dact1 responds 
to any signals that affect stroma. All-trans retinoic acid (ATRA) is known to signal 
through renal stroma and in turn stimulate UB branching, nephrogenesis and stroma 
pattering (Levinson and Mendelsohn, 2003a). I therefore tested the effects of ATRA 
on Dact1 expression by using kidney organ culture, quantitative real time PCR and 





4.2.1 Kidney culture with sodium chlorate or ATRA 
 
To set up chlorate-treated culture, E11.5 kidneys were dissected out and cultured in 
the presence of 30mM sodium chlorate. A control group was set up in parallel and 
cultured in the same way without adding sodium chlorate. The culture time was 24 
hours for quantification of expression levels and 72 hours for kidney morphology. 
 
To investigate the effects of ATRA on Dact1 expression, E11.5 kidneys were 
dissected out and subjected to organ culture (detailed in section 2.1.2) in the absence 
or presence of ATRA at various concentrations ranging from 10-8 to 10-5M. The 
concentrations tested were in the wide range of physiological tissue levels and far 
below the teratogenic dose (Horton and Maden, 1995). ATRA stock solution was 
made in absolute ethanol to the concentration of 10mM and was stored at -20°C for 
up to one week. Serial dilutions of ATRA were made by kidney culture media 
immediately before use. Kidneys were cultured for 72 hours during which culture 
media were changed daily. 
 
4.2.2 Quantitative real time PCR 
 
At the end of culturing, eight kidneys in each dish were collected, homogenised and 
subjected to RNA isolation followed by cDNA synthesis. Quantitative real time PCR 
reactions were carried out in duplicate. The expression levels were normalised to a 
housekeeping gene, Actb, and were then converted to levels relative to controls. Data 
collected from three independent experiments were analysed and shown as Mean ± 
SEM. The differences in expression levels between samples were examined by 
Student t tests. When a p-value was less then 0.05, the difference was considered to 





Immunofluorescence was done to confirm the typical effects of chlorate on kidney 
morphology. Rabbit anti-laminin antibody (Sigma) was used to outline the epithelial 
structures of cultured kidneys. The tissue preparation and the staining procedures are 
described in section 2.5. The secondary antibody used was TRITC-conjugated anti-
rabbit IgG (Sigma). Both antibodies were used at 1:100 dilution in PBS. 
 
In addition, I attempted to illustrate the effects of ATRA on Dact1 expression in the 
whole developing kidneys rather than in homogenised kidneys. As I have shown the 
applicability of RNA in situ hybridisation to the kidney in vitro culture system 
(Figure 3-15) and there was no suitable DACT1 antibody available (detailed in 




4.3.1 Dact1 and Dact2 are upregulated in kidneys cultured with chlorate 
 
The characteristic effect of chlorate on kidney morphology was confirmed and 
shown in Figure 4-1. Kidney morphology was evaluated by anti-laminin staining. In 
Figure 4-1, panel (a) shows that normal kidney morphology was found in kidneys 
cultured without sodium chlorate whilst panel (b) shows that UB branching was 
arrested at the T-bud stage when an E11.5 kidney cultured in the presence of 30mM 
sodium chlorate. Nephrons were found at the tip of the ureteric buds (arrows). 
Quantitative real time PCR revealed that the expression levels of both Dact1 and 
Dact2 genes were increased in chlorate-treated kidneys. The differences in 
expression levels between control and chlorate-treated kidneys were statistically 





Figure 4-1 Upregulation of Dact1 and Dact2 in chlorate treated cultured 
kidneys. Compared with controls (a), arrested UB branching at the T-bud stage and 
the nephrons at the tip area (arrow) found in kidneys cultured with 30mM sodium 
chlorate (b), confirmed its drug effect. Quantitative real time PCR showed 
upregulation of Dact1 (blue) and Dact2 (magenta) genes in chlorate treated cultured 
kidneys (c). Data collected from three independent experiments are represented as 
Mean ± SEM and were analyzed by student t test. * p=0.0072; **p=0.0053. 
 
4.3.2 ATRA upregulates Dact1 expression of kidneys growing in culture  
 
By using quantitative real time PCR, I found that ATRA was able to increase the 
expression level of Dact1 in a dose-dependent manner (Figure 4-2). At the 
concentration of 10-8M, ATRA did not have significant effects on Dact1 expression. 
At the concentration of 10-5M, however, ATRA can increase Dact1 expression level 








Figure 4-2 ATRA upregulates Dact1 expression in kidneys. Quantitative real time 
PCR showed upregulation of Dact1 in kidneys in a does-dependent manner.  Actb
was used as an internal control. Data were collected from three independent 
experiments and were represented as Mean ± SEM. Comparisons were made by 
Student t tests. The difference was considered to be statistically significant when a p-
value was less than 0.05. 
Because PCR is based on using homogenised tissues, the increased Dact1 expression 
seen in ATRA-treated kidneys may not properly reflect the actual Dact1 upregulation 
within renal stroma. In addition to better illustrating the effect of ATRA on Dact1 
expression in developing kidneys, RNA in situ hybridisation in ATRA-treated 
kidneys was able to answer whether ATRA enhanced the stromal pattern of Dact1 
expression or ATRA can even turn on Dact1 expression in cells of epithelial 
components. As shown in Figure 4-3, kidneys cultured in the presence of ATRA at 
the concentration of 10-5M (panel b) exhibited its normal honeycomb expression 
pattern. Compared to the control kidneys (panel a), ATRA seemed to enhance Dact1 






Figure 4-3 ATRA enhances Dact1 expression in kidneys. RNA in situ
hybridisation on E11.5 kidneys cultured in vitro for 72 hours showed that kidneys 
cultured in the presence of 10-5M ATRA (b) seemed to exhibite higher Dact1
expression level than those cultured without ATRA (a). This expression 




4.4.1 Sodium chlorate modulates Dact gene expression in developing kidneys 
 
In this study, I showed that both Dact genes were upregulated in kidneys cultured in 
the presence of 30mM sodium chlorate. This result confirmed that both Dact genes 
were modulated by known molecules in developing kidneys but the reason for this 
needs to be further analysed.  
 
By using the same concentration (i.e. 30mM) of sodium chlorate in kidney culture, 
Sainio et al. showed that sodium chlorate arrests UB branching leading to diminished 
mesenchymal factor GDNF (Sainio et al., 1997). However, I found that the 
mesenchymal gene Dact1 was upregulated by about 25% in response to chlorate. 
This finding at least suggested that Dact1 was not a downstream target of GDNF 
signalling. It might also be possible that ureteric buds normally sent out signals 
which negatively regulated Dact1 expression in the mesenchyme. Exogenous sodium 





I also found that the UB gene, Dact2, was upregulated by about 15% in kidneys 
cultured with chlorate. Although the reason for this upregulation remains unclear, it 
is not uncommon to see that gene expression in the ureteric buds remains in chlorate-
treated kidneys. Examples for these genes include Ret, Pax2 and Bmp7 (Godin et al., 
1998; Kispert et al., 1996; Sainio et al., 1997) 
 
A potential pitfall in the interpretation of my PCR results came from the nature of 
PCR. PCR is based on using homogenised tissues, but I was not sure if there is any 
difference in chlorate sensitivity among various cell populations in developing 
kidneys. An interesting example comes from the expression of Bmp7. In the 
developing kidney, Bmp7 is expressed initially in the UB followed by metanephric 
mesenchyme and the early tubules derived from the mesenchyme (Dudley et al., 
1995; Dudley and Robertson, 1997; Luo et al., 1995; Lyons et al., 1995; Vukicevic et 
al., 1996). However, when kidneys cultured with chlorate, Bmp7 expression in 
mesenchyme was abolished whilst its expression in ureteric buds was unaffected 
(Godin et al., 1998). This difference was discovered by histology analysis on 
Bmp7/lacZ transgenic mice. Errors may thus be introduced if Bmp7 expression is 
assayed in homogenised whole kidneys.  
 
In brief, I have shown that the expression of both Dact genes was modulated by the 
well known regulator, chlorate, in developing kidneys. I would not emphasise the 
extent of upregulation in these two genes because of the potential pitfall in using 
homogenised tissues. This potential pitfall does not detract quantitative real time 
PCR from being a powerful tool to quantify gene expression levels, but histology 
assays (e.g. RNA in situ hybridisation, immunofluorescence, etc) may serve as 
complementary tools especially when analysing gene expression in tissues or organs 
containing mixed cell populations. 
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4.4.2 Dact1 is involved in retinoid-mediated kidney development 
 
The retinoid-mediated kidney development is briefly reviewed in section 1.4.4, but 
nothing is known about the regulation between the stromal mesenchymal gene, 
Dact1, and retinoids. The first report describing the link between Dact1 and retinoids 
was based on the work described above (Lee and Davies, 2007). I have shown that 
exogenous ATRA increased Dact1 gene expression in renal stromal cells (Figure 4-
3). The concentrations of ATRA being tested ranged from 10-8 to 10-5M. I even tried 
to grow kidneys in the presence of higher concentrations of ATRA, but found that 
kidneys were not able to survive. This finding was consistent with those described in 
a rat model where researchers found markedly decreased nephron number, UB 
branching and Ret expression level at high concentrations of retinoids (Moreau et al., 
1998; Vilar et al., 1996).  
 
The mechanism by which ATRA upregulates Dact1 remains unclear. In addition to 
those stromal genes encoding for receptors and metabolic enzymes for RA, one 
stromal mesenchymal gene, Lgl1, has recently been reported to be upregulated by 
RA. The upregulation of Lgl1 by RA is then supported by the identification of a 
retinoic acid response element (RARE) in the promoter region of this gene (Quinlan 
et al., 2007). However, no RARE on the Dact1 gene has been published so far. I 
attempted to localise consensus RARE in the Dact1 promoter regions by using an 
online promoter analysis tool, Tfsitescan (http://www.ifti.org/cgi-
bin/ifti/Tfsitescan.pl) (Ghosh, 2000). None was identified.  
 
Despite the fact that the causes of Dact1 upregulation by ATRA are yet to be 
determined, the quantitative real time PCR performed in this study offered evidence 
that ATRA upregulated Dact1. The complementary histology assay, RNA in situ 
hybridisation, further demonstrated that this upregulation occurred in the renal 
stroma. Based on the Dact1 expression pattern described in chapter 3, it may be 
interesting to ask a question whether ATRA signals through Dact1 to facilitate 
stromal differentiation. One critical step before answering this question is to discover 
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the functions of Dact1 in developing kidneys. This will be described in chapter 5 and 
6. 
 
4.4.3 Implications from regulation of Dact1 and Dact2 
 
In this chapter, I have described the regulation of Dact1 and Dact2 expression by 
known regulators including chlorate and ATRA. Both Dact genes were upregulated 
by sodium chlorate. The expression of the stromal mesenchymal gene, Dact1, was 
also tested by ATRA which is known to signal through renal stroma. By using 
quantitative real time PCR and RNA in situ hybridisation, I showed that Dact1 was 
upregulated by retinoids in renal stroma. In addition to offering evidence that both 
Dact genes were regulated by known regulators in developing kidneys, the results 
presented in this chapter provided insights into potential functions of Dact genes. 
Dact1 may play a role in retinoid-mediated stromal differentiation, nephrogenesis, 
and UB branching. Dact2 may have a role in branching morphogenesis. The 









































Having characterised the expression patterns of both Dact genes in developing 
kidneys, an important question to address is what their functions in kidney 
development are. So far in the literature, however, reports on the biological functions 
of Dact1 and its orthologs have been very limited. Zebrafish Dpr1 is involved in 
somitogenesis. Loss-of-function studies, carried out by the injection of Dpr1 
morpholinos, show that brain anterior to the midbrain-hindbrain boundary is smaller. 
Gain-of-function assays are unable to offer useful information because of early 
embryonic lethality and non-specific toxicity caused by injection of Dpr RNAs 
(Waxman et al., 2004). In Xenopus, Dpr is required for notochord formation. By 
using antisense oligonucleotides to deplete Dpr, Cheyette et al. showed that the 
Xenopus embryos become acephalic or microcephalic. Overexpression of Dpr by 
injection of synthetic Dpr RNA into oocytes results in embryos with enlarged heads 
and curvature of the spine (Cheyette et al., 2002). Studies on the functional roles of 
Dact1 in mammals or in kidneys of any species have not yet been described. In this 
project, I aimed to explore the functions of Dact1 in mouse kidney development. 
Different approaches to this are described in this chapter and in chapter 6. 
 
A key strategy to answer the questions about the functions of gene of interest is to 
remove the gene from the system and look at its consequent phenotype. Following 
this strategy, one of the most promising methods to investigate the functions of a 
gene or protein in kidney development is to apply siRNA to in vitro kidney organ 
culture (Davies et al., 2004). This method is more cost effective and less time 
consuming than generation of knockout mice. It is also technically simple because 
kidney organ culture renders the kidney rudiment accessible to siRNA duplexes. In 
addition, researchers can use it to knockdown the gene of interest specifically at any 
time of their choosing.  
 
Before using this relatively new method, however, it is crucial to validate the siRNA 
duplexes in conventional 2D cell culture, which is now an established system for 
RNAi. siRNA-mediated RNAi is a sequence-specific, post-transcriptional gene 
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silencing mechanism and has been extensively reviewed elsewhere (Hannon, 2002; 
McManus and Sharp, 2002). Briefly, siRNAs consist of a duplex of 21-nt RNAs. 
Upon introduction into the cytoplasm of a cell, a siRNA recruits proteins that 
assemble into a RNA-induced silencing complex (RISC) (Paroo et al., 2007). The 
bound siRNA then unwinds and the RISC turns into an active form, carrying one 
strand of the siRNA. The siRNA strand subsequently guides the RISC to a 
complementary RNA molecule, where they cleave and destroy the cognate RNA 
(Figure 5-1). The original siRNA strand bound in the RISC remains intact, so the 
complex can go on to destroy other complementary mRNAs.  
 
 




NIH3T3 is a well-characterised mouse embryonic cell line and is one of the most 
commonly used cell lines for RNAi experiments (McManus and Sharp, 2002). More 
importantly, in Figure 3-4, I have already shown its expression of endogenous Dact1. 
Therefore, it was suitable for the purpose of verifying the silencing efficiency of 
Dact1 siRNA duplexes. In this chapter, I demonstrate the successful Dact1 silencing 
mediated by Dact1 siRNA and explore its putative functions in cell culture. The 
Dact1 depletion cellular phenotype identified in this study may offer insights into 
potential functions of Dact1 in developing kidneys.  
 
5.2 Experimental design 
 
5.2.1 Determination of siRNA transfection efficiency 
 
siGLO (Dharmacon) was a Cy3-labelled (therefore red-fluorescing) siRNA targeting 
a mouse housekeeping gene, lamin A. I used this powerful tool to optimize siRNA 
transfection conditions. The conditions of culturing NIH3T3 cells and the siRNA 
transfection procedures are described in chapter 2. Sixteen hours after transfection, 
cells were fixed by 4% PFA and counterstained with SYTOX Green nucleic acid 
stain (Invitrogen). Successfully transfected cells were shown as a green nucleus with 
perinuclear red dots whilst unlabelled cells were only marked by the green nuclear 
dye (Figure 5-5). Images were taken by confocal microscopy and the transfection 
efficiency was calculated as the ratio of transfected cells to all the counted cells.  
 
5.2.2 Transfection of siRNAs 
 
A pool of four siRNA duplexes targeting Dact1 was transfected into NIH3T3 cells. 
The sequences of these four duplexes and their target sites are shown in Table 2-3, 
Table 2-4, Figure 5-2 and Figure 5-3. Appropriate controls, including untreated cells, 
mock transfection without siRNA, and transfection with non-targeting siRNA, were 
carried out in parallel to detect any cellular effects caused by transfection process and 
to detect any off-target effects that might have resulted from the introduction of any 
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siRNA. Each treatment was performed in triplicate and the experiment layout is 





Figure 5-2 Mapping Dact1 siRNA duplexes on the mouse Dact1 transcript. 
Target sequences of the four siRNA duplexes are shown in red. Exons of mouse 
Dact1 are distinguished by alternative black and blue colour text. 
     1 ATGAAGCCGGACGCAGCGCGCGAGCCGGAGCCGCTGAGCCCCGGCCGGGGCGCGGAGGCC 
    61 GAGGGGCGCTGGCGCGAGAGGGGCGAGGCGGACACGGAGCGGCAGCGTACCCGCGAGCGC 
   121 CAGGAGGCCACGCTGGCGGGGCTGGCGGAGCTGGGGTACCTGCGGCAACGCCAAGAGCTG 
   181 CTGGTGCGCGGTGCGCTGCGCTGCTCCGGGACCGTGGGGACCGTCGCGCCGCGCTCCGGG 
   241 GAGCTGCGGGGAGACGCGGCGCAGCGCAGCCGCCTGGAGGAGAAGTTCCTGGAAGAGAAC 
   301 ATCTTGCTGCTGCGAAGGCAGTTGAATTGTTTGAGGAGAAGAGATGCCGGTTTGTTGAAT 
   361 CAGTTGCAAGAACTTGACAAGCAGATAAGTGACCTGAGACTGGATGTGGAGAAGACATCT 
   421 GAAGAGCACCTGGAGACAGACAGCCGGCCTAGCTCAGGGTTTTATGAGCTGAGTGATGGA 
   481 GCTTCGGGCTCCCTCTCTAACTCCTCCAACTCCGTGTTCAGTGAGTGTTTGTCCAGTTGC 
   541 CATTCCAGCACCTGCTTCTGCAGCCCCTTGGAGGCGGCCTTGACCATCTCAGACGGTTGC 
   601 CCCAAATCTGCAGATGTGAATCCTAAATACCAGTGTGATCTTGTGTCTAAAAACGGGAAT 
   661 GACGTATATCGCTACCCCAGTCCACTTCATGCTGTGGCTGTGCAGAGCCCAATGTTTCTC 
   721 CTTTGTCTGACGGGCAACACTCTGAGGGAAGAGGAGGGGCTTGGGAGCCATGCCAGCGAC 
   781 ATCTGCATTGGATCTGAACTGAACGCCACCAAAACAGACAATTCCCTGCCATCTCCAAGC 
   841 AGTTTGTGGTCCGCTTCCCATCCTGCATCCAGTAAGAAAATGGATGGGTATATTTTGAGC 
   901 CTCGTGCAGAAGAAAACACACCCTGTAAGGACCAATAAACCTAGAACCAGTGTGAACGCT 
   961 GACCCTACCAAGGGCCTTCTGAGGAATGGAAGTGTGTGTGTCAGGGCCCCTAGTGGCGTC 
  1021 CCACCGGGCAGTAGTGTGAACTTTAAGAATACAAAACAGATGTGTTTGCCCGCTGGGGGA 
  1081 ATAACCTCTTTGGAAAACGGGCCATTCTCCCCTCCTAAGCAGAGGTCCAAAGACTCAAAG 
  1141 ACAGACCAGTTAGAAAGCAAGAGGTTGGCTCTGCCGGAGAGCTGCTCGGCAGGCGCCGCC 
  1201 ATGGAACCCCAAAGCAAGCATGTGCCCAAAGCCGCCAAGGCAGCCTCTCAAGAGCTCACA 
  1261 AGGTGTCAAGCCGGGCTGGGGGAATCCATGAAGGAAAGCAATCAGGCCTCCGCTGTTTCT 
  1321 CCTAAAACAAGTCCTGGCAGAGGCCCTGTCGCCCCCGCAGAGAGCAAAGCCCTGCAGCTC 
  1381 CCGAAAAAGATGTCGCAGAAGAACAGCCTCCAGGCTGTGCCCGCGCTGGACAGGCCGGCC 
  1441 TTGGACTTCAAAAGCGAGGGCTCATCTCAAAGCCTCGAGGAAGGGCATCTGGTGAAAGCT 
  1501 CAGTTCATTCCGGGGCAGCAGGCGGCCGCCAGGCCTCACCGTGCACACAGGAACCCGGGT 
  1561 GTCGCAAGGAGCGCCACCTTGAAGGCCCGCGGCCAGGCAGCCATGGAACACGGCCTGCCC 
  1621 ACCGTCAGGGAGAAACCGCGGGCAGCAGGCAAGAAGTGCCGTTTCCCAGACGACTCGGAT 
  1681 ACAAATAAGAAATTCAGGAAGACCTCCGCCAAGGGCCGGCGCAGTGGCGGGCTGCAGGAC 
  1741 GCTGGCCTTCCCGGTAGGGCCCTGGGCACCGGCGGCCATCGGGCGGGTAGCAGGGCGCAC 
  1801 GCGCATGGCCGGGAGCCCGTGGTGGCCAAACCGAAGCACAAGCGAACCGACTACCGGCGG 
  1861 TGGAAATCGTCAGCCGAGGTCTCCTACGAAGAAGCCCTGCGGAGGGCCCGGAGGGCTCGC 
  1921 AGGGAGCACGGGGCTGCCTACCGGGTGGCTGTCGCCCTGCCTTACGCCAGCCCCTATGCC 
  1981 TACGTGCCCAGCGACTCCGAGTACTCGGCGGAGTGCGAGTCGCTCTTCCACTCCACGGTG 
  2041 GTGGACACCAGCGAGGACGAGCAGAGCAACTACACCACCAACTGCTTCGGCGACAGCGAG 
  2101 TCCAGCGTGAGCGAAGGCGACTTCGTGGGCGAGAGCACCACCACCAGCGACTCAGAGGAG 
  2161 AGCGGGGGTTTAATCTGGTCCCAGTTTGTCCAGACTCTCCCGATTCAAACGGTCACGGCC 
  2221 CCAGACCTCCACACCCGTCCCACAAAAACCTTTGTCAAAATCAAGGCTTCGCACAACCTC 
  2281 AAGAAGAAGATCCTCCGTTTCCGCTCTGGCTCTTTGAAACTGATGACTACCGTTTGAGTA 
  2341 GCTGATGTAGCGAGTGTCTTCTCCTCCCCCTAGTCTCTGAGAAAAAGAAAAAGGTGTTGT 
  2401 CTTAATATTTGTGTCATACTTAAATGGAATACTTTCCTTTCACTAGGATAAACCCAAGAT 
  2461 AAATTATGTCTCGCGGTCATGTATGGACGCTAGTGCCTTTAATGGAAGGTGAAGGATGTA 
  2521 TCTCTAGTTAGAAGTGAATATTGAGGTCTTAGTGGTGGTGATAGTGAATGCATTTTGATT 
  2581 ATCAGATGTTTCGTCCGAGTGTCTGGCCAAGTACAGGTGTGTGATGTTCAAGTTTTATTT 
  2641 GGATGAGACCTTTTGTTTCCAAGGTTCGTGGATAAAATTTTTAAGCCGTGAACTCGCTCC 
  2701 TTGATCCTTTAGGGCTTTGTCCCTGAAAGGGCTTTCCGGTTGAGGGGCATTGCATACAAT 
  2761 TGTGTAGAGTAGGTAGAAAAAACAAACAAACAAACAAAACAGTCATTGCTTTCTGTAAAT 
  2821 TTTTTACTATAGACAACACTCTCAGATGTCTCTCCATCCTATTTTCTTCTTAGAAGTACA 
  2881 CTTTTTACTGGATTTAGAACTTAGTAGACCAGACTTTTAATCTGGAGGTGGTAAACTGGA 
  2941 TAGGGAGACTGATAGGACCTTAAAAGGATTCACAAAAACCTTTGCCACCTGTAGTGCCTC 
  3001 CGCCTTCGTTACAGTAGCCCTTTCATGGGCCATATATCCAGCAGTTTTTGATGCCTTTCT 
  3061 ATCTCTCTGCTCCTAATTTGTAGCCAATACAACTGTTTGTCCCTTAGAGGGCTTGTCTTT 
  3121 GGGATAAAGTGTTGGTCCTTTGGTGCAAAGAAATTCACCCTTACTGGGCTTGACTCCAAG 
  3181 CCCAGAATTGCTCTCACCAAGCACTGGCCTGAACAGTAGTGCAGTTCAACCCTCACCGGA 
  3241 CCGCTGACTTATCTGGAAGGGCATTACATTTTTTAAAAAAGCTTTTGGTAAACAGTATTG 
  3301 TGTAAAATAGAGTTTTTAAAATACTGATATATGCATGTTTTGTGCATGAGTAGTAGTTCT 
  3361 TTGGATTCCTGTTTTGATATTCCTGTTGCTGAATTACTGTATGATATAAACAGTATGTGT 
  3421 TTTATATATATCATTGTGTAAATTTAATATAACACATTATATGCTGTACTAAATGATTTG 










Figure 5-3 Dact1 siRNA target sites and primer binding sites on the mouse 
Dact1 transcript. Schematic diagram depicts the target sites of Dact1 siRNA on 
mouse Dact1 transcript (scissor). Black bars and arrows indicate the binding sites of 
Dact1 primers used to detect the silencing efficiency. 
Figure 5-4 Plate layout of the siRNA-mediated Dact1 knockdown experiment. 
 
5.2.3 Detection of Dact1 silencing by quantitative real time PCR 
 
A time course experiment was done to determine the kinetics of knockdown. I found 
that the most significant knockdown, by quantitative real time PCR assay, was 48 
hours after transfection. In subsequent RNAi experiments, cells were harvested 48 
hours after transfection and then subjected to RNA extraction followed by cDNA 
synthesis. Actb was used as an internal control gene. Quantitative real time PCR was 
done as detailed in section 2.2.5. Primers were designed to flank the target site of 
Dact1 siRNA duplex 2 (refer to Table 2-3 and Figure 5-3) and also to amplify 
cDNAs made from all the potential Dact1 transcripts. Their sequences were listed in 
Table 5-1. Dact1 expression in each treatment group was normalised to Actb and 
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showed as the percentage of that in the untreated group. Data were obtained from 
three independent experiments and were represented as Mean ± SEM. 
 
 
Table 5-1 Real time PCR primers used to detect Dact1 silencing. The forward 
primer binds to the antisense strand, the reverse primer to the sense strand. All oligos 
are represented in a 5’ to 3’orientation. Actb was used as an internal control. 
Gene RefSeq accession 
number 
Frward Primer Reverse Primer 
Dact1 NM_021532 GCCGGTTTGTTGAATCAGTT CGAAGCTCCATCACTCAGC
Actb NM_007393 GATCTGGCACCACACCTTCT GTACATGGCTGGGGTGTTG
 
5.2.4 Cell counting 
 
Cells were plated at the density of 2x105cells/well in 6-well plates. Each treatment 
was carried out in triplicate and the experiment layout is depicted in Figure 5-4. 
Seventy-two hours after siRNA transfection, cells were harvested and counted by 
using a haemocytometer. The counting of cells was done blind by masking the 
labelling of treatments on glass slides. 
 
5.2.5 BrdU incorporation assay 
 
A BrdU incorporation assay was employed to evaluate the effect of Dact1 silencing 
on the proliferation of NIH3T3 cells. For this assay, cells were grown on coverslips 
in a 24-well plate and were plated at the density of 4x104cells/well. Seventy-two 
hours after siRNA transfection, cells were fixed and subjected to 
immunocytochemistry. The procedures of BrdU labelling and immunocytochemistry 
are detailed in section 2.7. Images were taken by confocal microscopy. When taking 
images, the labelling of treatments on glass slides was masked so that the subsequent 
cell counting on the images would be done blind. One thousand cells were counted 
per coverslip and the proliferation index was defined by BrdU labelling rate, which 
was calculated as the ratio of BrdU labelled cells to the total cell number counted. 




5.2.6 Statistical analysis  
 
When analyzing data from cell counting and BrdU proliferation experiments, a one 
way analysis of variance (ANOVA) was first used to compare the mean of each 
group. This was done by using the Microsoft Office Excel 2003 software program. 
The exact p-values were shown in the legends of Figure 5-7 and 5-8. When the p-
value was less than 0.05, the ANOVA test was considered to be statistically 
significant and Tukey’s post hoc tests were then introduced to evaluate whether 
differences between any two pairs of means were significant. This test was done by 





5.3.1 Effective knockdown of Dact1 in NIH3T3 cell cultures 
 
5.3.1.1 Satisfactory transfection efficiency 
 
To determine transfection efficiency, six independent experiments were performed 
and 500 cells were counted from each experiment. A successfully transfected cell 
showed a green nucleus with perinuclear red dots whilst untransfected cells only 
showed their green nuclei (Figure 5-5). The transfection efficiency was 96.33±0.87% 
(Mean ± SEM). Negative controls were done by mock transfection without siRNA 






Figure 5-5 siGLO in NIH3T3 cells. siRNA transfection efficiency was determined 
by the percentage of siGLO labelled cells. Inset depicts the characteristic perinuclear 
distribution of red dots (siGLO). Cells were counterstained by SYTOX Green 
nucleic acid stain (green). Scale bar =50µm (a), 25µm (b). 
 
5.3.1.2 Effective Dact1 knockdown at mRNA level  
 
By quantitative real time PCR, I found that the pool of four Dact1 siRNA duplexes 
effectively knocked down Dact1 expression to 25% of control values. Dact1 
expression was maintained at a high level among control groups (Figure 5-6), 
indicating the absence of unwanted effects caused by the transfection reagent, by 
transfection procedures or by the introduction of non-relevant siRNA. Taking 
together the results of transfection efficiency and knockdown efficiency, I concluded 
that it was sensible to use this optimised siRNA transfection method to further 







Figure 5-6 Dact1 knockdown efficiency in NIH3T3 cells. Cells treated with Dact1
siRNA showed only 25% expression of Dact1, whilst controls expressed Dact1 at a 
comparable level. Data were collected from three independent experiments and are 
expressed as Mean ± SEM. Comparisons were made by Student t tests. The 
difference was considered to be statistically significant when a p-value was less than 
0.05. 
5.3.1.3 Attempts to detect Dact1 silencing by Western blot 
 
Although I have shown the effective knockdown of Dact1 gene at mRNA level, it is 
desirable to demonstrate its knockdown effect at protein level (Anonymous, 2003; 
Duxbury and Whang, 2004; Hannon and Rossi, 2004; Huppi et al., 2005), provided 
that a specific primary antibody is available. For this purpose, 72 hours after 
transfection, cells were harvested to isolate protein lysates and then subjected to 
Western blot. The primary antibody used to detect DACT1 protein has been 
described in section 3.3.7, where I showed that it was not able to recognise mouse 
DACT1 protein in immunofluorescence assays. Despite my numerous attempts of 
trying different dilutions of primary and secondary antibodies, varying the type, 
strength, and washing time of the washing buffer, it always showed a laddering 
pattern on the Western blot. The same protein lysates run through the protocol in 
parallel but targeting by primary anti-GAPDH antibody yielded a single clear band 
of correct size. Because the primary antibody against DACT1 protein did not work, 
the attempt to show Dact1 silencing by Western blot had to be abandoned. 
 100
 
5.3.2 Dact1 silencing facilitates proliferation of NIH3T3 cells 
 
5.3.2.1 Cell number increases in Dact1 siRNA-treated NIH3T3 cells 
 
The idea of studying cell number came from the preliminary observation that cells 
transfected with Dact1 siRNA seemed more crowded then controls. Figure 5-7 
shows that, 72 hours after transfection, the cell number was greatly increased in 
Dact1 siRNA-treated cells while the cell number in the controls was unchanged. 
Data were derived from three independent experiments and were shown as Mean ± 
SEM. The differences of the means among groups were examined by one way 
ANOVA followed by Tukey’s post hoc comparisons. There was no difference in the 
cell number among three controls. The increase in cell number in Dact1 siRNA-
treated group was statistically significant.  
 
 
Figure 5-7 Cell number increases in Dact1 siRNA treated cells. Each group was 
carried out in triplicate and the experiment layout is depicted in Figure 5-4. Seventy-
two hours after transfection, cells were harvested and counted by using a 
haemocytometer. Counting was done blind by masking the labelling of treatment on 
glass slides. Data are shown as Mean ± SEM and were subjected to one-way 
ANOVA, followed by Tukey’s post hoc comparisons when main effects were 
significant. (p=0.017 in one way ANOVA; the p-values of paired comparisons in 
Tukey’s post hoc comparisons are shown)  
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5.3.2.2 Higher proliferation index in Dact1 siRNA-treated cells 
 
To further explore whether cell proliferation contributed to the increase in cell 
number found in Dact1 siRNA-treated cells, BrdU was introduced to label 
proliferating cells at metaphase and the proliferation index was calculated as the 
BrdU labelled rate. Panel (a) and (b) in Figure 5-8 showed that cells were more 
crowded in Dact1 siRNA transfected cells (b) than in controls (a). The BrdU 
labelling rate was calculated and plotted in panel (c), showing a higher proliferation 






Figure 5-8 Cells treated with Dact1 siRNA show a higher BrdU labelling rate.
BrdU immunocytochemistry is shown in panel (a) and (b). Red (TRITC) nuclei 
indicated BrdU labelled nuclei while unlabelled nuclei were counterstained by TO-
PRO-3 (blue). There were more red nuclei detected in Dact1 siRNA-treated cells (b) 
compared to controls (a). The BrdU labelling rates were calculated and plotted in (c). 
Data are shown as Mean ± SEM and were subjected to one-way ANOVA, followed 
by Tukey’s post hoc comparisons when main effects were significant. (p=0.001 in 
one way ANOVA; *p<0.05 vs. untreated in Tukey’s post hoc comparisons)  
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5.4 Discussion  
 
5.4.1 Specificity of this RNAi experiment 
 
Like all other loss-of-function approaches, RNAi has the concerns of specificity. 
Several mechanisms have been proposed to explain off-target gene silencing in 
RNAi experiments such as interferon response (Sledz et al., 2003), miRNA-like 
translation inhibition (Scacheri et al., 2004; Zeng et al., 2003), global 
stimulation/repression of genes by high concentrations of siRNA (Persengiev et al., 
2004), and mRNA degradation mediated by partial sequence complementation 
(Jackson et al., 2003). To reduce the risk of non-specific effects in RNAi 
experiments, I based my experimental design on published guidelines for RNAi 
experiments (Anonymous, 2003; Duxbury and Whang, 2004; Hannon and Rossi, 
2004; Huppi et al., 2005) and introduced appropriate controls including untreated 
cells, mock transfection without siRNA and transfection with non-targeting siRNA. 
Untreated cells were used as a reference to which all other samples were compared. 
Mock transfection without siRNA was used to detect effects resulted from the 
transfection reagent and procedures. Transfection with non-targeting siRNA was to 
detect cellular effects caused by the introduction of any siRNA.  
 
I also performed a titration experiment to determine the minimal concentration of 
Dact1 siRNA at which 75% knockdown efficiency was achieved, as assayed by 
quantitative real time PCR. The lowest concentration of siRNA determined by my 
titration experiment was 10nM which was one tenth of the concentrations 
recommended by the manufacturer and seen in the literature. Semizarov et al. 
showed that non-specific gene activation can be eliminated when the siRNA 
concentration is reduced from 100nM to 20nM (Semizarov et al., 2003). By using 
this lowest effective siRNA concentration, I showed the satisfactory knockdown 
efficiency at mRNA level while all these controls expressed comparable Dact1 
mRNA level (Figure 5-6). Additionally, in cell counting and proliferation assays, 
these controls revealed differences neither in cell number nor proliferation index. 
This evidence supports the idea that the increased proliferation seen in Dact1 siRNA-
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treated cells is a specific effect of Dact1 knockdown. One strategy to further 
strengthen my results may be the ‘multiplicity controls’ in which effective Dact1 
siRNAs targeting different regions of Dact1 would be used in separate experiments 
and expect them to give the same phenotypes because it is highly unlikely that 
different siRNAs will cause the same off-target effects (Jackson et al., 2003).  
 
However, the ultimate control for an RNAi experiment is the functional control in 
which a resultant phenotype is rescued by expression of the target gene in a form 
refractory to RNAi. Rescue experiments can be done by turning off inducible RNAi 
or by introducing a plasmid expressing the target mRNA which the RNAi sequence 
will not affect (Lassus et al., 2002). These methods are time-consuming and may 
cause inappropriate expression levels of a particular protein, which in turn will not 
rescue or can cause unexpected effects (Hannon and Rossi, 2004). Kittler et al. 
propose a promising method to do rescue experiment by using bacterial artificial 
chromosome (BAC) transgenesis. In this study, they make a transgenic human cell 
line expressing murine BAC harbouring mouse Snw1 and shows that it is resistant to 
siRNA probing human SNW1 (Kittler et al., 2005). The principle of this strategy is 
engineering a BAC construct carrying an orthologous gene from a closely related 
species together with its native regulatory sequences. Because of the ‘cross-species’ 
difference, this construct is divergent enough to escape from RNAi silencing. 
Furthermore, in contrast to the conventional cDNA-based constructs, BAC constructs 
are not driven by viral or model vertebrate promoters and thereby allow 
physiological gene expression. This strategy also allows the generation of 
alternatively spliced variants of the transgene. With these advantages, the application 
of BAC to RNAi rescue experiment is the best control so far for specificity (Sarov 
and Stewart, 2005). 
 
In summary, I have carefully followed the guidelines yet described (Anonymous, 
2003; Duxbury and Whang, 2004; Hannon and Rossi, 2004; Huppi et al., 2005) for 
RNAi experiments. The increased proliferation rate observed in Dact1 siRNA 
transfected NIH3T3 cells was likely to be intrinsic to the depletion of Dact1. Further 
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work, including multiplicity controls and rescue experiments, needs to be done to 
enhance confidence of these RNAi results. 
 
5.4.2 Potential mechanisms of Dact1-mediated growth control of NIH3T3 cells 
 
The mechanisms by which Dact1 mediates the growth control of NIH3T3 cell are yet 
to be elucidated. Analysis of the cell cycles of both my control and Dact1 depleted 
cells might help to dissect this process. Besides, in the literature so far, Dact1 has 
been reported as a crucial modulator in WNT signalling. Dact1 inhibits WNT-
mediated accumulation of soluble endogenous β-catenin and decreases activation of 
β-catenin responsive genes in Xenopus animal caps (Cheyette et al., 2002). 
Meanwhile, WNT3a has been documented as a stimulator of NIH3T3 cell 
proliferation (Yun et al., 2005). It can promote G1 to S phase progression in NIH3T3 
cells via activation of WNT/β-catenin, ERK (Yun et al., 2005) and PI3K-Akt (Kim et 
al., 2007b) pathways. Therefore, it is reasonable to hypothesize that silencing of 
Dact1 is able to turn on or enhance WNT/β-catenin signalling and thereby stimulates 
NIH3T3 cells to proliferate. This hypothesis needs to be tested by further 
experiments. 
 
5.4.3 Insights into kidney development 
 
Cell proliferation is one of the important mechanisms for renal growth. From E11.5 
to E16.5, kidneys double in size every nine to ten hours (Bard, 2002; Davies and 
Bard, 1998). Proliferation happens in every compartment of a developing kidney and 
contributes to nephron formation, UB branching and stroma patterning (Bard, 2002). 
A great number of molecules have been reported to regulate proliferation (Table 1-2) 
in developing kidneys but relatively few exert non-redundant effect on growth in 
each compartment. The role of Dact1 in regulating cell proliferation observed in 
NIH3T3 cells might add this mesenchymal gene onto the growing list of molecules 
modulating growth of developing kidneys. In addition, according to the expression 
pattern, Dact1 was expressed in mesenchyme at E11.5 and was expressed 
predominantly in the matured, differentiated medullary stroma by E14.5 (Figure 3-9). 
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Taken together the expression data and the implications from Dact1 knockdown 
phenotypes in NIH3T3 cells, Dact1 could be a proliferation-to-differentiation switch 
of a subset of mesenchymal cells in developing kidneys. Its function is further 
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Organ culture of isolated kidney rudiments has been a simple but powerful model to 
investigate kidney development since the 1950s. In this system (Figure 6-1), kidney 
rudiments can be isolated as early as E10.5 and cultured on a filter at a gas-medium 
interface. Kidney rudiments growing in this system are able to reproduce the events 
of first few days of renal development (Grobstein, 1953). Experimenters can further 
dissect the UB from its surrounding mesenchyme and reassemble them together in 
this culture system. This tissue recombination technique allows the construction of 
UB and mesenchyme from donors of different genotypes and thus helps to determine 
which tissues are affected by the mutation (Kreidberg et al., 1993). Besides, in 
classical gene targeting strategies, the analysis of the role of a given gene in the 
kidney development can be confounded by systemic effects of gene inactivation. 
Organ culture can provide a solution to this problem by isolating the kidney from the 
rest of the body. An additional limitation of transgenic approaches is that the role of 
a gene at a specific stage cannot be analysed if the deletion has disrupted earlier 
stages of development.  The organ culture model can be used to circumvent this 
problem too.  
 
 
Figure 6-1 Mouse kidney organ culture method (Davies, 2006).  
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In addition to the advantages of the kidney organ culture model mentioned above, 
advantage has been taken of high accessibility of the cultured kidneys to exogenous 
drugs, growth factors and antibodies for a long time. The feature of its high 
accessibility inspires experimenters to apply RNAi to this powerful model. Sakai et 
al. first described RNAi in organ culture of salivary glands, lungs, and kidneys. By 
using siRNA targeting fibronectin, an ECM protein, Sakai et al. showed that 
knockdown of fibronectin blocks cleft formation in cultured salivary glands and that 
this can then be rescued by exogenous fibronectin. More importantly for this thesis, 
in their supplementary information, they demonstrated that the same siRNA is able to 
replicate the effect of function-blocking anti-fibronectin antibody in cultured kidneys 
(Sakai et al., 2003). The second paper on the application of siRNA to kidney organ 
culture showed the ability of siRNA targeting Wt1 to generate a phenocopy of Wt1 
knockout mice. Davies et al. applied Wt1 siRNA to cultured E9.5 urogenital ridges, 
in which kidneys would normally form one day later, and showed renal agenesis. 
They also used the same techniques to target Pax2 and Wnt4 in cultured kidneys and 
proposed a hierarchy for Pax2, Wt1 and Wnt4 to control nephron maturation (Davies 
et al., 2004). These encouraging results make siRNA-mediated RNAi a promising 
tool to dissect gene functions in developing kidneys. 
 
By using this kidney organ culture model, a great amount of research exploring the 
interactions between the mesenchyme and UB has been done and has offered much 
insight into nephrogenesis and branching morphogenesis. One of the simplest and 
most useful assays to analyse kidney morphogenesis is counting the nephron and UB 
tip numbers as indicators for nephrogenesis and branching morphogenesis 
respectively (Davies et al., 2004). In the previous chapter, I have shown the 
validation of Dact1 siRNA in NIH3T3 cell culture and the increased cell 
proliferation as a result of Dact1 depletion. I therefore hypothesized that knocking 
down Dact1 in developing kidneys will stimulate nephron formation and/or UB 
branching. I put this hypothesis to the test by analysing the change in nephron and 
UB tip numbers in the kidney culture which have been transfected with Dact1 siRNA. 
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6.2 Experimental design 
 
6.2.1 siRNA transfection in kidney culture 
 
Dact1 siRNA duplexes used in this experiment were from Dharmacon and were 
validated in NIH3T3 cell culture as described in the previous chapter. The 
procedures of transfecting siRNA into kidney culture were based on that developed 
by Davies et al. (Davies et al., 2004). E11.5 kidneys were dissected and cultured as 
detailed in section 2.1.2 except using a different culture medium described below. 
Kidney cultures were set up separately into four dishes and labelled as untreated, 
mock transfection without siRNA, transfection with non-targeting siRNA and 
transfection with Dact1 siRNA. Appropriate amounts of siRNA and 5µl of 
siLentFect (Bio-rad) were diluted in 250µl of Richter’s medium (Gibco) 
supplemented with 10µg/ml transferrin in two separate tubes and were incubated at 
room temperature for 10 min. A transfection mix was made by mixing the solutions 
of these two tubes and incubated at room temperature for 20 min. 500µl of the 
transfection mix was then added into a clean bijou tube containing 2.5ml of 
transferrin supplemented Richter’s medium yielding 10nM siRNA. Kidneys were 
cultured in this medium in a humidified incubator at 37°C overnight and the medium 
was then changed back to normal culture medium (described in section 2.1.2). 
Kidney cultures were stopped 48 hours after siRNA transfection for RNA extraction 
and 72 hours after transfection for immunohistochemistry. 
 
6.2.2 Quantitative real time PCR to assay gene knockdown efficiency 
 
To obtain sufficient amount of RNA for the downstream cDNA synthesis and 
quantitative real time PCR assays, eight kidneys in the same culture dish were pooled 
together at the end of culturing and were homogenised for RNA extraction. The 
primers (Table 5-1) to amplify Dact1 gene were designed to flank the target site of 
Dact1 siRNA duplex 2 (refer to Table 2-3 and Figure 5-3 ) and to amplify cDNAs 
made from all the potential Dact1 transcripts. Dact1 expression in each treatment 
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group was normalised to Actb and was shown as the percentage of that in the 
untreated group.  
 
6.2.3 Immunohistochemistry to examine kidney morphology 
 
Seventy-two hours after transfection, kidneys were fixed and subjected to 
immunohistochistry. Nephrons were visualised by anti-WT1 antibody and ureteric 
buds by anti-Calbindin-D28K antibody staining. The procedures were detailed in 
section 2.5 and the antibodies used were listed in Table 6-1. Images were taken by 
confocal microscopy. When taking images, the labelling of treatments on glass slides 
was masked so that the subsequent counting of nephron and tip number on the 
images would be done blind. Seven kidneys from each treatment group were counted 
and averaged. A one way ANOVA was first used to compare the mean of each group. 
This was done by using the Microsoft Office Excel 2003 software program. When 
the p-value was less than 0.05, the ANOVA test was considered to be statistically 
significant and Tukey’s post hoc tests were then used to evaluate whether differences 
between any two pairs of means were significant. This test was done by an online 
calculator which can be found at the URL 
http://web.umr.edu/~psyworld/tukeyscalculator.htm.  
 
Table 6-1 Antibodies used to examine the kidney morphology. 
 
Name Manufacturer Host Dilutions Purpose  
Monoclonal anti-WT1 Invitrogen Mouse 1:400 To identify nephrons 
Anti-Calbindin-D28K Abcam Rabbit 1:200 To show ureteric buds 
FITC-anti-mouse IgG Sigma Goat 1:100 Secondary antibody 






6.3.1 Suboptimal knockdown efficiency of Dact1 siRNA in kidney organ culture 
 
To determine the Dact1 siRNA concentration to be used in kidney organ culture, 
10nM siRNA was used as a starting point based on my results from cell culture (refer 
to section 2.6.2 and Figure 5-6). Higher concentrations of siRNA were tried but they 
resulted in substantial reduction of Dact1 expression in non-targeting siRNA-treated 
kidneys. Therefore, 10nM of siRNA was used in the experiments described in this 
chapter. By quantitative real time PCR, the pool of four siRNA duplexes targeting 
different regions of Dact1 knocked down Dact1 mRNA to 60% of control values 
(Figure 6-2). Although there seemed to be an about 20% knockdown in the kidneys 
treated with non-targeting siRNA, the difference in the Dact1 expression was not 






Figure 6-2 Dact1 knockdown efficiency in E11.5 kidneys cultured in vitro for 48 
hours. Eight kidneys were used in each treatment group. Quantitative real time PCR
was performed to assay Dact1 expressions. The Dact1 expression level was 
normalised to Actb and is shown as percentage of the untreated group. Dact1 
expression is knocked down to 60% of the untreated control kidneys by Dact1
siRNA. This knockdown is statistically significant as judged by a Student t test 
(p=0.032).  Although there seems to be an about 20% knockdown in the kidneys 
treated with non-targeting siRNA, the difference in the Dact1 expression is not 
statistically significant (p=0.105). 
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6.3.2 Possible Dact1 knockdown phenotypes in kidneys 
 
Although the knockdown efficiency in kidney organ culture was not as good as that 
in NIH3T3 cell cultures (40% in kidneys and 75% in cells as shown in Figure 6-2 
and Figure 5-6), it might still be sufficient to produce a phenotype according to 
published work (Maeshima et al., 2006; Wang and Roy, 2006). Wang and Roy 
showed retarded formation of primordial follicles when Gdf9 siRNA was transfected 
into ovary organ culture and knocked down Gdf9 to 70% of controls (Wang and Roy, 
2006). I therefore used my optimised siRNA concentration and transfection 
procedures in cultured kidneys and analysed their morphology by counting the tip 
and nephron numbers. Cultured kidneys in the four groups seemed to grow and 
developed normally. Figure 6-3 (a) and (b) are representative images of controls and 
Dact1 siRNA-treated kidneys, respectively. No apparent morphological difference 
between them was detected. However, by carefully counting the tip and nephron 
numbers in each group, I found that Dact1 siRNA-treated kidneys seemed to have 
more branches than controls. The average UB tip number in Dact1 siRNA 
transfected kidney was ~75 per kidney compared with ~60 per kidney in the three 
control groups. The difference in tip number was statistically significant as judged by 
one way ANOVA (p=0.038) followed by Tukey’s post hoc comparisons (p<0.05 
when compared Dact1 siRNA-treated kidneys to any controls). There was no 
significant difference in nephron number among the four groups (Figure 6-3 (c)). 
This result seemed to confirm the hypothesis that Dact1 silencing leads to increased 






Figure 6-3 Dact1 knockdown phenotypes in E11.5 kidneys cultured in vitro for 
72 hours. Kidneys cultured in different treatments were fixed and proceeded to
immunohistochemistry. In (a) and (b), ureteric buds were stained with anti-calbindin-
D28K antibody (red) while nephrons were stained by anti-WT1 antibody (green). 
Representative images for renal morphology are shown in (a) and (b) for untreated 
and Dact1 siRNA treated cultured kidneys, respectively. The number for both UB 
tips and nephrons were counted from six kidneys in each treatment. Data are plotted 
in (c) and are represented as Mean ± SEM. Red bars refer to the number of UB tips 
while green bars refer to nephron numbers. Kidneys treated with Dact1 siRNA 
exhibited more UB tips (p=0.038 in one-way ANOVA; the p-values of paired 
comparisons in Tukey’s post hoc comparisons are shown). There were no significant 
differences in nephron number among the four groups (p=0.124 in one-way 
ANOVA) Scale bar =100µm. 
 
6.3.3 Transfection efficiency of siRNA in kidney organ culture 
 
The suboptimal Dact1 mRNA knockdown efficiency and the small increase in the 
UB tip number observed in the Dact1 siRNA-treated kidneys cast doubt on the 
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transfection efficiency in kidney organ culture. Although the transfection procedures 
had already been optimised by using siGLO in 2D cell culture (refer to chapter 5), it 
is still necessary to test this transfection indicator in the 3D organ culture. The 
demonstration of the successful use of siGLO in ovary organ culture suggests it be an 
efficient transfection indicator in 3D organ culture (Wang and Roy, 2006). I 
therefore transfected siGLO of several concentrations, ranging from 10 to 500nM, 
into E11.5 cultured kidneys following the procedures described in section 6.2.1. 
Twenty-four hours after transfection, kidneys were washed in PBS (5 min x 2) and 
subjected to imaging. Phase contrast images showed that siGLO seemed to penetrate 
into the lumen of the UB and the loose mesenchyme. However, it was barely 
detected in the cap condensates, which are critical precursors of nephrons (Figure 6-
4). This uneven distribution of fluorescently-labelled siRNA was seen in all the 
kidneys with various concentrations of siGLO being tested. It implied that not all the 
kidney cells were equally affected by the siRNA. It may therefore explain the 
suboptimal knockdown efficiency detected by quantitative real time PCR and the 




Figure 6-4 Uneven distribution of fluorescently-labelled siRNA in cultured 
kidneys. On E11.5 kidneys cultured in vitro for 24 hours, siGLO was unevenly 
distributed throughout the kidneys. It seemed to reach the lumen of the UB and the 
loose mesenchyme (LM) but not the cap condensates (CC). Scale bar =100µm. 
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6.3.4 Prior enzymatic digestion of kidney does not help siRNA penetration 
 
The fluorescently-labelled siRNA was taken up by most of cells growing in 2D 
culture (Figure 5-5) but distributed unevenly in the 3D organ culture (Figure 6-4). 
This preliminary observation implied that in organ culture, cells have unequal 
chances to access and therefore take up siRNAs. This uneven distribution may result 
from diffusion pathways packed with ECM and the whole architecture containing 
fully-formed basement membranes. These elements could act as barriers to diffusion 
or they can trap siRNAs via multiple low-affinity charge interactions. Pretreatment 
of the whole organ by enzymatic digestion before being cultured may facilitate the 
diffusion of the lipid-complexed siRNAs.  
 
Enzymatic techniques in combination with chelating agents have been widely used to 
dissociate tissues. A common example is trypsin together with EDTA. Trypsin 
cleaves the peptide bonds on the carbon side of arginine and lysine (Voet et al., 2002) 
and EDTA chelates the divalent cations that are present at the cell adhesions to the 
ECM (Gailit and Ruoslahti, 1988). Prolonged exposure of trypsin-EDTA leads to 
disruption of ECM structure (Teebken et al., 2000), which is a critical component 
modulating kidney development (Davies et al., 1995). By carefully use of trypsin-
EDTA, experimenters can successfully separate the embryonic kidney into its 
component tissues, the ureteric bud and the mesenchyme. These separated 
component tissues can be re-combined and grow normally in the organ culture 
system (Sainio, 2003b). Also, carefully trypsinised kidneys without separation into 
ureteric buds and mesenchyme still can grow normally in organ culture (Lindström, 
personal communication). Therefore I decided to treat the kidneys with trypsin-
EDTA followed by culturing and siRNA transfection.  
 
Trypsin-EDTA medium was prepared as 500µl of trypsin-EDTA (Sigma) and 5µl of 
DNase in 2.5ml of MEM. E11.5 kidneys were dissected and the organ cultures were 
set up by using the trypsin-EDTA medium. After being incubated at 37°C for 10 min, 
the culture medium was replaced by fresh complete culture medium to inactivate 
trypsin. siGLO transfections were then followed according to the procedures 
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described in section 6.2.1. One day after transfection, kidneys were mounted and 
scanned by confocal microscopy. In addition to using siGLO to assay the transfection 
efficiency, I set up groups of kidney cultures for mock transfection, transfection with 
non-targeting siRNA and for normal kidney culture without trypsin-EDTA 
pretreatment. These kidneys were then assayed by quantitative real time PCR to 
examine if knockdown efficiency improved. Unfortunately, with the trypsin-EDTA 
pretreatment, siGLO was still unevenly distributed and the confocal images found it 
to be trapped in the middle portion of the kidney. The result of quantitative real time 
PCR did not show any improvement in knockdown efficiency.   
 
6.3.5 Transfection efficiency in alternative culturing methods for kidney 
rudiments 
 
The preceded enzymatic digestion of kidneys did not much improve the siRNA 
transfection efficiency. More intensive digestion might break the diffusion barrier 
more efficiently but caused impaired nephrogenesis and decreased branching (data 
not shown). Therefore I turned to another established culture system where 
metanephric mesenchyme was manually dissected out and cultured in a hanging drop. 
In this way, siRNA might gain more direct access to the cells. More importantly, in 
early kidneys, mesenchyme is easier for siRNA to penetrate than epithelia (Davies et 
al., 2004). Hanging drop culture is able to support induced mesenchymal cells to 
grow and form tubular structures for up to four days (Sainio, 2003b), which is long 
enough to assay the siRNA transfection efficiency. Metanephric mesenchyme from 
E11.5 kidneys was dissected out and incubated in a hanging drop at 37°C for 6 hours. 
The composition of the hanging drop was 100nM of siGLO and 1.2µl of siLentFect 
(Bio-Rad) in MEM. At the end of culturing, tissues were washed in PBS twice and 
then were mounted for imaging. In this way, siGLO seemed to diffuse into most of 
the mesenchymal cells. As shown in Figure 6-5, phase contrast micrograph (a) 
illustrates the mesenchyme. When scanned through the whole thickness of the 
mesenchyme by a confocal microscope, siGLO was found to distribute through the 
whole tissue. Panel (b) showed a representative optical confocal section of the 
middle part of the mesenchyme. This encouraging result suggested better siRNA 
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transfection efficiency in metanephric mesenchyme cultured in a hanging drop. 
However, if carrying out siRNA experiments in this way, it was extremely difficult 
to assay the gene knockdown efficiency by quantitative real time PCR because of the 
tiny size of the tissues. It was also difficult to analyze the morphological phenotypes 
in these fragmented tissues. 
 
The improved siRNA transfection efficiency seen in the mesenchymal hanging drop 
culture inspired me to culture the whole kidney in a hanging drop. The whole kidney 
hanging drop culture would also make the subsequent quantitative real time PCR and 
morphology analysis easier. E11.5 kidneys were dissected and incubated with the 
transfection mix in a hanging drop for 6 hours. The composition of the hanging drop 
was as described in the previous paragraph. At the end of culturing, tissues were 
washed by PBS twice and then were mounted for imaging. Unfortunately, as shown 





Figure 6-5 Using fluorescently-labelled siRNA as a transfection indicator in 
various culturing methods for kidney rudiments. Phase contrast micrograph (a) 
and an optical confocal section at the middle part of the mesenchyme (b) showed that
siGLO seemed to enter into most of the mesenchymal cells when cultured in a 
hanging drop containing siGLO. However, when whole kidneys were cultured in a 
hanging drop (c), siGLO were not able to diffuse into kidneys. Panel (d) was an 
overlay of the phase contrast micrograph and TRITC channel confocal image 
showing that kidneys failed to uptake siGLO when cultured in the same way as 
described by Wang and Roy (Wang and Roy, 2006). Scale bar =50µm in a,b,c; 
200µm in d. 
 
Wang and Roy described a successful siRNA transfection method in ovary organ 
culture in which siGLO was taken up by more than 90% of the ovarian cells (Wang 
and Roy, 2006). I adopted their method but using E11.5 kidneys instead of ovaries. 
Kidneys were cultured on a cell culture insert fitted into a 24-well plate. Appropriate 
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amount of siRNA and 10µl of Metafectene Pro (Biontex) were diluted in 80µl of 
OptiMEM in two separate tubes and incubated at room temperature for 10 min. 
Transfection mix was made by mixing the solutions of these two tubes and incubated 
at room temperature for 20 min. 160µl of transfection mix was then added into a 
clean bijou tube containing 640µl of transferrin (10µg/ml) supplemented DMEM 
yielding 100nM siGLO. Kidneys were cultured in 400µl of this mixture for 6 hours. 
At the end of culturing, tissues were washed by PBS twice and then were mounted 
for imaging. However, siGLO did not enter into the kidney, as shown in Figure 6-5 
(d). This may indicate that the diffusion barrier to siRNA was present in kidneys but 




6.4.1 How can Dact1 be a negative regulator of UB branching? 
 
The kidney phenotype of Dact1 knockdown found in this study answered the 
question about the functions of Dact1 in kidney development. This phenotype raised 
one interesting question: how does Dact1 silencing result in more UB branching? 
Two ideas might help to answer this question. One was that the Dact1 silencing lead 
to localised proliferation of mesenchymal cells around the UB tips. The localised cell 
proliferation in turn stimulate UB branching. In this study, Dact1 siRNA was added 
into the organ culture when Dact1 was expressed by mesenchymal cells of the 
kidney (Figure 3-9). Some of these mesenchymal cells took up Dact1 siRNA and as 
development proceeded, they became condensed at the UB tips. As implicated from 
the results of Dact1 silencing in the embryonic mesenchymal cell line NIH3T3 
(Figure 5-8), mesenchymal cells were encouraged to proliferate once Dact1 was 
silenced. These processes generated high cellular proliferation zones around the UB 
tips. Cells in these zones might send out paracrine signal to stimulate ureteric buds to 
branch. The temporospatial expression pattern of Dact1 (as described in section 3.3.4) 
seemed to support this hypothesis. In normal E14.5 kidneys, Dact1 expression levels 
were much higher in the medullary stroma, which was the compartment with less cell 
proliferation, than the nephrogenic zone (Figure 3-9). This seemed to imply that 
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Dact1 expression was turned off when cells were about to proliferate in the 
nephrogenic zone.  
 
The other idea came from known molecules regulating UB branching. As reviewed 
in section 1.2.1, the GDNF/Ret pathway is perhaps the best-characterised pathway 
for UB branching. I would hypothesised that silencing of Dact1 in mesenchymal 
cells results in increased generation of GDNF and thus stimulates UB branching. 
These two ideas were not mutually exclusive. Instead, both of them might be present 
and complementary to each other. Experiments including the detection of 
proliferation marker such as proliferating cell nuclear antigen (PCNA) (Winyard et 
al., 1996), and the expression of Gdnf, Ret and Wnt11 in Dact1 siRNA-treated kidney 
organ culture are required to test these hypotheses. 
 
6.4.2 Pitfalls of application of siRNA to kidney culture 
 
Since the first application of RNAi in organ culture (Sakai et al., 2003), siRNA-
mediated RNAi has been successfully applied to several organ culture systems 
including kidneys (Davies et al., 2004), palatal shelves (Shiomi et al., 2006), lungs 
(Gill et al., 2006; Sakai et al., 2003), ovaries (Wang and Roy, 2006), urogenital 
ridges (Zhan et al., 2006), Wolffian ducts (Maeshima et al., 2006), and 
atrioventricular canals (Mercado-Pimentel et al., 2007) (Table 6-2). By showing 
impressive phenotypes in various organs, these successful studies encourage the use 
of siRNA as a tool for investigating organ development in in vitro culture system.  
 
However, the expanding use of siRNA in organ culture also urges a need to evaluate 
the difficulties this field might have. The siRNA-mediated RNAi response depends 
mainly on the overall transfection efficiency. Fluorescently-labelled siRNA may be a 
good indicator to illustrate siRNAs delivered to the cells. Among the examples listed 
in Table 6-2, only one of them use the fluorescently-labelled siRNA to demonstrate a 
satisfactory transfection efficiency achieved (Wang and Roy, 2006). Using siGLO in 
my project, I have shown the diffusion problems in the whole kidneys cultured on the 
classical organ culture system (Figure 6-4), in a hanging drop (Figure 6-5c) and on a 
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cell culture insert (Figure 6-5d). Satisfactory transfection efficiency seemed to be 
achieved only when isolated metanephric mesenchyme in a hanging drop culture 
where cells can have more direct access to siRNAs (Figure 6-5ab). Besides, as seen 
in Table 6-2, the large amount of siRNA used in the experiments (Sakai et al., 2003; 
Shiomi et al., 2006) also indicates the poor transfection efficiency in organ culture.  
 
The diffusion barrier may vary from organ to organ because in early salivary gland, 
Sakai et al. found that epithelium is easier for siRNA to be delivered than 
mesenchyme (Sakai et al., 2003) whilst the opposite results are found in early 
kidneys (Davies et al., 2004). Also by using the same culture systems, transfection 
indicator and procedures as that described by Wang and Roy (Wang and Roy, 2006), 
I have shown that kidneys were harder for siRNA to enter than ovaries. Additionally, 
the diffusion barrier can vary between developmental stages within the same organ. 
As shown in Figure 6-4, at the stage of mesenchymal condensation (Davies and Bard, 
1998), an intra-mesenchymal barrier seems to form that hinders penetration of 
siRNA into the cap condensates. New strategies need to be developed to overcome 
the problems of siRNA delivery in organ culture. 
 
The second problem for applying siRNA-mediated RNAi in organ culture was the 
methods to detect gene knockdown efficiency. In 2D cell culture, it is desirable to 
detect gene knockdown efficiency at mRNA and protein levels by using quantitative 
real time PCR and Western blot respectively (Anonymous, 2003; Duxbury and 
Whang, 2004; Hannon and Rossi, 2004; Huppi et al., 2005). However, in organ 
culture, it is often difficult to perform these assays in the limited number of cells 
within the tissues. For example, in a E11.5 kidney, there is only 200-300 cells in the 
UB and a few thousand cells in the mesenchyme (Sainio, 2003b). These cell numbers 
are approximately 1% of those used for an RNAi experiment carried out in 2D cell 
culture. This may partly explain why about half of the published work did not show 
the knockdown efficiency (Table 6-2).  
 
Off-target effect is also a crucial concern of an RNAi experiment carried out in organ 




to force the system by delivering extremely large amount of siRNA (Sakai et al., 
2003). This may lead to numerous undesired effects as a high concentration of 
siRNA has been shown to cause off-target effects in 2D cell culture (Persengiev et al., 
2004; Semizarov et al., 2003). Therefore appropriate controls, including mock 
transfection, transfection with non-targeting siRNA, and functional rescue 
experiments should also be done to show that the phenotype is intrinsic to the 
depletion of the target gene.  
 
 Table 6-2 Successful applications of siRNA-mediated RNAi in organ culture 
 
Organ Targeted genes Time (hours) %KD Verification siRNA 
concentration (nM) 













oligofectamine (Sakai et al., 2003) 
Kidney  Wt1, Wnt4, Pax2 NS NS IF (for Wt1) 200 oligofectamine (Davies et al., 2004) 
Kidney  Gdnf NS NS NS 200 oligofectamine (Michael et al., 2007) 








lipofectamine 2000 (Maeshima et al., 2006) 
Urogenital 
ridges 
Alk2, Alk3, Smad1, 
Smad5, Smad8 
NS NS NS 200 oligofectamine (Zhan et al., 2006) 
Ovary  Gdf9 216 33 
30 
Real time PCR 
IF 
100 transfectane (Wang and Roy, 2006) 
Lung  Fak  NS NS IF 16 lipofectamine 2000 (Gill et al., 2006) 
Palatal shelves Smad2 24 60 WB 500 oligofectamine (Shiomi et al., 2006) 






Real time PCR 
Real time PCR 
10* 
10* 
oligofectamine (Mercado-Pimentel et al., 2007) 
siRNA-mediated RNAi has been successfully applied to salivary glands, kidneys, Wolffian ducts (WD), urogenital ridges, ovaries, lungs, palatal shelves and 
atrioventricular (AV) canals. Gene knockdown (KD) was verified by immunofluorescence (IF), Western blot (WB) and real time PCR.*two transfections of 10nM 




6.4.3 New directions of application of siRNA to kidney culture 
 
New strategies have been developed to deliver siRNA into cultured organs more 
reliably. The common feature of these strategies is to dissociate the tissues into cells, 
deliver siRNA or shRNA into cells and re-aggregate these cells followed by in vitro 
culture. For example, Park et al. dissected ovaries and used enzymes to dissociate 
them into cell suspensions. They then used lipid transfection reagent to deliver 
siRNA into either oocytes or somatic cells. In this way, they showed transfection 
efficiencies of 40-50% and 30-40% for each cell type respectively and knockdown of 
Wee1 expression to 30-40% of wild type levels. The transfected cells (and 
untransfected controls) were aggregated with phytohaemagglutinin and coated with 
sodium alginate. These alginated cells were then encapsulated by calcium alginate 
and thus formed the reconstructed ‘ovaries’. These reconstructed ‘ovaries’ were 
cultured for four days. Compared with sham controls, the ones with Wee1 
knockdown showed irregular follicle shape (Park et al., 2006).  
 
This dis-aggregation and re-aggregation strategy and other new methods for 
culturing organotypic tissues from dispersed cells are being steadily reported in 
various organs including retinas (Palfi et al., 2006), teeth (Song et al., 2006), skins 
(Mildner et al., 2006), blood vessels (Perez-Pomares et al., 2006), neurons (Ajioka 
and Nakajima, 2005), cartilages (Rosowski et al., 2006), and livers (Zhu et al., 2007). 
Many of these systems seem to offer more direct access to siRNA or shRNA, albeit 
the transfection methods may vary. In the tooth model, Song et al. showed that 92% 
shRNA delivery efficiency were achieved when E13.5 molar mesenchyme was 
dispersed into a single cell suspension (Song et al., 2006). To date, there have not 
been reports on kidney culture using the dis-aggregation and re-aggregation strategy 
but the dispersed embryonic kidney cells, at least at E11.5, retain their ability to grow 
organotypically when re-aggregated and cultured (Unbekandt, personal 
communication). This technique may therefore be promising to sharpen the tool of 





In summary, by using the conventional lipid mediated transfection method in the 
whole kidney organ culture, I have shown that Dact1 was knocked down to 60% of 
controls. This suboptimal knockdown efficiency may partly be explained by the 
uneven distribution of the siRNA. According to the distribution pattern shown by 
fluorescently-labelled siRNA, the loose mesenchyme of the cultured kidneys seemed 
to be able to take up siRNA. Also most mesenchymal cells cultured in a hanging 
drop seemed to take up siRNA. Although there was diffusion problems in kidney 
organ culture, these preliminary observations seemed to support that substantial 
amount of Dact1 siRNA reached the right place where Dact1 was expressed (Figure 
3-9). The observed subtle increase in UB branching in kidneys treated with Dact1 
siRNA might be intrinsic to the sub-optimally delivered Dact1 siRNA. In organ 
culture, sometimes it is not easy to know how much a given gene been depleted will 
exhibit its phenotype. Wang and Roy showed a Gdf9 knockdown phenotype in 
ovaries when 70% of expression remained (Wang and Roy, 2006). The encouraging 
results from the dis-aggregation and re-aggregation of kidney cells render more 
direct access to siRNA delivered and may therefore overcome the diffusion problems 
delineated by fluorescently-labelled siRNA (Figure 6-4). In the future, adopting this 
new strategy, together with the appropriate controls done in this experiment, will 








































Branching morphogenesis is a crucial event for permanent kidney development. This 
process begins with the outgrowth of an unbranched epithelial tube, called ureteric 
bud, from the Wolffian duct. The UB grows towards and invades the metanephric 
mesenchyme where it is induced to undergo branching morphogenesis so that the 
epithelial tube finally turns into a tree-like arrangement of tubules. Meanwhile, the 
epithelial tree induces some of the surrounding mesenchymal cells to aggregate, 
condense and epithelialise into vesicle, comma-shaped bodies, S-shaped bodies, 
developing capillary loop and maturing glomerulus (Abrahamson and Wang, 2003; 
Davies, 2006; Saxen, 1987). Disruptions in UB branching, for example in Gdnf 
(Moore et al., 1996; Pichel et al., 1996), Ret (Schuchardt et al., 1994) and Gfrα1 
(Cacalano et al., 1998) knockout mice, cause severe renal malformation or agenesis.  
 
There are three main models to study metanephric branching morphogenesis: in vivo, 
in organ culture and in cell culture. In vivo approaches have the advantage that 
development is seen in a genuine environment but its disadvantages include poor 
access and potentially being confounded by systemic effects on the embryos. Organ 
culture has many advantages described in the previous chapter but seems to have 
diffusion barrier to siRNA (Figure 6-4). Cell culture models are based on a few 
kidney-derived epithelial cell types that can be induced to develop branching tubules 
in 3D collagen matrices. MDCK, mIMCD-3, and UB cells have all been used for this 
system (Cantley et al., 1994; Montesano et al., 1991; Sakurai et al., 1997a).  
 
MDCK cells derive from an unknown site of the adult dog nephron (Feifel et al., 
1997). When embedded in matrices, these cells proliferate and form cysts with the 
same apico-basal polarity as a normal UB. These cysts form branching tubules when 
cultured in the presence of HGF (Montesano et al., 1991). mIMCD-3 cells derive 
from adult mouse inner medullary collecting duct (Rauchman et al., 1993). When 
suspended in matrices, these cells multiply and form cysts. These cysts are induced 
to form branching tubules in response to HGF (Cantley et al., 1994) or ligands of 
epidermal growth factor (EGF) receptor, including EGF and TGFα (Barros et al., 
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1995; Sakurai et al., 1997b). An immortalised cell line derived from the UB (Barasch 
et al., 1996) is capable of generating branching tubules in collagen I matrix in the 
presence of medium conditioned by BSN mesenchymal cell line (Sakurai et al., 
1997a). These culture systems allow experimenters to analyse branching 
morphogenesis from a single cell type in the absence of the indirect effects from 
mesenchymal development that would be present in organ culture. Most of all, these 
cell culture models have a great advantage that the cells can be transfected before use. 
This advantage allows advanced genetic manipulations (e.g. transfection with 
mutants and reporter genes) to be performed on them. In this project, I took 
advantage of this and transfected mIMCD-3 cells with plasmids expressing Dact2 
shRNA before growing them in the 3D collagen I gel. 
 
It has been postulated that tubulogenesis requires cell migration and cell proliferation 
prior to the formation of lumen-containing tubules (Orellana and Avner, 1998). Cell 
migration is widely understood as the movement of individual cells that undergo a 
cyclic 5-step process: protrusion of the leading edge, cell-matrix interaction and 
formation of focal contacts, localised proteolysis, actomyosin contraction and 
detachment of the trailing edge (Friedl and Wolf, 2003). However, in tubulogenesis, 
cells migrate in a fashion called ‘collective cell migration’ (Friedl and Wolf, 2003; 
Zegers et al., 2003). In this migration mode, cells are mobile yet simultaneously 
connected by cell-cell junctions. When in contact with the substrate, collectively 
moving cells develop multicellular outward ruffling at substrate binding sites and 
generate traction. This force generation occurs only at the free pole of the cell group. 
A unipolar leading edge is thus formed. If the moving cells at the leading edge 
remain connected to other cells by cell-cell junctions, the trailing edge drags the 
neighbour cells along the emerging migration track (Friedl et al., 2004). The simplest 
approach to study collective cell migration is the ‘wound healing assay’ in which an 
artificial wound is created by a needle scratch across a confluent monolayer of cells 
and the distance between the two margins or the whole area of the wound was 




The effect of gene silencing caused by siRNA-mediated RNAi is transient and 
frequently lasts for only 3–5 days in cell culture (Holen et al., 2002). Although this 
may be sufficient for many applications, the insufficient longevity of the silenced 
state limits its use in the mIMCD-3 cell-collagen matrix model. Another potential 
problem is the transfection efficiency because mIMCD-3 is a difficult-to-transfect 
cell line. The solution to these problems is the stable expression of RNAi effector 
molecules from plasmids or viral vectors. Vector-based RNAi also permits co-
expression of reporter genes such as GFP or luciferase, which facilitates tracking of 
transfected cells (Amarzguioui et al., 2005). 
 
One of the aims of this project was to investigate the functional roles of Dact2 in 
developing kidneys by using siRNA-mediated RNAi in kidney organ culture system. 
However, as Dact2 was expressed by the UB epithelium, which is more difficult for 
siRNA to enter (Davies et al., 2004) and the diffusion problems of the 3D organ 
culture system are yet to be overcome, an alternative RNAi-based approach was 
employed to explore potential Dact2 functions in mammalian kidney development. 
This alternative strategy was composed of vector-based RNAi, the wound healing 
assay and the mIMCD-3 cell-collagen matrix model and aimed to discover the 
potential role of this UB marker, Dact2, in renal branching morphogenesis. I made 
mIMCD-3 cell lines that stably expressed plasmids harbouring Dact2 shRNA 
sequences. The negative control cells were mIMCD-3 cells which stably expressed 
the same vector but harboured scrambled artificial sequences. Gene knockdown 
efficiency was assayed by quantitative real time PCR. A wound healing assay was 
used to examine if Dact2 plays a role in collective cell migration. Based on the 
significant differences in wound healing assay seen between Dact2 knockdown and 
controls cells, these cells were then grown in 3D collagen gel to evaluate the impact 
of Dact2 knockdown on branching morphogenesis.  
 131
 




To study the Dact2 functions in mIMCD-3 cells, which were the key materials used 
in the following experiments, the critical step was to confirm their expression of 
Dact2. Conventional end-point RT-PCR was used for this purpose. The procedures 
are detailed in section 2.2.3. The sequence of the forward primer is 
5’ACGGCTAAGGAGACAGGATG3’ and the sequence of the reverse primer is 
5’GGACAGTGGTCTCATCAGCA3’. The binding sites of these primers on the 





Figure 7-1 Binding sites of PCR primers used to illustrate the expression of 
Dact2 in mIMCD-3 cells. Schematic diagram shows the binding sites of PCR 
primers on Dact2 gene.  Coloured bars refer to different exons i.e. exon 1 (blue), 
exon 2 (yellow), exon 3 (magenta) and exon 4 (green). The forward primer binds to 
the antisense strand, the reverse primer to the sense strand.  
 
7.2.2 Generation of Dact2 shRNA stable cell lines 
 
The procedures for generating Dact2 shRNA stable cell lines are detailed in section 
2.8. There were four clones of plasmids encoding different Dact2 shRNA sequences 
and one clone of negative control (NC) plasmid with scrambled artificial sequences 
to be separately transfected into mIMCD-3 cells. The insert sequences are listed in 
Table 7-1 and were mapped to the Dact2 transcript as shown in Figure 7-2 and 
Figure 7-3. Cells that stably expressed Dact2 shRNA and NC shRNA were obtained 
by antibiotic resistant clonal selection and their expressions of Dact2 mRNA were 
assayed by quantitative real time PCR. The sequences of primer used are listed in 
Table 3-3. The Dact2 primer pair was the one used to profile its expression in 
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developing kidneys (described in chapter 3) and it happened to flank the target 
sequences of plasmid clone 3 and clone 4 (Figure 7-3). 
 
Table 7-1 Insert sequences on shRNA plasmids.  












Figure 7-2 Mapping Dact2 shRNA target sequences on the mouse Dact2
transcript. Target sequences of the four plasmids encoding Dact2 shRNAs are 
shown in red (clone 1), brown (clone 2), green (clone 3) and magenta (clone 4).
Exons of mouse Dact2 are distinguished by alternative black and blue colour text. 
     1 GGATTTTCCATTTTAATCAGCTTACAAATAGGAACGTGCGTCTTGCAATGTAAATTTTTT 
    61 TCTTTTGTAATTTTTTTAAATTTAAAAACCTAAACAAAACCTTTGCCTATGCTTAAGCTC 
   121 CTCTCTGTCCCTCTGCGGAGGGGCTTTTGGCCTTCCCCGATGAGCTCATAGGTCCCAGGG 
   181 GCGCAGGGGTTGGGCGAGGGCGCGGCCGGTCGACGGGGCGGGCAGGGGGCGGCCGCTGTG 
   241 ACCTCGGGCGTCGCAAACACCGCCCTCCGCGGCCAGCGATAGGTCCCAACCCACCTAAGC 
   301 GACCTGCAGCCGGGGGCGGGGAGACGCGACGGGGACGCGCGGCGCGGCGGTTGAGCGTCC 
   361 GGGAGATGTGGGCACCGAGCGGCCAGGGGCCCGCGGGTTGGGACCGCCGCAGGGTGGGCG 
   421 CGCGACTACGAGCCGCACTGGCCGGGCTGCAGGAGCTTCAGGGGCTGCGAGCCACGCAGC 
   481 AAGCACGCGTGCGGGGAGCTCTGGGCCTGCACCCTGCGCCAGGGCCCCGCGGCCAGGAGC 
   541 TGCGTCTGGAGGCGGCGCTGACCGCGCTACGGGAGCAGCTGTCACGGCTAAGGAGACAGG 
   601 ATGCTGGCCTGAAGACACACTTGGACCAGCTGGATCAGCAGATAAGTGAACTACAGCTGG 
   661 ATGTGAGCAGGTCTTCTTGCGAGGCCTTGGATAGTGACAGCAGACCCAGCTCAGGTTTCT 
   721 ATGAGCTGAGCGATGCTGGTTCCTGTTCTCTGTCCACCTCCTGCGCATCTGTTTGCAGCG 
   781 ACCGTCTATCCCCCTCCCTGGGTAGCTGGCTGCCTGTGTTCCAGCCCTCCAAGTCCAGGT 
   841 CTGGCATCGGGGACTGGCGACCACGCTCTGCTGATGAGACCACTGTCCCTGCATGGAGCC 
   901 CACAGCTCACAGAAGATAGCAGGCTCCTGCATGGTGCAGAGGGCACAGGCCGGCTGACGG 
   961 GCATGTTCCGGCCCAGACCAGTATCTACAGGTGATCTCGAAAGAGTCCTTCCAGCTGACG 
  1021 TGGGGCTCCAGAGAGCTGGTACTGATGCTGCACATCTCCTGGGCCAGGGGATAGAGATCC 
  1081 CAGCCCACGCCCTGGACCCCACGTACCAGCGTGACCTGGTGGCCAGGGGAGGCCAGGAGG 
  1141 TGTACCCATATCCCAGCCCCCTCCATGCGGTGGCCCTGCAGAGTCCCCTCTTCGCTCTGC 
  1201 CCAAAGAAGCCCCGTGTTTTGACATCTGCTCACCTCCCCAGGAGCCTCCTCTGGTCCCTG 
  1261 TTGATGAGAACAGGACTCAACCTGAGCCGATCCGTGAGCTGGGCTCAGCCGAAGCCTACA 
  1321 TCCACAGGCTGTTGCATCTGCGGGGCCAAGAGCTCCCCCTGAGAGATGTGGGGCAGGAGC 
  1381 AGGGAGGTGACACAGCTGCTTTTCCACCGAAGCCCTGTGGCCAGAGGTCGGAGAGCACAT 
  1441 GTCAGCTGGAGAAGCAGGCCTGTGGAGCTGACAGGGGAGGACTGAAACTAGGTAGGGGTG 
  1501 CTGCCAAGGACAGCCTCAAGCAACATGGGCCTGTGTCCCTTGTGGGTGCTGAGCCCCTCA 
  1561 GCAGCCCCCTAAAGGAAGAAACCATTCCTTGGAATCCCTGTGTCCATGGAGACAATACTG 
  1621 TTGGTTCCTCACCCTGCTCCCAGGCCCAACAGCCTCTTAATGACTGTGGCCAAGGACCAG 
  1681 TCCTGTCACCATCCAGGGTGTTGGGCACTGAGAGCCCACCTCTGGCCCCGGAGCCCTTTG 
  1741 CCTATACATCCTGCACCACTGGTGAAACCTCTCCCGTGAAGCTGAGGATGGGCTTTTCCC 
  1801 AAAACAAGGCCGTGAAGGTCAGAAGAAGAGTTAGTGAGAAAGTCCCGAGGCTAGGGAAGC 
  1861 AGCTCCCTCCACAACCAGAGAGGCAGCGGGTCACAGAGCGGGACCCCTCCAGGCCCCATC 
  1921 AGGGAGGTCTCAGCAGGAGGCCCACACTGGCCCGGGAGCCTCCTGGACGCTCCTGCTCTG 
  1981 AGTCCACCCTCTACCCCGTGCCCTTCCTTGTCCCCGTAGTGGTGGCCCAGAGGGAAAGTT 
  2041 ACCCAACGTCACCCCAAGCGTTCTTCCCAATGGAGGCAGCTCTCCTCAGCTCAGCAGCCA 
  2101 GGCGGAAGCAGCGCAGGTGGCAGTCCACCATGGAGATCTCAGCCAAAGCCGGTTCAGTCA 
  2161 GCCAACCTGGGCCCAGCATGGGGCTCCCTAGGTCCCCAGCCAAGAGAGGAAGTGGTCCCA 
  2221 GGGCCCAGAGTAGGCCCACACTTGCCCGTCAGGATGCCTGTGCGAGGTGTGAGTCGGACC 
  2281 CCTCGGAGCACTCTGCAGACTGCACCTCACTCTACCACTCCACCATTGCCGAGACCAGCG 
  2341 AGGACGAGGAGGCGAGTGACCACACTGCCAACCGCTTTGGGGACGAGTCCAGCAGCAACG 
  2401 ATTCAGAAGGGTGTTTCCGGGGCAGCCGCCGTCGCCTGGCAATAGGCAGTGCAGAGGCTG 
  2461 GGCAAGGGGGGTGGGCCTGGCCTCGGGTGCCCCCCCAGCAGCCCTCACGGGCCCCAGGAA 
  2521 ACACCAGGCCACCCTTGCCCCCTGTGCCCAAACTGTGCCGCATCAAGGCCTCCAAGGCCC 
  2581 TGAAGAAGAAGATCCGAAGGTTTCAGCCAGCAGCCCTGAAGGTCATGACCATGGTGTGAT 
  2641 GGCAGTGTTTCAGGACAAGCCTAGGACCCCAGAAGGTGCCATATGATGTGGTACCCCGTG 







Figure 7-3 Dact2 shRNA plasmids target sites and primer binding sites on the 
mouse Dact2 transcript. Schematic diagram depicts the target sites of Dact2
shRNAs on the mouse Dact2 transcript (scissor). Black bars and arrows indicate the 
binding sites of Dact2 primers used to detect the silencing efficiency. P: plasmid. 
 
7.2.3 Wound healing assay 
 
Cells that stably expressed Dact2 shRNA and NC shRNA were used in a wound 
healing assay. 1x106cells per well were plated in G418 media in a 6-well plate. The 
following day, when cells had formed a monolayer, a straight scratch wound was 
created by a yellow pipette tip. Cells were then washed by G418 media for three 
times and were subjected to time-lapse microscopy (Zeiss Axiovert 200). The setting 
parameters of time-lapse imaging system included 10X objectives and 25ms 
exposure time. Images were taken at the same position of each well at 10-min 
intervals over 24 hours. Stacks of images of the same well were converted into an 
AVI movie by the software IPLab (Scanalytics). Wound areas were also measured at 
two-hour intervals by the same software. 
 
7.2.4 BrdU incorporation assay 
 
To investigate whether cell proliferation affects the wound healing in these cells, a 
BrdU incorporation assay was performed together with this wound healing assay. 
Four hours after a scratched wound was made, a short pulse of BrdU (20µM) was 
introduced for 45 min. Cells were then fixed and subjected to BrdU 
immunocytochemistry as detailed in section 2.7.2. At the end of the 
immunocytochemistry, cells were mounted and imaged by confocal microscopy. 
When taking images, the labelling of clones on glass slides was masked so that the 
subsequent cell counting on the images was done blind. Two hundred cells were 
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counted per coverslip and the proliferation index was defined by BrdU labelling rate, 
which was calculated as the ratio of BrdU labelled cells to the total cell number 
counted. Data from three independent experiments were collected and subjected to 
statistical analysis. By using the Microsoft Office Excel 2003 software program, a 
one way ANOVA was used to compare the means of each group. When the p-value 
was less than 0.05, the ANOVA test was considered to be statistically significant. 
 
7.2.5 3D collagen gel cell culture 
 
To prepare the collagen I gel matrix, appropriate volumes of each component were 
calculated as 20µl of 10X PBS, 2.3µl of 1N NaOH, 77µl of distilled water and 100µl 
of rat tail collagen type I (BD Biosciences) for a well in a 24-well plate. These 
components were mixed together in a sterilised tube on ice. 5000 cells were added to 
the collagen mixture and seeded in each well. This low cell density was used to avoid 
cell–cell contact when cells were seeded. 200µl of the cell/collagen I gel mixture was 
plated onto a coverslip at the bottom of a 24-well plate and incubated in a humidified 
incubator at 37°C for 20 min. HGF was added into G418 culture medium to yield a 
final concentration of 25ng/ml. 500µl of HGF medium was carefully added into each 
well. Cells in collagen gel matrices were cultured at 37°C with 5% CO2. The HGF 
medium was changed every three days. After seven days, cells were fixed by 4% 




7.3.1 mIMCD-3 cells expressed endogenous Dact2   
 
RT-PCR was used to verify the presence of Dact2 expression in mIMCD-3 cells. In 
Figure 7-4, in the presence of RT, RNA samples from mIMCD-3 cells showed a 
single band of correct size (305 bp) on agarose gel whilst negative control, RNA 






Figure 7-4 mIMCD-3 cells express Dact2. Compared with a 100bp ladder (left 
lane), PCR ethidium bands of the correct size for Dact2 cDNA are present in 
mIMCD-3 cell RNA samples with RT added (+) but not samples when no RT was 
added (−). 
 
7.3.2 Effective Dact2 knockdown in stably transfected mIMCD-3 cells 
 
Quantitative real time PCR was used to assay Dact2 knockdown efficiency in 
mIMCD-3 cells. The Dact2 expression level was normalised to a housekeeping gene, 
Actb. Data were expressed as percentage of the control clones that harboured plasmid 
encoding scrambled artificial sequences. Knockdown of Dact2 in several mIMCD-3 
clones was verified by using quantitative real time PCR. Most clones showed 
satisfactory knockdown efficiency except the ones expressing plasmid clone 3 (Table 
7-2). In Table 7-2, the names of cell clones are composed of a number and a letter. 
The number refers to the shRNA plasmids transfected. Figure 7-5 showed the 
knockdown efficiencies in the selected clones. In clones 1b and 4c, Dact2 expression 
was reduced to 10% of control cells. These two clones of cells were therefore chosen 
for the subsequent wound healing assay and the 3D collagen gel culture. In the 
wound healing assay and 3D culture experiments, these clones were designated P1 
and P4 respectively. 
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Table 7-2 Relative expression of Dact2 in all the clones tested. 
 
Cell clones Relative expression of 
Dact2 (% of control) 
Cell clones Relative expression of 
Dact2 (% of control) 
1a 16.1 3a 61.3 
1b (P1) 9.8 3b 51.3 
1c 12.0 3c 49.8 
2a 43.0 4a 185.1 
2b 28.7 4b 11.2 






Figure 7-5 Dact2 silencing efficiencies in selected clones stably expressing Dact2
shRNA. Quantitative real time PCR showed that the relative Dact2 expression in 
selected clones of mIMCD-3 cells. Dact2 expression was normalised to Actb and was 
expressed as percentage of the control. Control refers to cells transfected with 
negative control plasmid. In clone 1a, 1b and 4c, Dact2 expression was knocked 
down to about 10% of the control. Data are represented as Mean ± SEM. The 




7.3.3 Dact2 is required for the coordinated migration of renal epithelial cells 
 
Having verified the knockdown efficiencies in Dact2-depleted mIMCD-3 cells, a 
wound healing assay was used to examine their phenotypes. After wounding, cells 
were monitored by time-lapse imaging system for 24 hours. These experiments were 
carried out independently three times and representative images for control clone, P1 
and P4 at time zero, three hours and six hours after wounding are shown in Figure 7-
6. Six hours after wounding, control cells closed the wound but the wounds of the 
Dact2 knockdown cells, clone P1 and P4, were still open. At the end of the whole 
24-hour monitoring by time-lapse imaging system, images taken at two-hour 
intervals were picked from the stacks of images for each clone. These images were 
analysed by measuring the wound area at each time point relative to the area at time 
zero. The calculated percentage of wound area is plotted and shown in Figure7-7. 
Control cells took six hours to close the wound. Clone P1 and P4 cells took ten and 
18 hours to heal the wound, respectively. Compared to control cells, both clone P1 
and P4 cells moved more slowly. Although both P1 and P4 expressed comparably 
low Dact2 mRNA levels (Figure 7-5), clone P4 cells moved far more slowly than 
clone P1 cells (Figure 7-6, 7-7 and AVI movies in attached CD). Nevertheless, clone 
P1 and P4 served as multiplicity controls for each other in an RNAi experiment. The 
phenotype was a specific result of Dact2 depletion because it is very unlikely that 
different shRNAs will lead to the same off-target effects (Jackson et al., 2003). In 
addition to the rate of wound closure, aberrant motility responses were also noted in 
Dact2 knockdown P1 and P4 cells. Unlike control cells, which showed a coordinated 
sweeping of a joined-up epithelial sheet, cells lacking Dact2 exhibited a much 







Figure 7-6 Collective migration of mIMCD-3 cells in response to wounding.
Cells for wound healing assay were monitored by time-lapse imaging system for 24 
hours. Images taken at time zero, three and six hours after wounding were shown. 
Cells lacking Dact2 (clone P1 and P4) moved more aberrantly and slowly than 
control cells. By six hours, control cells already closed the wound whilst the wounds 
were still present in clone P1 and P4. Clone P4 cells moved more slowly than clone 





Figure 7-7 Time course of the wound healing assay. In wound healing assays, 
images taken at two-hour intervals were chosen to measure the area of the wound. 
The area at each time point was measured as the percentage of the area at time zero. 
Data were collected from three independent experiments and are represented as 
Mean ± SEM. Control cells (pink) took six hours to close the wound. Both clones of 
cells lacking Dact2 moved more slowly than control cells. Clone P4 cells (blue) took 





Figure 7-8 Amoeboid movements in Dact2-depleted cells. In wound healing 
assays, amoeboid migration movements were noted in both clones of Dact2-depleted 
cells but not in control cells (upper panel). Red circles in lower panel (clone P4 cells) 
highlight some individual cells showing amoeboid movements. This amoeboid 
migration movement is better demonstrated in the AVI movies in the attached CD. 
 
In some epithelial cells, for example human corneal epithelial cells, scratching a 
wound induces cell proliferation and migration of the surrounding intact cells, which 
finally closes the wound (Yin et al., 2007). However, in the well-researched MDCK 
wound healing model, cell proliferation does not contribute to the healing of the 
wound (Fenteany et al., 2000; Sponsel et al., 1994). To examine whether disruption 
in cell proliferation contributes to the delayed closure of the wound in Dact2-
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depleted mIMCD-3 cells, I performed a BrdU incorporation assay in both control and 
Dact2-depleted cells four hours after scratching the wound. Low power images 
(Figure 7-9 a,b,c) were to illustrate the distribution of BrdU-labelled cells across the 
wound. High power images, clearly showing the BrdU-labelled pink nuclei and the 
unlabelled blue nuclei, were taken for cell counting. The calculated proliferation rate 
was plotted in panel (d). Figure 7-9 showed that both control and clone P4 cells had 
similar proliferation rate but clone P1 cells seemed to show an increased proliferation 
rate. However, this difference in proliferation rate was not statistically significant as 
examined by one-way ANOVA (p=0.149). Therefore, in response to wounding, 
Dact2 knockdown impeded mIMCD-3 cells migration, probably by changing the 






Figure 7-9 Proliferation does not affect the rate of wound closure. A BrdU 
incorporation assay was performed four hours after wounding in control (a), clone P1 
(b) and clone P4 (c) cells. BrdU labelled cells showed pink nuclei (arrows) while 
unlabelled cells were counterstained by TO-PRO-3 (blue). Inset is to show more 
clearly the pink and blue nuclei. BrdU labelling rate was calculated and is plotted in 
panel (d). Control and clone P4 cells showed similar proliferation rates. Clone P1 
seemed to exhibit a higher proliferation rate but the difference in the proliferation 
rate was not statistically significant (p=0.149 in one-way ANOVA). Scale bar = 
50µm in a,b,c; 25µm in the inset.   
 
7.3.4 Dact2 knockdown cells form more jagged cysts in 3D collagen matrices 
 
Based on the Dact2 knockdown phenotypes in collective cell migration as 
demonstrated by a wound healing model, one step further towards understanding the 
function of Dact2 in kidney development was to grow these cells in the 3D collagen 




expected to form cysts during the first few days. These cysts are induced to generate 
branching tubules in the presence of HGF (Cantley et al., 1994). When I grew control 
and Dact2 knockdown mIMCD-3 cells, their morphology was inspected daily by 
using a microscope. In the presence of HGF, cysts and branching tubules were all 
found in control, P1 and P4 cells because these cells were not synchronised when 
seeding. However, there seemed to be a subtle difference between control and Dact2-
depleted cells. Most of the cysts formed by control cells showed round and smooth 
edges and were therefore termed as ‘round cysts’. However, most cysts found in 
either P1or P4 cells exhibited uneven edges and were called as ‘jagged cysts’. Forty 
cysts were picked randomly and counted in each clone of cells and the percentage of 
jagged cysts was calculated and plotted in Figure 7-10. When counting the cysts, the 
labels of the cells were masked so that the counting was done blind. In untransfected 
cells and cells expressing NC plasmid, jagged cysts accounted for only ~30% of the 
total cysts whilst in Dact2-depleted cells, the percentage of jagged cysts reached 
~60%. This experiment was done only once due to the time available in my PhD 
project. The preliminary observation needs to be verified by repeating the 3D 





Figure 7-10 Cysts formed by mIMCD-3 cells in 3D collagen I matrices. Phase 
contrast photomicrographs showed a ‘round cyst’ (a) whose edge was smooth and a 
‘jagged cyst’ (b) with its uneven contour. Both cysts could be found in control and 
Dact2 knockdown cells. The percentage of the jagged cysts for each clone of 
mIMCD-3 cells is shown in panel (c). Dact2 knockdown cells seemed to exhibit 





7.4.1 A promising RNAi tool made to investigate branching morphogenesis 
 
The stable mIMCD-3 cell lines expressing Dact2 shRNA were promising tools to 
investigate Dact2 functions in cell culture based models. They offered satisfactory 
Dact2 knockdown efficiency (Figure 7-5) and were able to overcome problems 
encountered by siRNA-mediated RNAi such as low transfection efficiency in hard-
to-transfect cell lines and the longevity of the silenced state. The longevity of the 
silenced state is critical when growing these cells in 3D matrices to investigate 
branching morphogenesis. The phenotypes of aberrant cell migration and increased 
jagged cyst formation were seen in both clones studied, though the latter was a 
preliminary observation. These different clones expressing distinct sequences of 
Dact2 shRNA (P1 and P4) served as the multiplicity controls to confirm that these 
phenotypes were specific to Dact2 depletion because it is barely possible for 
different shRNAs to cause the same off-target effects (Jackson et al., 2003). Similar 
strategies to look at epithelial morphogenesis have recently been reported in 
mIMCD-3 cells (Mai et al., 2005) and MDCK cells (Aijaz et al., 2007; Kim et al., 
2007a). Mai et al. made stable mIMCD-3 cell lines expressing Pkhd1 shRNA and 
showed that these cells exhibited impaired tubulogenesis in 3D culture. They then 
turned to 2D culture assays, including wound healing assay, to further investigate the 
possible mechanisms underlying the impaired tubulogenesis (Mai et al., 2005). 
 
Two strategies in designing the constructs that may provide additional insights into 
this system include co-expression of reporter genes such as GFP or luciferase and the 
inducible expression of RNAi effectors like tetracycline-inducible promoter system 
(Gossen et al., 1995). The former allows tracking of the transfected cells and 
illustrating the transfection efficiency. The latter provides a major advantage to 
reverse the knockdown of the gene though may cause some level of leakiness, which 
may result in significant gene repression in the absence of induction (Lin et al., 2004).  
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7.4.2 Dact2 and known molecules modulating collective cell migration 
 
Dact2-depletion resulted in uncoordinated cell migration and amoeboid migration 
behaviour of individual cells (Figure 7-6, 7-8 and AVI movies in the attached CD) 
but the mechanisms are yet to be investigated. Clues may lie in the well-
characterised wound healing model using another kidney-derived epithelial cell line, 
MDCK cells. (Fenteany et al., 2000). Following scratch wounding of MDCK 
epithelial cell monolayers, cells move in to close the gap as a continuous sheet while 
strictly maintaining cell–cell junctions. This wound closure is driven by cell 
migration, with active protrusive crawling in multiple rows of cells from the wound 
margin (Farooqui and Fenteany, 2005), rather than by purse-string contraction or cell 
proliferation (Fenteany et al., 2000; Sponsel et al., 1994). MDCK cell sheet 
migration depends on Rac and phosphoinositides (Fenteany et al., 2000), GSK3 
(Farooqui et al., 2006), ADP-ribosylation factor 6 (ARF6) (Santy and Casanova, 
2001), c-Jun-N-terminal kinase (Altan and Fenteany, 2004) and Raf kinase inhibitor 
protein (Zhu et al., 2005). Many of these molecules directly or indirectly affect actin 
filament reorganization, assembly and disassembly and thus affect the generation of 
the driving force of wound closure (Farooqui et al., 2006; Friedl and Wolf, 2003). 
Therefore, the future plans to investigate the mechanisms by which Dact2 modulates 
collective cell migration in mIMCD-3 cells may include the examination of actin 
organisation and dynamics in Dact2-depleted cells and the interaction between Dact2 
and known molecules described in MDCK wound healing models.  
 
Immediately before this thesis was compiled, a project student in this lab found 
impaired formation of perimarginal actin bundles only in those Dact2-depleted 
mIMCD-3 cells I made, but not in control cells (Ekiert, personal communication).  In 
MDCK wound healing models, the formation of this perimarginal actin bundle 
depends on Rho activity (Fenteany et al., 2000). Hence, the encouraging finding of 
impaired actin bundle formation in Dact2-depleted cells suggests that research into 




In addition to the force generation, the amoeboid migration observed in Dact2-
depleted cells was reminiscent of migration of leukocytes and some tumour cells 
(Farina et al., 1998; Friedl et al., 2001). These cells show weakened adhesiveness for 
ECM due to their deregulated integrin expression (Jaspars et al., 1996; Kraus et al., 
2002; Rintoul and Sethi, 2001). Hence the adhesion molecules including integrins in 
these Dact2-depleted mIMCD-3 cells also need to be examined. More importantly, a 
novel mechanism of cancer cell migration is described as collective amoeboid 
transition (CAT). Hegerfeldt et al. showed that in multicellular clusters that emanate 
from primary melanoma explants, anti-β1 integrin antibodies induce not only the loss 
of collective movement, but also the dissemination of individual cells that adopt β1-
integrin-independent amoeboid migration (Hegerfeldt et al., 2002). As Dact2 
depletion was able to change the collective mIMCD-3 epithelial sheets into 
amoeboid cellular movements, Dact2 might play a role in tumourigenesis and 
invasiveness. It is therefore critical to work out the mechanisms by which Dact2 
governs CAT.  
 
7.4.3 From amoeboid movement to the formation of jagged cysts 
 
In 3D culture, a single cell can proliferate and its clone will eventually form a hollow 
sphere that is lined by a monolayer of polarised epithelial cells. This structure, 
referred to as a cyst, can be induced to generate branching tubules by growth factors 
such as HGF (Cantley et al., 1994; Wang et al., 1990). Both cysts and tubules may 
represent the basic building blocks for the formation of more complex epithelial 
organs. Each cell in a well-developed cyst are polarised and have three types of cell 
surface domain: an apical surface domain that borders the lumen; a basal surface 
domain that attach to the ECM and a lateral surface domain that adheres to 
neighbouring cells. To form such an organised structure, cells need to proliferate, 
migrate and differentiate following an intrinsic mechanism that can precisely 
coordinate their individual behaviour. During the process of the cyst formation, cells 
often lack one or more surface domains. Cells lacking a lateral surface domain divide 
to generate a neighbour; cells lacking an apical surface domain create apical lumens; 
cells lacking a basal surface domain die. These cells differentiate further to attain 
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three types of surface domain and finally form a cyst with the apical surface facing 
the lumen (Lin et al., 1999; O'Brien et al., 2002). Disruptions in molecules 
modulating the arrangement of these three surface domains result in abnormal cyst 
formation. For example, O'Brien et al. showed that dominant negative Rac1 causes 
inverted apical polarity of the MDCK cells and thus forms cell arregates without 
lumens (O'Brien et al., 2001). 
 
The underlying mechanisms for the Dact2-mediated jagged cyst formation are yet to 
be elucidated. The three surfaces rule in the generation of cysts (O'Brien et al., 2002) 
seems to offer some implications. Aijaz et al. showed that depletion of Apg-2 in 
MDCK cells causes irregular cysts by retarding the recruitment of the junctional 
protein ZO-1, which affects the lateral surface of polarised epithelial cells in cysts 
(Aijaz et al., 2007). Following this three surfaces rule and taking into account my 
results of the wound healing assay seemed to offer implications on the possible 
mechanisms of the jagged cyst formation. The amoeboid migration observed in 
Dact2-depleted cells indicated potential errors in integrins, which are key factors 
defining the basal surfaces of the polarised epithelial cells (Zegers et al., 2003). 
Besides, Dact2-depleted cells showed impaired organisation of acitn (Ekiert, 
personal communication), which locates at the apical surfaces of polarised epithelial 
cells in a normal cyst (O'Brien et al., 2001; Verkoelen et al., 2000). Finally, the 
uncoordinated migration seen in a Dact2-depleted cell collective might reflect errors 
in the microfilament networks which connect cell-cell junctions. The reduced tension 
between cells might therefore cause the cells of the cyst to spread out when growing 
in 3D matrices. Staining of markers for each surface domain of epithelial cells in 
cysts, for example, gp135 for apical surface, ZO-1 for lateral surface and type IV 
collagen for the basal surface (Wang et al., 1990), will help to delineate the 
underlying mechanisms for the jagged cyst formation in the Dact2-depleted cells.  
 
Notably, however, jagged cysts seemed to account for ~30% of the total cysts in both 
the wild type mIMCD-3 cells and the cells transfected with control plasmids. The 
presence of jagged cysts in wild type cells might indicate that jagged cyst was a stage 
prior to the round cyst stage in the development of tubules. Dact2-depleted cells 
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formed more jagged cysts (~60%) and might thus show delayed tubulogenesis. 
Analysis of the jagged cysts from both control and Dact2-depleted cells by 
polarisation markers may offer more insights. If the staining of the polarisation 
markers shows significant differences in these morphologically similar jagged cysts 
derived from control and Dact2-depleted cells, it indicates that Dact2 modulates the 
polarisation of the normal cysts. If the analysis proves jagged cysts are the same in 
both control and Dact2-depleted cells, it implies that Dact2 depletion causes delayed 
round cyst formation via mechanisms other than polarisation. In either case, Dact2 
depletion may result in more jagged cysts and thus delays tubulogenesis. 
 
A major limitation of these experiments comes from the origin of the mIMCD-3 cells. 
Because these cells are derived from adult but not embryonic kidneys, the results 
obtained from this model system might not be very authentic when applied to the 
very complex processes in kidney morphogenesis. Embryonic kidney cell lines have 
been developed (Barasch et al., 1996; Sakurai et al., 1997a). These cell lines may be 
more suitable in this model system for shedding light on kidney development. 
Although the exact mechanism leading to the pronounced increase in the jagged cyst 
formation seen in Dact2-depleted cells remains to be elucidated, the results that I 
have shown in this chapter will help contribute to a better understanding of the 








































8.1 Experimental conclusions 
 
Mammalian kidney development is controlled by a complex molecular network. In 
this thesis, I have presented two genes, Dact1 and Dact2, in this network. I 
confirmed their expression in developing kidneys, described their temporospatial 
expression patterns and investigated their functions in various model systems for 
kidney development. All the results were previously unreported. The experimental 
conclusions are described below. 
 
8.1.1 Dact1 and Dact2 have distinct expression profiles in the developing kidneys 
 
Using quantitative real time PCR, I have shown that Dact1 and Dact2 exhibit distinct 
temporal expression profiles from embryonic to postnatal kidneys. Dact1 was 
detected in kidneys at all embryonic stages tested (e.g. from E11.5 to E17.5) and was 
expressed at a very low level in adult kidneys. Among the embryonic stages I 
analysed, the level of Dact2 in kidneys increased from E11.5, peaked at E17.5 and 
reduced postnatally. In adult kidneys, the Dact2 expression level is comparable to 
that at E14.5. In addition to the different time-frame of expression, Dact1 and Dact2 
showed a distinctive spatial pattern of expression in kidneys.  
 
By using RNA in situ hybridisation, I have shown that Dact1 was expressed by the 
metanephric mesenchyme. In kidneys at later developmental stages when renal 
stroma developed, Dact1 was expressed predominantly by the medullary stroma. 
Many of the stromal cells die via apoptosis by birth (Coles et al., 1993). This is 
probably the reason that Dact1 was hard to detect in adult kidneys by in situ 
hybridisation. The very low level of Dact1 expression in adult kidneys was 
confirmed by quantitative real time PCR. The paralogous gene Dact2 was expressed 
exclusively by the ureteric buds of the kidneys throughout the developmental stages. 
The distinct expression patterns of Dact1 and Dact2 suggest different functional 
roles in the kidney development.  
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8.1.2 Dact1 negatively regulates cell proliferation and UB branching 
 
To discover the functions of Dact1 in kidney development, I used a siRNA approach 
to knockdown Dact1 in a cell culture system. While verifying Dact1 siRNA in 
conventional 2D cell cultures, I found differences in the growth rates between Dact1 
siRNA-treated and control groups of cells. In cells in which Dact1 was knocked 
down, there was an increase in cell number and cell proliferation index. I therefore 
hypothesised that Dact1 negatively regulated cell proliferation, designed sets of 
experiments to test this hypothesis and confirmed it.  
 
Next, I moved from using a 2D cell culture to use a kidney organ culture which is 
more physiologically relevant than the 2D cell culture system. I found that knocking 
Dact1 down by siRNA-mediated RNAi in kidney organ culture seemed to stimulate 
UB branching although the transfection efficiency was not very satisfactory. It is 
common for researchers to encounter difficulties when trying to deliver siRNAs into 
cultured kidneys using chemical-based delivery vehicles (e.g. siLentFect or 
Lipofectamine) (Vanio, personal communication).  The problem of efficient delivery 
of RNAi effectors into kidneys growing in culture needs to be overcome. If a more 
satisfactory delivery efficiency can be achieved, I would like to test whether this 
increase in UB branching is indeed a phenotype caused by the depletion of Dact1 in 
the kidneys. Caution has to be applied when drawing conclusions about the function 
of a gene based on analysing siRNA phenotypes. The conclusion would be stronger 
if the same phenotype (i.e. increased UB branching) were also observed when 
cultured kidneys were transfected by several individual Dact1 siRNAs targeting 
different regions of Dact1. In addition, performing cell proliferation assays in the 
kidney organ culture which has been transfected with Dact1 siRNA will help answer 
whether Dact1 regulates UB branching by increased cell proliferation. This work 
will fill the gap between the cellular phenotype and kidney phenotype observed.  
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8.1.3 Dact2 is required for renal epithelial sheet migration 
 
By using stable mIMCD-3 cell lines, I have shown that Dact2 is required for renal 
epithelial sheet migration. Cells lacking Dact2 showed slow and amoeboid 
movements. This phenotype was confirmed by different clone of cells expressing 
shRNA targeting distinct Dact2 sequences. Our preliminary observation of impaired 
formation of actin bundles in Dact2-depleted cells supported the observed cellular 
phenotype in the wound assay and opened the way to new research into the interplay 
between Dact2 and cytoskeletal systems. Additionally, the amoeboid movements 
seen in Dact2-depleted cells indicated errors in cell-cell and/or cell-matrix 
interaction. Both cell-cell and cell-matrix interactions are important factors for a 
normal round cyst formation. Therefore, the amoeboid movement seemed to support 
the interesting observation in the 3D gel tubulogenesis model where Dact2 
knockdown favoured the formation of jagged cysts. This observation need to be 
tested by repeating the experiments to obtain enough samples for statistics. This 
preliminary observation supported the idea that Dact2 acts as an intrinsic factor to 
control branching morphogenesis. 
 
8.1.4 Dact genes and kidney development 
 
Mouse kidney development starts from the reciprocal induction between the 
metanephric mesenchyme and the ureteric buds. It was very interesting to study both 
Dact genes in one project because Dact1 and Dact2 happen to be expressed by each 
of the components of the developing kidneys. Understanding each of these Dact 
genes in developing kidneys is like understanding kidney development from two 
important angles.  
 
Dact1 is expressed in the metanephric mesenchyme during early kidney development 
(E11.5 and E12.5) and is later detected in the renal stroma (E14.5).  So far in the 
literature, most efforts made to the investigation of MET during kidney development 
have focused on the metanephrogenic mesenchyme.  In my study, the temporospatial 
expression pattern of Dact1 highlighted the heterogeneous nature of the metanephric 
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mesenchyme and the importance of renal stroma in kidney development. By using 
the siRNA approach to explore the potential functions of Dact1 in an embryonic 
mesenchymal cell line, Dact1 was found to be a negative regulator of cell 
proliferation. The finding that Dact1 was expressed in the differentiated medullary 
stroma in developing kidneys and the results of being a negative regulator in cell 
culture suggested that Dact1 might be a proliferation-to-differentiation switch of 
stromal mesenchyme in the developing kidneys. This feature somehow resembled a 
transcription factor, Pbx1, which is expressed by renal stroma. Pbx1 deficient 
kidneys initiate nephrogenesis but exhibit sustained proliferation of the mesenchyme 
without subsequent differentiation (Schnabel et al., 2003). Notably, however, Pbx1 
regulates signals sending from stroma to control proliferation and differentiation of 
metanephrogenic mesenchyme whereas Dact1 might regulate proliferation and 
differentiation of the stroma itself. 
 
In addition, the discovery of Dact1 to be a negative regulator of UB branching drew 
my attention from renal stroma to another compartment (i.e. the ureteric buds) of the 
developing kdineys. Distinct from the plausible link between stromal signals and Ret 
proposed by Batourina et al. (Batourina et al., 2001) (also reviewed briefly in section 
1.4.4), this finding seemed to offer new insights into the regulatory role of renal 
stroma in UB branching.  
 
Dact2 was identified as a UB marker and has addressed several intriguing questions 
on branching morphogenesis. It was not a critical factor for the collecting duct cells 
to survive but it was quite important for the normal migration movement of an 
epithelial sheet. Cells lacking Dact2 seemed to dissociate with their neighbours and 
attempted to spread out from the epithelial sheet. When growing in 3D gels, Dact2-
depleted cells seemed to spread out the smooth edges that they ought to form 
resulting in more jagged cysts observed. These results did demonstrate the biological 
functions of Dact2 in collecting duct cells and also shed light on potential roles of 
Dact2 in branching morphogenesis of kidneys. I might expect to see abnormal 
branching patterns of ureteric buds in kidneys where Dact2 has been depleted. 
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8.2 Future perspectives 
 
Although this thesis has addressed two main questions regarding the expressions and 
functions of both Dact genes in cell and kidney organ culture systems, inevitably 
many questions still remain. Some of the questions have already been discussed in 
each result chapter. However, many avenues remain to be explored. They are 
discussed below. 
 
8.2.1 Potential signalling pathways regulated by Dact1 to control cell 
proliferation in developing kidneys 
 
Many signalling pathways, such as WNT, TGFβ, EGF, and Sonic Hedgehog (Shh), 
are known to control cell proliferation. To work out the signalling pathway by which 
DACT1 acts to control cell proliferation in developing kidneys, I would here try to 
narrow down the candidate pathways based on the literature and the results presented 
in this thesis. Among the proteins known to control cell proliferation in developing 
kidneys (as summarised in Table 1-1), the β-catenin downstream gene N-myc is 
proved to control metanephric mesenchymal cell proliferation (Bates et al., 2000). 
Like Dact1, N-myc is expressed by the metanephric mesenchyme (Shimono et al., 
1999). DACT1 has been shown to directly bind to DVL (Cheyette et al., 2002) and 
has been implicated in WNT/β-catenin pathway in various developmental contexts as 
discussed. Therefore, it will be interesting to investigate whether DACT1 binds to 
DVL and acts as an antagonist of β-catenin leading to the repression of N-myc-
modulated cell proliferation in the metanephric mesenchyme (Figure 8-1). This 
postulated pathway indicated that DACT1 regulates the size of the mesenchymal cell 
population. Experiments including BrdU incorporation assay and N-myc expression 





Figure 8-1 Proposed pathway for DACT1 in WNT/β-catenin/N-myc-mediated 
cell proliferation. In (a), DACT1 binds to DVL so that β-catenin is degraded by the 
destruction complex. The downstream gene N-myc is inactivated and the cell stops to 
proliferate. When DACT1 is depleted (b), DVL binds to the destruction complex in 
response to WNT signaling. β-catenin is stabilised and translocated into the nucleus 
to activate N-myc driving the cell to proliferate (Modified from Moon et al., 2004). 
 
Interestingly, the pattern of the canonical WNT/β-catenin signalling activity seems to 
support the idea that DACT1 is a negative regulator of β-catenin in developing 
kidneys. By using β-catenin-responsive TCF/βGal reporter transgenic mice, Iglesias 
et al. demonstrated that intense canonical WNT signalling was evident in epithelia of 
the branching UB and in nephrogenic mesenchyme during its transition into renal 
tubules. Antibodies against active (nonphosphorylated) β-catenin were used to 
confirm that the transgene expression reflects endogenous canonical WNT/β-catenin 
signalling activity. As kidney development proceeds, the TCF signal is found only in 
the nephrogenic zone (Iglesias et al., 2007). The areas showing TCF signal are zones 
where cells undergo extensive proliferation. From my results, hardly any Dact1 was 
expressed in these areas. On the contrary, in the medullary stroma, where cells do not 
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undergo much proliferation, cells express high levels of Dact1 but exhibit 
undetectable canonical WNT/β-catenin signalling activity. Other factors known to 
control cell proliferation in many compartments of the developing kidneys (i.e. IGF 
I/II, RA, Glypican-3 as summarised in Table 1-1) might exert their effects by 
repressing DACT1 activity in developing kidneys. To examine this hypothesis, it will 
be desirable to use embryonic mesenchymal cell culture systems where no indirect 
effect from other compartment of developing kidneys can be found.  
 
8.2.2 Functional roles of Dact1 in the development of renal stroma 
 
While I have already shown that Dact1 was expressed by the medullary stroma at 
E14.5 (Figure 3-9) and have explored its functions in branching morphogenesis and 
nephrogenesis, the question on its role in the development of renal stroma remains. 
Finding the function of a gene in the development of renal stroma, which is less 
understood than the metanephrogenic mesenchyme and the ureteric buds, will be a 
new research area worthy of exploring.  
 
The better characterised stromal marker, Foxd1, seems to be a promising target to 
investigate. Foxd1 is strongly expressed in the nephrogenic zone whereas Dact1 is 
expressed in the medullary stroma. Implicated from the complementary expression 
pattern of Foxd1 and Dact1, it will be interesting to find out whether these two genes 
counteract each other to specify the fate of the mesenchymal cells. Mesenchymal 
cells that express high levels of Foxd1 and low levels of Dact1 might have the 
features of stromal progenitors and locate in the nephrogenic zone. On the other hand, 
mesenchymal cells that express high levels of Dact1 and low levels of Foxd1 might 
become differentiated medullary stroma cells. Using Dact1 siRNA to silence Dact1 
at early stage kidneys growing in culture might therefore change the boundary 
between the nephrogenic and medullary zones. Dact1 silencing might result in more 
mesenchymal cells expressing low levels of Dact1 while maintaining high levels of 
Foxd1 and eventually lead to a wider nephrogenic zone (Figure 8-2). This model can 
also be tested by generating Dact1 mutant mice and comparing the width of the 
nephrogenic zone in mutant and wild type kidneys. Additionally, the Dact1 mutant 
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mice are very likely to offer great understanding of the functional roles of Dact1 in 





Figure 8-2 Proposed model for the interaction between Foxd1 and Dact1. At 
E11.5, a group of mesenchymal cells express high levels of Foxd1 (red ball) and 
another group of mesenchymal cells express high levels of Dact1 (pale pink ball).
When kidneys cultured in the presence of Dact1 siRNA, Dact1 is knocked down and 
Foxd1 might be turned on (magenta ball). This eventually leads to a wider 
nephrogenic zone. The value and ‘+’ are simply to indicate the possible relative 
expression levels of both genes. 
 
Another interesting question is whether Dact1 is involved in the retinoid-mediated 
stromal differentiation. Retinoids have been shown to modulate embryonic 
differentiation and cell identity determination (Means and Gudas, 1995). They are 
also involved in epithelial differentiation in mammalian developing kidneys (Gilbert, 
2002; Moreau et al., 1998). In chapter 3 and 4, I have shown that Dact1 was 
normally expressed by the differentiated medullary stroma (Figure 3-9) and this 
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expression pattern was further enhanced by the exogenous ATRA in organ culture 
(Figure 4-1 and 4-2), it might be possible that ATRA upregulate the Dact1 
expression in subsets of mesenchymal cells, which in turn differentiate into the 
medullary stroma. Difficulties in experiments for this hypothesis may lie in the 
choosing of the appropriate medullary stroma marker. According to the expression 
patterns, candidate markers may include the transcription factor Pod1 (Quaggin et al., 
1999) and the stromal nidogen extracellular matrix protein Snep (Leimeister et al., 
2004), though the functions of these molecules in developing kidneys are yet to be 
characterised. In addition, these stromal markers on their own could be partner 
proteins that Dact1 work with to control stromal development. This will also be a 
new area to be explored. 
 
8.2.3 Can Dact2 control cell migration through TGFβ signalling pathway? 
 
In this project, I have shown that Dact2 is required for the collective migration of 
collecting duct cells (described in details in section 7.3.3). An intriguing question 
following this result is to identify the intracellular signalling pathway in which Dact2 
is involved in regulating the migration of collecting duct cells. Implications from the 
MDCK cell wound healing model, including potential proteins with which Dact2 
may work, have been discussed in section 7.4.2. In addition, as DACT2 has been 
shown to antagonise Nodal activity by promoting the degradation of ALK4 and 
ALK5 receptors (Zhang et al., 2004), it will be interesting to explore whether Dact2 
controls cell migration through this pathway. TGFβ1 signals through ALK4 (Figure 
1-4) and has been shown to inhibit the migration of human proximal tubular cells 
(Tian and Phillips, 2003). This may suggest a hypothesis that Dact2 silencing 
enhances the inhibitory effect of TGFβ1 on the migration of renal epithelial cells. 
Although Dact2 has been shown to antagonise Nodal activity in zebrafish, Nodal is 
not an ideal pathway to investigate until its expression in the developing kidneys is 
confirmed (as reviewed in section 1.4.3). 
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8.2.4 Is Dact2 required for normal branching morphogenesis? 
 
The promising observation that Dact2-depleted cells formed more jagged cysts in 3D 
tubulogenesis model suggested a role for Dact2 in branching morphogenesis. 
Analysis of the markers for each surface domain of epithelial cells in cysts will offer 
valuable information on the function of Dact2 in this tubulogenesis model (as 
discussed in the section 7.4.3). Furthermore, TGFβ1 is proved to inhibit UB 
branching in kidney organ culture (Bush et al., 2004; Ritvos et al., 1995) and is able 
to inhibit mIMCD-3 cells to branch in the 3D culture system (Sakurai and Nigam, 
1997). Complementary to the wound healing assay on the Dact2 and TGFβ1-ALK4 
pathway, it would be sensible to use the 3D tubulogenesis model to test whether 
Dact2 silencing increases the cellular sensitivity to TGFβ1 when the branching is 
being inhibited. Besides, if new methods (discussed in section 6.4.3) can offer better 
delivery of siRNA into kidney organ culture, experimenters will then be able to look 
for the embryonic kidney phenotype when Dact2 is silenced. Alternatively, 
generation of Dact2 mutant mice will offer considerable insights into the functional 





In summary, this thesis characterised the expression patterns of Dact1 and Dact2 in 
embryonic and postnatal mouse kidneys. The functions of both genes were 
investigated in various model systems. Dact1 was expressed by the metanephric 
mesenchyme followed by the medullary stroma. It acted as a negative regulator of 
cell proliferation in 2D cell culture. It also seemed to be a negative regulator of UB 
branching in kidney organ culture but did not affect nephrogenesis. Dact2 was 
expressed exclusively by the ureteric buds. It was required for the collective 
migration of renal epithelial cells. Silencing of Dact2 seemed to generate more 
jagged cysts in the 3D tubulogenesis model. More work is required to investigate the 
underling mechanisms of the phenotypes observed and explore more functional roles 




Now may be the time to review the question list raised in section 1.6. Apparently this 
thesis answered some of these important questions. The remaining questions on the 
list and some interesting questions followed this study, which have already been 
discussed in this thesis, will be the future plans for the investigation of Dact genes in 
mammalian kidney development. I would use Table 8-1 as a summary of this thesis 
and the future plans. 
 
Table 8-1 Summary of this thesis and the future plans.  
1. When, where and how are Dact genes expressed in developing kidneys? 
Answer: described in chapter 3.   
 
2. What developmental events of kidney development are Dact genes involved? 
(a) UB induction (c) Nephron induction 
(b) UB branching (d) Nephron differentiation 
 (e) Stromal development 
Answer: b for Dact1; others need to be tested in the future.  
 
3. What cellular events are modulated by Dact genes? 
(a) proliferation (c) migration 
(b) apoptosis (d) differentiation 
Answer: (a) for Dact1 and (c) for Dact2 in this thesis.  
 
4. What are the possible signalling pathways that Dact genes are involved in 
regulating kidney development? 
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